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PRL Prolactin 
PTEN Phosphatase and tensin homolog 
PVA Polyvinyl alcohol  
PVP Polyvinyl pyrrolidone  
Raf/Ras Protein superfamily 
RNA Ribonucleic acid 
rt Room temperature 
RT- Reverse transcriptase negative 
RTKs Receptor tyrosine kinases 
   
 
 
  
RT-PCR Reverse Transcription and Polymerase Chain Reaction 
s.e.m. Standard error of the mean 
SCC Side chain cleavage 
SCF Stem cell factor. 
SDF-1 Stromal derive factor-1  
SDF-1   Stromal derive factor-1  
SMAD Intracellular proteins 
StAR Steroidogenic acute regulatory protein 
STAT Signal transducers and activators of transcription 
TACE/ADAM Tumor necrosis factor-alpha converting enzyme 
TCM-199 Tissue culture medium 199 
TE Trophectoderm 
TGF Transforming growth factor 
TM Transmembrane domain 
TNFR Tumour necrosis factor receptor 
TRAIL TNF-related apoptosis-inducing Ligand 
TUNEL Terminal deoxynucleotidyl transferase dUTP nick end labeling 
TZP Transzonal projection 
UK United Kingdom 
v/v Volume/volume 
VEGF Vascular endothelial growth factor 
wt/vol Weight/volume 
ZP Zona pellucida 
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Among non-primate species, guinea pig (Cavia porcellus) is used as a laboratory animal 
since the late 18th century and remains an essential species in many areas of research. 
It is an excellent animal model for the study of reproduction in humans and domestic 
animals because of spontaneous ovulation and active corpora lutea, long gestation 
period and type of placenta. As in woman, guinea pigs have small to medium-sized 
litters, low ovulation rate and only few preimplantation embryos can be obtained from 
one female. Similarly, the immature resting oocytes in the guinea pig ovary are on the 
true diplotene stage as in women and they are more sensitive to ionic radiation than mice 
oocytes. Therefore, some studies have suggested that guinea pig may represent an 
alternative animal model than mice for investigations on ovarian infertility in women that 
show premature ovarian failure as a consequence of radiotherapy. In this sense, it is 
widely known that the insulin like growth factor (IGF-1) and epidermal growth factor 
(EGF) are implied in the regulation of many ovarian processes throgouth their receptors. 
EGF and its receptor (EGF-R) are involved in the ovulation process, oocyte maturation, 
steroidogenesis of follicle and luteinization of corpus luteum in humans and animal 
species. In addition, Insulin-like growth factor-1 (IGF-1) system plays an important role 
in the regulation of ovarian folliculogenesis, steroidogenesis and apoptosis prevention 
and is luteotropic in corpus luteum and promotes early embryo development. 
Firthermore, the gene expression of IGFs and their binding proteins (IGFBPs) differ from 
women with normal ovaries and those with polycystic ovary syndrome (PCOS). 
 
Nowadays, animal models for the study of ovarian physiology in relation with these 
growth factors and this syndrome are lacking but there is clear evidence that the role of 
the EGF and IGF system in relation to follicular health needs to be further investigated. 
Both systems are important for the normal function of the ovary in animals and human. 
However, no studies in guinea pig model exist in relation with the effect of both EGF and 
IGF-1 systems in the ovary and the quality of the oocytes. For these reasons, the 
characterization of EGF and IGF-1 system in the guinea pig ovary could be an approach 
to establish a suitable model for the study of mechanisms of ovarian health that can help 
to elucidate ovarian failure process derived of imbalance in these growth factors. 
 
In this context, the development of in vitro follicle culture and in vitro oocyte maturation 
systems in the guinea pig seems to be necessary to provide an in vitro model to study 
the effect of EGF and IGF system in the ovarian physiology and to improve IVM systems 
in human Assisted Reproductive Tecnologies (ARTs) and in the guinea pig. By this way, 
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we can also considerably reduce the number of animals required in the lab and subjected 
to hormonal treatments to obtain Metaphase- II (M-II)-oocytes in vivo by replacing them 
with in vitro alternatives and avoiding the application of hormonal treatments. Besides, 
IVM system could be a important biothecnology for conservation of genetic pool of 
valuable guinea pig strains for their socioeconomic value in some Andean countries due 
to the poor results in superstimulation protocols in this species. Although some 
investigations of follicular development have been accomplished, IVM protocols are 
rarely developed in the guinea pig model, and cellular mechanisms that occur during 
oocyte maturation are unknown in this specie.  
 
Therefore, main goals of the present PhD work were: 1) to characterize the EGF and the 
IGF-1 systems in different structures of the guinea pig ovary and; 2) to study the effect 
of both growth factors (EGF and IGF-1) supplemented in vitro on oocyte maturation. All 
these objectives would lead to the stablishment of a useful animal model for the study of 
both systems in ovarian physiology and the setting up of an in vitro defined maturation 
system based in the supplementation with EGF and IGF-1 useful in this specie as a 
souce of M-II- oocytes for ARTs improvement. 
 
The first experiment include two studies carried out to investigate mRNA (messenger 
ribonucleic acid) expression of candidate genes ((EGF, EGF-R, IGF-1, IGF-1R (Insulin-
like growth factor-1 Receptor), IGFBPs)) in different ovarian structures, and after that in 
cumulus-oocyte complexes (COCs) in order to describe the differential expression 
pattern of mRNA encoding for such genes. For this objective, a total of 26 ovaries from 
adult animals were used. Antral and preovulatory follicles as well as corpus luteum were 
mechanically isolated to study the gene expression of candidate genes in each structure 
per separate (Experiment 1.a) by RT-PCR (Reverse Transcription and Polymerase 
Chain Reaction). The gene expression of a total of 73 oocytes and their corresponding 
cumulus cells (CCs) separately were also evaluated (Experiment 1.b) by the same 
technique.  
 
The Experiment 1.a. clearly demonstrated that mRNA for all candidate genes were 
expressed in the main ovarian structures involved in the final oocyte growth and 
maturation, such as antral and preovulatory follicles, and in the early embryo 
development, such as corpus luteum. Therefore, this Thesis demonstrates that the 
guinea pig ovary differentially expressesall the constituents of EGF and IGF-1 system 
included the six IGFBPs. Then, in the ovary the highest expression levels of EGF, EGF-
R and IGF-1 and IGF-1R was showed in antral follicle compared to preovulatory follicle. 
 Summary 
III 
 
The relative mRNA expression of the IGFBP-1, 2 and 4 was significantly increased in 
the preovulatory follicles whereas IGFBP-3 and 5 were higher in antral follicle. The 
mRNA transcripts for IGFBP-6 showed similar gene expression among them. These 
results indicate that IGFBPs may be modulating the IGF-1 function in antral follicle and 
preovulatory follicle modulating IGF-1 bioavaibility. Corpus luteum showed diferentially 
expression being higher for EGF-R, IGF-1R and IGFBP-1 and 2 compared with the gene 
expression in preovulatory follicle. In current work, there were found mRNA transcripts 
for all IGFBPs but gene expression was found greater for IGFBP-1 and 2, whereas the 
rest of IGFBPs, showed lower mRNA transcripts compared with the follicles. These 
findings evidenced that, EGF and IGF-1 system modulate the antral follicle and 
preovulatory follicle development and the corpus luteum function by an autocrine and 
paracrine mechanism of action in the guinea pig ovary, since all structures studied have 
the ability to express both growth factors, their receptors and the IGFBPs in different 
levels. The highest gene expression of EGF and EGF-R, and IGF-1 and IGF-1R in antral 
follicle could be showing that this system can be particularly involved in the selection of 
the dominant follicle and adquisition of oocyte competence in the guinea pig model.  
 
In the COCs (Experiment 1.b) the results showed that mRNA transcripts of all candidate 
genes were significantly higher in the oocytes than in CCs, except for IGF-1R and 
IGFBP- 5.The expression of IGFBP-6 was found similar in oocytes and CCs. This may 
suggest an important bidirectional communication between the oocyte and their CCs 
throgout this system and a key regulatory role of the IGFBPs in the IGF-1 availability. 
Our results suggest that cumulus cells respond to IGF-1 more than the oocyte since CCs 
showed a higher IGF-1R gene expression and lower mRNA transcripts for the majority 
of the IGFBPs. In fact, low levels of IGFBPs in CCs can be explained by the interaction 
of IGF-1 with follicle-stimulating hormone (FSH) and their role in steroidogenic production 
by CCs. Our results indicate that both isolated oocytes and their CCs can directly 
respond to EGF and IGF-1 throughout their receptors and that the IGF-1 action can be 
greatly modulated by IGFBPs in the COCs, since they can express mRNA transcripts for 
all IGFBPs. Therefore, these finfdings corroborate the implication of both systems in 
oocyte maturation in the guinea pig. 
 
Once gene expression study was performed, the aim of the second experiment was to 
localize in the ovary and in the COCs the receptor of EGF and IGF-1 to confirm if all 
structures studied respond to both growth factors. Besides, we immunolocalized all 
IGFBPs described above to verify the possible implication of those IGFBPs in the 
modulation of IGF-1 function during foliculogenesis, early luteal function, oocyte 
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maturation and early embryo development.  
 
Therefore, in Experiment 2.a. a total of 18 ovaries were used and 20 sections was 
analyzed for EGF-R and IGF-1R and a total of 12 ovaries and 288 sections for the 
IGFBPs. The ovarian follicles were classified as primordial, primary, secondary and 
antral follicle according to the morphology of the follicular cells. The intensity of 
immunohistochemical staining was graded as follows: (–) no immunostaining; (+) weak 
staining; (++) moderate staining and (+++) strong staining. The immunohistochemistry 
results in the ovary confirmed that EGF-R, IGF-1R and IGFBPs 1-6 were widely and 
differentially immunolocalized in primordial, primary, secondary and antral follicle, and in 
corpus luteum in guinea pig. 
 
EGF-R and IGF-1R were immunolocalized with stronger intensity in granulosa cells and 
oocytes of antral follicle that confirms the findings of the gene expression study for both 
receptors. IGF-1R showed stronger immunostaining also in early follicles, which could 
be indicating that although both growth factors are implicated in the follicular 
development and oogenesis, probably IGF-1 is exerting a key role also in the earlier 
stages of folliculogenesis. However, further studies are needed to corroborate this 
hypothesis. In this sense, follicles at all stages of development also exhibited 
immunoreaction of each IGFBPs studied. All IGFBPs were distributed in all follicular 
compartments (granulosa and theca cells and oocyte) and in corpus luteum, although 
diferential intensity was evidenced. In general lines, all the IGFBPs except IGFBP-1 and 
2 showed moderate to weak signal in all follicular structures (oocytes, granulosa cells, 
theca cells) and in all follicular stages included antral follicle. In contrast, IGFBP- 2 
showed high immunostaining in the granulose cells of all follicular stages, whereas the 
IGFBP-1 signal decreased when the follicles achieved the antral stages. These findings, 
suggests the influence of EGF and IGF-1 in the follicular development in the guinea pig. 
It can confirm that the important role noted for IGF-1 in the earlier stages of follicle 
development can be differently modulated by the IGFBPs, and especially by the IGFBP-
2, since it showed the most intense signal in the granulose cells in all stages of the 
follicular development. 
 
In corpus luteum stronger intensity was found for EGF-R and IGF-1R as well as for 
IGFBP- 2 and 3, whereas signal was moderate and weak for the rest of IGFBPs studied. 
These findings indicate the key role in luteal function and angiogenesis for IGF-1 and 
EGF probably by enhancing progesterone (P4) production on luteal cells of guinea pig 
as has been demonstrated by in other mammals. 
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In COCs indirect immunofluorescence assays carried out in Experiment 2.b. showed 
that EGF-R and IGF-1R were present in immature and in vitro matured oocytes and CCs. 
Both of them were detected in the cellular membrane but signal was significantly higher 
after maturation. These findings match with the mRNA results obtained in the first 
experiment of this Thesis, and confirm that the COCs of guinea pig can respond to EGF 
and IGF-1 throughout their receptors in a paracrine and autocrine manner during oocyte 
maturation process. Fluorescence signal was also found for all the IGFBPs in the cell 
membrane of both oocytes and CCs. Oocytes showed lower intensity for IGFBP- 3 and 
6 compared with their CCs whereas in CCs IGFBP-1, 4 and 5 fluorescence was higher. 
Therefore, these results indicate that IGFBPs seems to be implicated in the modulation 
of the action of IGF-1 between the oocyte and CCs since all IGBBPs proteins were 
localized in both of them. However, are needed more investigations to study the 
differences found between the gene expression and immunofluorescence study of 
IGFBP-2, 3, 5 and 6 in the COCs of guinea pig. 
 
In this experiment, and taking account that the EGF and IGF-1 system can be acting on 
the steroidogenic function of the corpus luteum, and therefore indirectly affect the early 
embryo development, we also decided to check if the EGF and IGF-1 system could also 
be involved directly on the early embryos. Therefore, the inmunolocalization of both 
receptors was studied in early embryos of guinea pig. A total of 23 females were used. 
Ovulation was confirmed by the presence of a mucous plug in the vagina and by means 
of vaginal smears. Embryos were recovered at day 2, 3 and 4 after the formation of 
mucous plug by flushing of the reproductive tract and classified as: 2 to 4-cells embryos, 
8 to 16-cells embryos and morula. EGF-R and IGF-1R immunofluorescence was 
observed in the cell membrane of the blastomeres in all embryo stages. The intensity of 
the signal was temporally increased through preimplantation embryo development. 
These findings imply that both growth factors could be directly regulating the early 
embryo development throgouth their receptors in guinea pig. 
 
On the other hand, set up an IVM protocol as an alternative method in this specie to the 
unsuccessful gonadotropin treatments for superovulation will be helpful; besides, it will 
be a procedure to obtain large numbers of M-II-oocytes in vitro for biomedical research 
applications in ARTs. However, find an IVM medium results a complex process given 
that every laboratory uses different methods and additives. Gonadotropins are the 
primary regulators of oocyte maturation, but taking account the results of the first and 
second experiments of this Thesis, in absence of hormones, EGF and IGF-1 could be 
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good candidates to be used in free-serum IVM systems in the guinea pig. Use of defined 
medium is highly desirable in ARTs as well. As a consequence, in Experiment 3 we 
studied the direct effect of the EGF and IGF-1 on oocyte in vitro maturation in the guinea 
pig. Nevertheless, due to the lack of knowledge about the processes involved in the 
cytoplasmic maturation in guinea pig oocytes, fistly we characterized some cytoplasmic 
markers to stablish the cellular patterns that occur in guinea pigs during their maturation 
and to set the basis that improves IVM protocols in this specie.  
 
In this sense, migration of cortical granules and redistribution of mitochondria are 
necessary events for the oocyte to acquire the capability to support fertilization and early 
embryonic development. Hence, in the Experiment 3.a. we characterized, by the first 
time in the guinea pig, the compatible cortical granules and mitochondrial migration 
patterns related with the oocyte cytoplasmic maturation. After that, we studied a possible 
defined- non hormonal IVM medium using EGF and/or IGF-1 (Experiment 3.b., 3.c., 
and 3.d.) assessing: M-II rate, cytoplasmic oocyte maturation, in terms of cortical 
granules migration and mitochondrial relocation, apoptosis rate and; estradiol (E2) and 
P4 production by the COCs as a possible indirect way to determine the quality of COCs 
after IVM. The viability of CCs as well as their steroidogenic ability is essential in the 
acquisition of the oocyte competence during maturation. 
 
For the study of the cortical granules and mitochondrial patterns we used immature and 
in vitro matured oocytes. The results showed that cortical granules migrated to the 
periphery were the main pattern observed in the oocytes after IVM whereas in immature 
oocytes homogeneous distribution of cortical granules was prevalent. It has sense 
because cortical granules positioned under the plasma membrane of the mature oocyte 
prevent polyspermy; also is related to oocyte competence and to its capacity to be 
fertilized and to maintain viable early embryo development. Then, the cortical granules 
patterns defined for the guinea pig were: 1) non-migrated, in which the cortical granules 
appeared distributed throughout the cytoplasm (considered non- cytoplasmically 
matured); 2) partially migrated in which most of the cortical granules spread throughout 
the cortical area and; 3) migrated, in which cortical granules appeared adjacent to the 
plasma membrane (considered cytoplasmically matured). Regarding with the 
mitochondrial oocyte patterns characterized, our findings showed that mitochondria 
migrated to the periphery in the most of the oocytes after IVM, whereas in immature 
oocytes homogeneous distribution was prevalent. Therefore, the mitochondrial patterns 
defined for the guinea pig were: 1) non-migrated, where the mitochondria were 
homogeneously distributed throughout the cytoplasm (considered non-cytoplasmically 
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matured); 2) partially migrated, where the mitochondria were heterogeneously 
distributed with granular aggregations and; 3) migrated, when the mitochondria were 
relocated to the nuclear pole (considered cytoplasmically matured).  
 
After that and to assess the possible effect of EGF and IGF-1 on the oocyte maturation 
in the guinea pig, a dose response experiments were performed as follows. A total of 
1746 COCs were used in three experiments and each experiment was repeated four 
times.  
 
In Experiment 3.b., COCs were IVM with 0, 10, 50, 100 ng/mL (nanograms/milliliter) 
EGF or 10% Fetal Calf Serum (FCS). The results showed that supplementation with 50 
ng/mL of EGF in maturation media improved M-II rate and cytoplasmic maturation, both 
in terms of CG migration and mitochondrial redistribution; besides the quality of CCs 
seemed to be enhanced, since lower apoptotic rate and higher E2 and P4 secretion by 
COCs were found.  In Experiment 3.c., COCs were IVM with 0, 50, 100, 200 ng/mL IGF-
1 or 10% FCS. Higher rates of M-II and CGs periphericlly located in oocytes, greater 
amounts of E2 and P4 released by COCs and lower index of apoptosis in CCs were found 
when 100 ng/mL IGF-1 were added to the maturation media. Both experiments 
corroborate that COCs respond to EGF and IGF-1 directly throughout their 
corresponding receptors and that both growth factors improve the oocyte maturation, 
steroidogenic response and the viability of the CCs. Therefore, these results suggest 
that the use of both growth factors appear to be as a suitable option to use in the IVM 
medium in the guinea pig specie. 
 
In Experiment 3.d., 500 COCs were supplemented with the concentrations of EGF and 
IGF-1 that showed the best maturation results in experiments 3.b., and 3.c., (50 ng/mL 
EGF and 100 ng/mL IGF-1), with or without FCS as follows: group 0 (non- 
supplemented); group EI (EGF + IGF-1); group EI-FCS (EGF + IGF-1 + 10% FCS) and 
group FCS (10% FCS). As we expected, the addition of both growth factors together with 
FCS improved nuclear maturation, CG migration rate in oocytes, steroid-level secretion 
of COCs, and reduced apoptotic index in CCs compared to those COCs in vitro- matured 
without growth factors. The interaction between growth factors and CCs can modify 
steroid production, which indirectly affects oocyte maturation and proliferation of CCs. 
Surprisingly, both growth factors together did not exert a synergic effect on oocyte 
maturation compared when they were added alone. Moreover, no significant 
improvements were found in mitochondria patterns as well as occurred in experiment 
3.c. in which only IGF-1 was added. The cellular and molecular mechanisms by which 
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IGF-1 alone or together with EGF influences on mitochondrial migration are unknown for 
any specie. The apoptotic rate of COCs in the group supplemented with both growth 
factors together with FCS was lower compared to the rate obtained in COCs cultured 
with 50 ng/mL EGF or 100 ng/mL IGF-1 alone but no significant differences were found 
among groups.  
 
Therefore, based on our results, the use of 50 ng/mL EGF appears to be the better option 
to use in the IVM medium in the guinea pig specie. However, 100ng/mL IGF-1 could be 
also a suitable defined medium, since the percentage of mitochondrial migrated was 
quite well. Therefore, in the guinea pig model serum free in vitro maturation systems with 
EGF or IGF-1 alone could provide similar oocyte maturation rates than those that used 
FCS.  
 
In conclusion, this Thesis has characterized the EGF and IGF-1 sytems in guinea pig 
ovary, COCs and early embryos establishing the posible role of EGF and IGF-1 system 
in the follicle development, oocyte maturation, luteogenesis and early embryo 
development in an autocrine a paracine manner. These findings provide the first 
evidence that both growth factors could be involved in the regulation of ovarian 
physiology in the guinea pig model. In this line, we evidencied the beneficial effect of 
supplementation of both growth factors in vitro on oocyte maturation, thus stablishing a 
valuable system for oocyte maturation in a defined medium for the guinea pig. 
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Entre las especies no primates, la cobaya (Cavia porcellus) se utiliza como animal de 
laboratorio desde finales del siglo XVIII en muchas áreas de investigación. Además, es 
un buen modelo animal para el estudio de la reproducción en humanos y animales 
domésticos debido a su ovulación espontánea, cuerpo lúteo activo, largo período de 
gestación y tipo de placenta. De manera similar a la mujer, la cobaya tiene un tamaño 
de camada pequeño y baja tasa de ovulación, de tal forma que solo unos pocos 
embriones preimplantacionales pueden ser obtenidos de una hembra. Así mismo, los 
oocitos inmaduros en reposo en el ovario de la cobaya se encuentran en la etapa de 
Diplotene como en la mujer, y son más sensibles a la radiación iónica que los oocitos 
de ratones. Por lo tanto, algunos estudios han sugerido que la cobaya puede representar 
un modelo animal alternativo para las investigaciones sobre infertilidad ovárica como 
consecuencia de la radioterapia. En este sentido, el factor de crecimiento similar a la 
insulina (IGF-1) y también el factor de crecimiento epidérmico (EGF) están implicados 
en la regulación de muchos procesos fisiológicos ováricos a través de la unión con sus 
receptores. Así, el EGF y su receptor (EGF-R) regulan la ovulación, la maduración del 
oocito, la esteroidogénesis del folículo y la luteinización del cuerpo lúteo en humanos y 
en distintas especies animales. Además, el factor de crecimiento similar a la insulina tipo 
1 (IGF-1) juega un papel importante en la regulación de la foliculogénesis ovárica, en la 
esteroidogénesis, en la prevención de la apoptosis; es luteotrópico en el cuerpo lúteo y 
promueve el desarrollo embrionario temprano. Además, la expresión génica del EGF, 
IGF-1 y sus proteínas de unión (IGFBPs) difieren de las mujeres con ovarios normales 
y de aquellas que tienen el síndrome de ovario poliquístico (PCOS, Polycystic Ovarian 
Syndrome).  
 
Actualmente, los modelos animales para el estudio de la fisiología ovárica son escasos, 
pero hay evidencias claras de que el papel del sistema EGF e IGF en relación con la 
salud folicular necesita ser investigado más a fondo ya que ambos sistemas son 
importantes para la función normal del ovario en animales y humanos. Sin embargo, no 
existen estudios en el modelo de la cobaya en relación con el efecto de ambos sistemas 
EGF e IGF-1 en el ovario y la calidad de los oocitos. Por estas razones, la 
caracterización del sistema del EGF y del IGF-1 en el ovario de cobaya podría ser un 
enfoque para establecer un modelo adecuado para el estudio de la fisiología ovárica, 
que pueda ayudar a elucidar el proceso de fallo ovárico derivado del desequilibrio en 
estos factores de crecimiento. 
 
En este contexto, el cultivo folicular in vitro y el desarrollo de sistemas de maduración in 
vitro (IVM, In vitro maturation) de oocitos en la cobaya son biotecnologías importantes a 
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desarrollar en estas especies para estudiar el efecto del sistema del EGF y del IGF-1 en 
la fisiología ovárica y para mejorar los sistemas IVM en las tecnologías de reproducción 
asistida (ARTs, Assisted Reproductive Techniques) en humana y en la cobaya. De esta 
manera, también podemos reducir considerablemente el número de animales 
requeridos en el laboratorio y sometidos a tratamientos hormonales in vivo para obtener 
oocitos en metafase II (M-II), reemplazándolos con alternativas in vitro y evitando la 
aplicación de tratamientos hormonales. Además, la IVM podría ser una biotecnología 
importante para la conservación de la reserva genética de valiosas cepas de cobayas, 
por su valor socioeconómico en algunos países andinos, debido a los pobres resultados 
en los protocolos de súper-estimulación que se obtienen en esta especie. Sin embargo, 
los protocolos de IVM raramente se han desarrollado en la cobaya y los mecanismos 
celulares que ocurren durante la maduración del oocito son desconocidos en esta 
especie. 
 
Por lo tanto, los principales objetivos del presente trabajo doctoral fueron: 1) caracterizar 
el sistema del EGF y del IGF-1 en diferentes estructuras del ovario de la cobaya y; 2) 
estudiar el efecto de la suplementación de ambos factores de crecimiento (EGF e IGF-
1) en la MIV de oocitos. Estos objetivos pretenden caracterizar el sistema EGF e IGF-1 
y sentar las bases para utilizar la cobaya como modelo animal útil para el estudio de 
ambos sistemas en la fisiología ovárica, así como establecer un posible sistema de IVM 
basado en la suplementación con EGF e IGF-1 que resulte útil en esta especie. 
 
El primer experimento incluye dos estudios llevados a cabo para investigar la 
expresión de mRNA (messenger Ribonucleic Acid) de EGF, EGF-R, IGF-1, IGF-1R, e 
IGFBPs 1-6 en diferentes estructuras ováricas y en los complejos cúmulo-oocito (COCs, 
cumulus-oocyte complexes) con el fin de describir el patrón de expresión de dichos 
genes. Para este objetivo se utilizaron un total de 26 ovarios de animales adultos. Los 
folículos antrales y preovulatorios y el cuerpo lúteo se aislaron mecánicamente para 
estudiar la expresión génica en cada estructura por separado (Experimento 1.a) 
mediante una reacción en cadena de polimerasa precedida de una retrotranscripción 
(RT-PCR). También se evaluó la expresión génica de un total de 73 oocitos y sus 
correspondientes células del cúmulo (CCs) (Experimento 1.b) utilizando la misma 
técnica. 
 
El experimento 1.a. demostró claramente que el mRNA de todos los genes candidatos 
se expresaba los folículos antrales y preovulatorios, principales estructuras ováricas 
implicadas en el crecimiento y la maduración final del oocito y, en el cuerpo lúteo, cuya 
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producción esteroidogénica esta indirectamente relacionada con el desarrollo 
embrionario temprano. Por lo tanto, esta Tesis Doctoral demuestra que el ovario de la 
cobaya expresa diferencialmente el sistema del EGF e IGF-1, así como las IGFBPs 1-
6. En el ovario, los niveles de expresión más altos de EGF, EGF-R, IGF-1 e IGF-1R se 
evidenciaron en los folículos antrales en comparación con los folículos preovulatorios. 
La expresión relativa de mRNA de las IGFBP-1, 2 y 4 fue superior en los folículos 
preovulatorios, mientras que las IGFBP-3 y 5 fueron mayores en los folículos antrales. 
Los transcritos de mRNA para la IGFBP-6 mostraron una expresión génica similar en 
ambos tipos. Estos resultados indican que las IGFBPs podrían regular la 
biodisponibilidad de IGF-1 en los folículos antrales y folículos preovulatorios. En el 
cuerpo lúteo la expresión génica del EGF-R, el IGF-1R y las IGFBP-1 y 2 fue superior 
en comparación con la expresión génica de los folículos preovulatorios. Se encontraron 
transcritos de mRNA para todas las IGFBPs aunque la expresión génica fue mayor para 
las IGFBP-1 y 2, mientras que para el resto de las IGFBPs se encontraron menores 
cantidades de mRNA en comparación con los folículos. Estos hallazgos evidenciaron 
que los sistemas EGF y del IGF-1 pueden estar implicados en la regulación del 
desarrollo folicular en los estadios antral y preovulatorio y en la función del cuerpo lúteo 
por un mecanismo de acción autocrino y paracrino, ya que todas las estructuras 
estudiadas tienen la capacidad de expresar ambos factores de crecimiento, sus 
receptores y las IGFBP 1-6 en diferentes niveles. El incremento en la expresión génica 
del EGF, IGF-1 y de sus receptores en los folículos antrales podría demostrar que este 
sistema está particularmente involucrado en la selección del folículo dominante y en la 
adquisición de la competencia de oocitos en la cobaya.  
 
En los COCs (Experimento 1.b) los resultados mostraron que los transcritos de mRNA 
de todos los genes candidatos eran significativamente más altos en los oocitos que en 
las células del cúmulo (CCs, Cumulus cells), excepto para IGF-1R e IGFBP-5. La 
expresión de IGFBP-6 fue similar en oocitos y CCs. Esto puede sugerir que existe una 
importante comunicación bidireccional entre el oocito y sus CCs, a través de estos 
factores de crecimiento y sus receptores, y un papel regulador clave de las IGFBPs en 
la biodisponibilidad del IGF-1 y su efecto en el oocito. Las CCs podrían ser más 
receptivas a la acción del IGF-1 que el oocito ya que muestran una mayor expresión 
génica de su receptor y pero menor para la mayoría de la IGFBPs. De hecho, los 
menores niveles de mRNA de las IGFBPs en las CCs pueden estar relacionados con la 
interacción de IGF-1 con hormona folículo estimulante (FSH, Follicle-Stimulating 
hormone) y su papel en la producción de esteroides por las CCs. Por lo tanto, nuestros 
resultados indican que tanto los oocitos aislados como sus CCs pueden responder 
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directamente al EGF y al IGF-1 a través de sus receptores y que la acción de IGF-1 
puede ser modulada en gran medida por IGFBPs en los COCs, ya que pueden expresar 
transcritos de mRNA para todas las IGFBPs. Por lo tanto, estos resultados corroboran 
la implicación de ambos sistemas en la maduración de los oocitos de cobaya. 
 
Una vez realizado el estudio de expresión génica, el objetivo del segundo experimento 
fue localizar en el ovario y en los COCs el receptor del EGF y del IGF-1 para confirmar 
que todas las estructuras estudiadas respondían a ambos factores de crecimiento. 
Además, se immunolocalizaron todas las IGFBPs descritas anteriormente para verificar 
la posible implicación de las IGFBPs en la modulación de la función del IGF-1 durante 
la foliculogénesis, la función lútea temprana, la maduración de los oocitos y el desarrollo 
temprano del embrión. 
 
Por lo tanto, en el Experimento 2.a. Se utilizaron un total de 18 ovarios y se analizaron 
20 secciones para cada receptor de los factores de crecimiento (EGF-R e IGF-1R) y un 
total de 12 ovarios y 288 secciones para las IGFBPs 1-6. Los folículos ováricos se 
clasificaron como folículos primordiales, primarios, secundarios y antrales según la 
morfología de las células foliculares. La intensidad de la tinción inmunohistoquímica se 
clasificó de la siguiente manera: (-) no inmunoticción; (+) tinción débil; (++) tinción 
moderada y (+++) tinción fuerte. Los resultados de la inmunohistoquímica en el ovario 
confirmaron que el EGF-R, el IGF-1R y las IGFBPs 1-6 estaban amplia y 
diferencialmente inmunolocalizados en folículos primordiales, primarios, secundarios y 
antrales, y en cuerpo lúteo de los ovarios de cobaya. 
 
El EGF-R y el IGF-1R fueron inmunolocalizados con una intensidad elevada en las 
células de granulosa y en los oocitos de los folículos antrales, de acuerdo con los 
hallazgos del estudio de expresión génica para ambos receptores. El IGF-1R también 
mostró una inmunotinción más fuerte en los folículos preantrales, lo que podría indicar 
que, aunque ambos factores de crecimiento están implicados en el desarrollo folicular y 
la oogénesis, probablemente el IGF-1 está también desempeñando un papel clave en 
las etapas tempranas de la foliculogénesis. Sin embargo, se necesitan más estudios 
para corroborar esta hipótesis. En este sentido, los folículos, en todas las etapas del 
desarrollo, también mostraron inmunorreacción para cada IGFBPs estudiadas. Todas 
las IGFBPs se inmunolocalizaron en todos los compartimentos foliculares (oocito, 
células de la granulosa y de la teca) y en el cuerpo lúteo, aunque se evidenciaron 
diferentes intensidades. En líneas generales, excepto la IGFBP-1 y 2, todas las IGFBPs 
mostraron una señal de moderada a débil en todas las estructuras foliculares y en todos 
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los estadios foliculares incluidos los folículos antrales. Por el contrario, la IGFBP-2 
mostró una inmunotinción fuerte en principalmente en las células de la granulosa en 
todos los estadios del desarrollo folicular, mientras que la señal de la IGFBP-1 se redujo 
en las células de la granulosa conforme los folículos aumentaron de tamaño, es decir 
en los antrales. Estos resultados indican la posible influencia del EGF y del IGF-1 en el 
desarrollo folicular. La acción del IGF-1 desde las etapas tempranas de la 
foliculogénesis parece estar regulada de manera diferencial por las IGFBP 1-6, 
especialmente por la IGFBP-2, ya que es la que muestra la señal más intensa en las 
células de la granulosa de todas las etapas. 
 
En el cuerpo lúteo se encontró mayor intensidad para EGF-R e IGF-1R, así como para 
las IGFBP-2 y 3, mientras que la señal para el resto de las IGFBPs fue moderada o 
débil. Estos hallazgos indican el papel clave del IGF-1 y del EGF en la función lútea y 
en la angiogénesis, probablemente aumentando la producción de progesterona en 
células luteales de la cobaya como ha sido demostrado en otros mamíferos. 
 
Los ensayos de inmunofluorescencia indirecta llevados a cabo en el Experimento 2.b. 
demostraron que el EGF-R y el IGF-1R estaban presentes en los oocitos y en las CCs 
de COCs inmaduros y madurados in vitro. Ambos receptores fueron detectados en la 
membrana celular, pero la señal fue significativamente mayor después de la 
maduración. Estos hallazgos coinciden con los resultados del mRNA obtenidos en el 
primer experimento de esta Tesis Doctoral y confirman que los COCs de cobaya pueden 
responder directamente al EGF e IGF-1 a través de sus receptores de una manera 
paracrina y autocrina durante el proceso de maduración de los oocitos. La señal de 
fluorescencia para todas las IGFBPs también se encontró en la membrana celular de 
los oocitos y de las CCs. Los oocitos mostraron menor intensidad para la IGFBP-3 y 6 
en comparación con sus CCs, mientras que en las CCs la fluorescencia de las IGFBP-
1, 4 y 5 fueron mayores. Por lo tanto, estos resultados indican que las IGFBPs parecen 
estar implicadas en la modulación de la acción del IGF-1 entre el oocito y las CCs de la 
cobaya ya que todas las proteínas IGFBPs se localizaron en ambas estructuras. Sin 
embargo, se necesitan más estudios para ahondar sobre las diferencias encontradas 
entre los resultados de la expresión génica y de inmunofluorescencia de las IGFBP 2,3,5 
y 6 en los COCs. 
 
Teniendo en cuenta que los sistemas EGF y del IGF-1 pueden actuar sobre la función 
esteroidogénica del cuerpo lúteo y por lo tanto, afectar indirectamente al desarrollo 
embrionario temprano, en este experimento decidimos comprobar si tanto el EGF como 
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el IGF-1 podrían estar involucrados directamente en el desarrollo embrionario temprano. 
Por lo tanto, la inmunolocalización de ambos receptores fue estudiada en embriones 
tempranos de la cobaya. Se utilizaron un total de 23 hembras para este estudio. La 
ovulación fue confirmada por la presencia de un tapón mucoso en la vagina y por medio 
de frotis vaginales. Los embriones fueron recuperados al día 2, 3 y 4 después de la 
formación del tapón mucoso mediante el lavado del tracto reproductor y fueron 
clasificados como: embriones de 2 a 4 células, embriones de 8 a 16 células y mórulas. 
Se observó inmunofluorescencia para el EGF-R y del IGF-1R en la membrana celular 
de los blastómeros en todos los estadios embrionarios estudiados. La intensidad de la 
señal aumento temporalmente a lo largo del desarrollo embrionario preimplantacional. 
Estos hallazgos implican que ambos factores de crecimiento pueden estar involucrados 
en el desarrollo embrionario temprano de la cobaya a través de sus receptores.  
 
Teniendo en cuenta estos resultados, sería útil instaurar un protocolo de IVM basado en 
la adición de los factores de crecimiento estudiados. De esta manera, la IVM se podría 
utilizar como un método alternativo en esta especie a los tratamientos de superovulación 
con gonadotropinas ya que no ofrecen resultados satisfactorios. Además, sería un 
procedimiento para obtener in vitro un gran número de oocitos en M-II para aplicaciones 
en la investigación biomédica en las ARTs. Sin embargo, encontrar un medio de IVM 
resulta un proceso complejo dado que cada laboratorio utiliza diferentes métodos y 
aditivos. Las gonadotropinas son los principales reguladores de la maduración de los 
oocitos, pero teniendo en cuenta los resultados del primer y segundo experimento de 
esta tesis, en ausencia de hormonas, el EGF y el IGF-1 podrían ser buenos candidatos 
para ser utilizados en sistemas de IVM libres de suero en la cobaya. El uso de un medio 
definido es también altamente deseable en las ARTs. Como consecuencia, en el 
Experimento 3 se estudió el efecto de la suplementación del EGF y del IGF-1 sobre la 
maduración in vitro de oocitos de cobaya. Sin embargo, y dada la falta de conocimientos 
sobre los procesos celulares involucrados en la maduración citoplasmática del oocito de 
la cobaya, consideramos que el primer paso era caracterizar algunos de esos 
marcadores en el oocito para establecer los mecanismos celulares que ocurren en la 
cobaya durante su maduración y como base sobre la cual estudiar los protocolos de IVM 
en esta especie. 
 
En este sentido, la migración de los gránulos corticales y la redistribución de las 
mitocondrias son eventos necesarios para que el oocito adquiera la capacidad para 
apoyar la fertilización y el desarrollo embrionario temprano. Por lo tanto, en el 
Experimento 3.a. caracterizamos por primera vez en la cobaya, los patrones 
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compatibles con la migración de los gránulos corticales y la redistribución de las 
mitocondrias altamente relacionados con la maduración citoplasmática del oocito. 
Después, ensayamos un posible medio de IVM definido y no hormonal usando EGF y/o 
IGF-1 exclusivamente (Experimento 3.b., 3.c., y 3.d.) evaluando: la tasa de M-II y la 
maduración citoplasmática del oocito en términos de migración de los gránulos 
corticales y redistribución mitocondrial. También se estudió la tasa de apoptosis en las 
CCs y la producción de estradiol (E2) y progesterona (P4) por los COCs como una posible 
vía indirecta para determinar la calidad de los COCs después de la IVM, ya que la 
viabilidad de las CCs y su capacidad esteroidogénica son factores esenciales en la 
adquisición de la competencia del oocito durante la maduración. 
 
Para el estudio de los patrones de gránulos corticales y mitocondrias se utilizaron 
oocitos inmaduros y madurados in vitro. Los resultados demostraron que los gránulos 
corticales migrados a la periferia fueron el patrón principal observado en los oocitos 
después de la IVM, mientras que en los oocitos inmaduros se observó una distribución 
homogénea de los gránulos corticales. Estos resultados tienen cierto sentido fisiológico 
ya los gránulos corticales colocados debajo de la membrana plasmática del oocito 
maduro evitan la polispermia, por lo tanto, están relacionados con la competencia del 
oocito y con su capacidad para ser fecundado y para mantener un desarrollo 
embrionario temprano viable. Los patrones de gránulos corticales definidos para la 
cobaya fueron: 1) patrón no migrado, en el que los gránulos corticales aparecieron 
distribuidos en la totalidad del citoplasma y cuyos oocitos fueron considerados no 
madurado citoplasmáticamente; 2) patrón parcialmente migrado, donde la mayor parte 
de los gránulos corticales se extendieron a través del área cortical y; 3) patrón migrado, 
en el que los gránulos corticales aparecieron adyacentes a la membrana plasmática. 
Estos oocitos fueron considerados citoplasmáticamente maduros.  
 
Respecto a la caracterización de los patrones mitocondriales de los oocitos, nuestros 
hallazgos demostraron que las mitocondrias migraron a la periferia en la mayoría de los 
oocitos después de la IVM, mientras que en los oocitos inmaduros fue frecuente 
encontrar una distribución homogénea de las mismas. Por lo tanto, los patrones 
mitocondriales definidos para la cobaya fueron: 1) patrón no migrado, donde las 
mitocondrias aparecieron distribuidas homogéneamente a lo largo del citoplasma y 
cuyos oocitos fueron considerados no maduros citoplasmáticamente); 2) patrón 
parcialmente migrado, donde las mitocondrias se encontraron distribuidas 
heterogéneamente con agregaciones granulares por el citoplasma y; 3) patrón migrado, 
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cuando las mitocondrias fueron redistribuidas en el polo nuclear. Estos oocitos fueron 
considerados citoplasmáticamente maduros. 
 
Después de realizar esta caracterización y para evaluar el posible efecto del EGF e IGF-
1 sobre la maduración de los oocitos en la cobaya, se realizaron experimentos de dosis-
respuesta como se describe a continuación. Un total de 1746 COCs fueron utilizados en 
tres experimentos y cada experimento fue repetido cuatro veces. 
 
En el Experimento 3.b., los COCs fueron MIV con 0, 10, 50, 100 ng/mL de EGF o 10% 
de suero fetal bovino (FCS, Fetal Calf Serum). Los resultados demostraron que la 
suplementación con 50 ng/mL de EGF en el medio de maduración mejoró la tasa de M-
II y la maduración citoplasmática, tanto en términos de migración de los GC y 
redistribución mitocondrial; además la calidad de las CCs parecía mejorar, ya que 
mostraron una tasa de apoptosis menor y se incrementó la secreción de E2 y P4. En el 
Experimento 3.c., los COCs fueron IVM con 0, 50, 100, 200 ng/mL de IGF-1 o 10% de 
FCS. El medio suplementado con 100 ng/mL de IGF-1 produjo las tasas más altas de 
M-II, incrementó el porcentaje de oocitos con granulos corticales localizados en la 
periferia, redujo la tasa de apoptosis en las CCs significativamente y mejoró la secreción 
steroidogénica de los COCs. Ambos experimentos corroboran que los COCs responden 
al EGF e IGF-1 directamente a través de sus receptores correspondientes y que ambos 
factores de crecimiento mejoran la maduración de los oocitos, la respuesta 
esteroidogénica y la viabilidad de las CCs. Por lo tanto, estos resultados sugieren que 
el uso de ambos factores de crecimiento parece ser una opción adecuada para usar en 
el medio de MIV en la cobaya. 
 
En el Experimento 3.d., 500 COCs fueron madurados in vitro utilizando las 
concentraciones de EGF e IGF-1 que mostraron los mejores resultados de maduración 
en los experimentos 3.b. y 3.c. (50 ng/mL de EGF y 100 ng/mL del IGF-1), con o sin 
FCS, como se detalla a continuación: grupo 0 (no suplementado); grupo EI (EGF + IGF-
1); grupo EI-FCS (EGF + IGF-1 + 10% FCS) y grupo FCS (10% al FCS). Como se 
esperaba, la adición de ambos factores de crecimiento junto con FCS mejoró la 
maduración nuclear, la tasa de migración de los granulos corticales en los oocitos, la 
secreción de esteroides de los COCs y redujeron el índice apoptótico en las CCs en 
comparación con los COCs madurados in vitro sin factores de crecimiento. La 
interacción entre ambos factores de crecimiento y las CCs puede modificar la producción 
de esteroides, lo que afecta indirectamente a la maduración del oocito y a la proliferación 
de las CCs. Sorprendentemente, ambos factores de crecimiento juntos no tuvieron un 
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efecto sinérgico sobre la maduración de los oocitos cuando los resultados fueron 
comparados con los que se obtuvieron cuando se añadieron por separado. Además, no 
se encontraron mejoras significativas en los patrones mitocondriales entre los grupos 
experimentales, así como ocurrió en el experimento 3.c. en el que sólo se añadió IGF-
1. Los mecanismos celulares y moleculares por los cuales el IGF-1 solo o junto con el 
EGF influyen en la migración mitocondrial son desconocidos para cualquier especie. La 
tasa apoptótica de los COCs en el grupo suplementado con ambos factores de 
crecimiento y con el FCS fue inferior comparado con la tasa obtenida en los COCs 
cultivados solo con 50 ng/mL de EGF o 100 ng/mL de IGF-1, aunque no se encontraron 
diferencias significativas entre ellos. 
 
Basándose en nuestros resultados, y en nuestras condiciones experimentales, el uso 
de 50 ng/mL de EGF parece ser la mejor opción para el medio IVM en la cobaya. Sin 
embargo, la utilización de 100 ng/mL de IGF-1 no se descarta completamente, ya que, 
aunque no alcanzaron diferencias significativas, el porcentaje de migración mitocondrial 
alcanzado fue bastante bueno. Por lo tanto, nuestros resultados demuestran que con 
los sistemas de maduración in vitro suplementados con EGF o IGF-1, se podrían 
alcanzar tasas de maduración similares a las que se obtienen cuando se usa FCS.   
 
En conclusión, en esta Tesis Doctoral se ha caracterizado el sistema EGF e IGF-1 en el 
ovario de la cobaya, es los COCs y en embriones tempranos, estableciendo el posible 
papel del sistema del EGF y del IGF-1 en el desarrollo folicular, la maduración del oocito, 
la luteogénesis y el desarrollo embrionario temprano de manera autocrina o paracrina. 
Estos hallazgos proporcionan la primera evidencia de que ambos factores de 
crecimiento podrían estar implicados en la regulación de la fisiología ovárica en la 
cobaya. En esta línea, se demostró el efecto beneficioso de la suplementación de ambos 
factores de crecimiento in vitro sobre la maduración del oocito, estableciendo así un 
sistema valioso para la maduración de oocitos en un medio definido sin suero para la 
cobaya. 
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1.1 Guinea pig as an experimental model 
 
The Guinea pig (Cavia porcellus) belongs to Caviidae family (Pritt, 2012). It is a 
hystricomorph rodent originating from South America (Quesenberry, 2004). They were 
first domesticated by the Andean Indians of Peru because they were used as a food 
source and as a sacrificial offering to the Incan Gods (Morales, 1995). Peru and Ecuador 
are the main countries in the Andean region where guinea pig were distributed. 
Nowadays this animal is a good low-cost protein source, especially for the poorest 
population in these regions (Avilés et al., 2014). Also, the guinea pig is involved in folk 
traditions and traditional medicine (Morales, 1995). Therefore, genetic diversity 
conservation of this species is indispensable for their socio economical importance. 
 
Since the late 18th century, guinea pig has been frequently used as a laboratory animal 
(Clemons and Seeman, 2011). Availability of commercial strains and their peaceful 
nature make them a useful research model that has been extensively and historical used. 
Then ‘guinea pig’ has become asynonym of ‘experimental subject’ (Anderson et al., 
2015). They are useful in research of anaphylaxis, asthma, immunology, infectious and 
nutritional diseases, and otology among others (Craig, 1995; Hauser et al., 2005; Yu et 
al., 2017). Despite its important role in laboratory animal science, guinea pig utilization 
has declined dramatically in recent decades. For example, this species was used in 
about 27,000 scientific experiments in the UK (United Kingdom) in 2004, that means<1% 
of total animal research (Dorsch et al., 2008), mainly because mice and rats have 
replaced them. However, in some very specific research the guinea pig continues to be 
a reference model as for example in immunology due to the antigen-macrophage 
interaction similar to humans (Hoff et al., 2011; Larrouy-Maumus et al., 2017).  
 
From a genetic point of view, it is a more suitable model than the mouse or rat since the 
primordial oocytes of guinea pig present at birth a typical diplotene configuration like the 
equivalent stage in women while primordial oocytes from mouse or rat have a dyctiate 
appearance. The pool of primordial oocytes is the most menaced, since they are present 
throughout life and genetic damage from radiation may accumulate for considerable 
periods before entering maturation and being ovulated. Studies have confirmed that 
guinea pig oocyte has high radio-resistance and are suitable for more detailed studies in 
relation to genetic risks (Jacquet et al., 2001), representing one of the best models for 
the genetic hazard of radiation in human (Jacquet et al.,1995). 
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In addition, this species remains essential in reproductive research areas such as 
Artificial Reproductive Technics (ARTs). In this sense, it is the only laboratory rodent with 
a complete estrous cycle, consisting of both follicular and luteal phases that resemble 
those of cows, ewes and pigs and the menstrual cycle in humans. In contrast, most 
laboratory rodents like mice, rats and hamsters exhibit endocrinologically different 
incomplete estrous cycles which lack of functional luteal phases (Suzuki et al., 2003). 
Additionaly to easily defined ovarian cycle and active corpus luteum, the guinea pig is 
also a suitable animal model for the study of reproduction in humans because this 
species presents also long gestation period and spontaneous ovulation (Suzuki et al., 
2003; Carter et al., 2006, Carter, 2007). Pups exhibit mature central system at birth that 
makes them a very pertinent model for studies of teratology, for example in deleterious 
genes that act at different stages of gestation or in congenital diseases (Cardin et al., 
2016). Finally, it has been suggested that in vitro culture of guinea-pig blastocysts can 
serve as a good model for the study of implantation in humans, since the interstitial type 
of implantation and trophoblast formation observed in guinea pigs and women share 
similarities (Verkeste et al., 1998; Mess, 2007).  
 
1.2. Anatomical description of the guinea pig reproductive system 
 
The reproductive system of guinea pig is constituted by a pair of ovaries and oviducts, a 
bicorne uterus, cervix and vagina (Figure 1). 
 
i. Ovary: the ovaries have an ovoid shape and are located in the abdominal cavity, 
near the kidneys between the third and fourth lumbar vertebra. The averaged 
measurements are 7 mm (millimeters) long and 4 mm width. The ovaries surface 
is generally smooth except for the projecting mature follicles during ovulation 
cycles (Grégoire, 2012). 
 
ii. Oviduct: the oviduct collects and transports the mature oocyte (in Methaphase II) 
and the early embryo to the uterine horn and the fertilization process take place in 
there. In the guinea pig the oviducts measuring about 57 mm long and 1.5 mm 
width (Grégoire, 2012). 
 
iii. Uterus: the uterus is bicorne, Y-shaped and consists of two horns which form a 
V. Measuring approximately 37 mm long and 6 mm width (Grégoire et al.,2012). 
Dorsal side is in contact to the rectum and the ventral side is adjoining to the 
intestines and the dorsal side of the urinary bladder. 
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iv. Cervix: the cervix is a portion of the uterus with Y-shape. It´s connected at the 
vagina and consists of a series of small mucosal thickenings extending over the 
side walls to converge ventrally in the center (Grégoire, 2012). Its consistency is 
hard (Popesko et al.,1998). 
 
v. Vagina: is a fibroelastic muscular tube, measuring 3 cm long by 1 cm width 
approximately. It is located in the pelvic cavity related in its dorsal side with rectum 
on its ventral face and body with the neck of the bladder. Features that distinguish 
other rodents and the guinea pig is the presence of an epithelial membrane 
covering the vaginal orifice except in the estrus phase and parturition (Grégoire, 
2012). 
 
vi. Vulva: is an external opening which has inverted Y-shaped. It has an outer 
diameter smaller than that of the cervix and has a thin wall. It joins in the pelvis 
floor and bends ventrally to the area of the ischial arch where it opens to the outside 
through the vaginal opening (Grégoire, 2012). Vulvar hole has recess forming two 
small lips at the bottom of the meatus having a similar appearance to the anal 
sphincter (Popesko et al., 1998). 
 
 
 
Figure 1. Anatomical representation of guinea pig female reproductive tract. Drawing adapted 
from Silverman, 2005. 
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1.3. Ovarian physiology  
 
1.3.1. Estrous cycle: follicular and luteal phase 
 
Guinea pigs are polyestrous animals and ovulate spontaneously (Sisk, 1976). The 
female is sexually mature at about three months old (Stockard and Papanicolaou, 1917). 
The first estrus occurs around 68 days of age (range 33-134 days) (Mills and Reeds, 
1971) and begins the day after ovulation. Estrus have a mean length of 17.5 ± 2.1 days 
(range 15–21 days) (Myers et al., 1936; Hutz et al., 1990; Rocca and Wehner, 2009) 
(Figure 2). The follicular development begins the day after ovulation and consists in two 
waves. The largest follicles of the first wave reach their maximal diameter (500-750 µm) 
at Days 10–11 of the cycle but become atretic because progesterone (P4) are elevated 
and the negative feedback provokes suppression of luteinizing hormone (LH) (Garris and 
Foreman, 1984). The demise of the corpus luteum allows the development of the second 
follicular cohort until ovulation. This wave takes about 6 -7 days; there is a recruitment 
of small follicles (Bland, 1980; Hutz et al., 1990) and a selection of the 3 to 5 largest 
follicles at Day 10. Then P4 concentrations decrease rapidly after Day 12 and it is a clear 
increase in LH levels between 13 and 15 Days (Wisel et al., 1991), which will stimulate 
ovulation. Finally, ovulation occurs at the end of the second wave (Day 17 of the cycle) 
(Logothetopoulos et al., 1995). 
 
 
Figure 2. Estrous cycle of guinea pig. CL: Corpus luteum; FSH: Follicle-stimulating hormone; LH: 
luteinizing hormone.  
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The initial study of the estrous cycle in the guinea pig was done by Stockard and 
Papanicolaou (1917) and Ishii (1920). They identified different phases in the estrous 
cycle that are describes below. Phases can be easily identified by cytological study to 
assess the stage of the cycle: 
 
i. Proestrus: This period maintains for 1-1.5 days. The external genital organs 
become swollen. Rupture of the vaginal membrane and a serous secretion is 
produced (in some instances turbid or viscous), but in the majority of cases is more 
or less transparent. This is followed by the estrus period. Excess of viscous 
transparent liquid secretion during the last 4 or 5 hours (h) of proestrus. 
 
ii. Estrus: Secretion similar than final stage of proestrus continues for 6 or 7 h from 
the estrus period. The vaginal membrane continues open during estrus (2-3 days), 
covering the begining of period sexual behavior and the period of ovulation. Estrus 
lasts 8–11 h. Females exhibit lordosis, with rear quarters elevated and present 
swollen congested vulva and a vaginal membrane perforate (Harper, 1968; 
Phoenix, 1970). To assess the estrous cycle stage, also vaginal impedance 
measurements can be used in this species (Lilley et al., 1997). 
 
iii. Metaestrus: Lasts 3 days and might be considered as the period of recovery of 
the estrus changes. 
 
iv. Diestrus: Lasts 11–12 days and complete the estrous cycle. It is characterized by 
the presence of active corpus luteum that produces P4. Other studies have shown 
that there is an elevation of plasma P4 and estradiol (E2) coincident with this phase 
(Challis et al., 1971; Garris and Foreman, 1984; Hutz et al., 1990). 
 
Some interesting data from this species is that a fertile postpartum estrus occurs 2 to 10 
h post- parturition (Rowlands, 1949; Sisk, 1976). There is not demonstrated evidence of 
cycle synchronization in grouped females (Donovan and Lockhart, 1972; Harned and 
Casida, 1972). 
 
1.3.2. Oogenesis and follicular development 
 
The ovary is a highly organized organ constituted of germ cells (oocytes) and somatic 
cells (granulosa, theca and stromal cells). Main functions comprise endocrine action 
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(steroid biosynthesis) and reproductive function (foliculogenesis and oocyte production). 
Their functional subunits are the follicles that grow from primordial follicle to antral one. 
Oogenesis is the formation, development and maturation of female gametes, that begin 
in the germ cells of fetal ovary (Findlay et al., 2015; Grive and Freiman, 2015). Following 
Deoxyribonucleic acid (DNA) replication, two consecutive rounds ofmeiotic division, 
called Meiosis I (MI) and Meiosis II (MII), begins and reduce chromosomes to generate 
haploid gametes (Cohen and Holloway, 2015). 
 
In guinea pig once the gonad has been formed, the ovogonias undergo a phase of 
interstitial mitotic multiplication and surround themselves with layers of germ cells from 
embryonic stages to sexual maturity. The number of germ cells per ovary increases from 
about 27.000 at the half of gestation period ((30 days post-coitum (p.c.)) up to a 
maximum of 105.000 at 41 days p.c. Further, the initial stock of germ cells undergoes a 
heavy depletion to reach the number of 13.000 to 12-month post-partum (p.p.). This 
decrease is due to the continuous atresia process that affects germinal cells from the 
earliest stages of development and that will be referred below. The ovogenesis process 
ends around the 50th day p.c. There are a large number of oocytes in the leptotene stage 
at 35 days p.c. with zygotene at about 40 days p.c. and pachytene at 50 days p.c. 
Oocytes are in the diplotene stage at birth. This phase of meiosis is blocked until puberty. 
In guinea pig, the period of gonadal division and entry into meiosis takes place before 
the parturition, phenomenon comparable to the woman. The number of oocytes in the 
adult animal ovary is highly dependent on the initial recruitment of the pool of primordial 
follicles (McGee and Hsueh, 2000).  
 
Folliculogenesis is the process of follicular development. Somatic cell types in the follicle 
interact by differents mechanisms promoting follicular growth, oocyte maturation and 
subsequent corpus luteum formation (Richards and Pangas, 2010; El-Hayek and Clarke, 
2016). Below we will describe the most important characteristics of the different follicles 
present in the ovary: 
 
The primordial follicles are consisting of one oocyte enclosed by a single layer of 
squamous granulosa cells and a basal lamina. They are continually recruited during 
reproductive life into the growth phase to produce fertilizable oocytes. Studies 
demonstrated that survival of primordial follicles is maintained through the PI3K 
(Phosphatidylinositol 3-kinase) pathway (Reddy et al., 2005; Liu et al., 2006). They lack 
vascular supply, so nutrition and paracrine signaling occur by diffusion from GC which 
create a close microenvironment. In early stage oocytes and follicles in which follicle-
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stimulating hormone (FSH) receptors are not expressed yet, follicular growth is 
dependent on Kit-Kit ligand (KL) signaling (Albertini and Barret, 2003). Kit exists on the 
surface of oocytes, and KL is produced in the granulosa cells. KL activates the PI3K 
pathway in primordial oocytes, followed by phosphorylation of Akt (protein kinase B) and 
Foxo3a (forkhead box O3A) (John et al., 2008). The FOXO family is a main target of Akt 
and it suppresses the activation of primordial follicles and maintains dormancy by 
promoting pro-apoptotic genes (Reddy et al., 2005). Other studies, also have 
demonstrate phosphatase and tensin homolog (PTEN) plays an inhibitory role in the 
primordial oocyte activation (John et al., 2008; Reddy et al., 2005), and have reported 
successful in vitro activation of mammalian primordial follicles with synthetic PTEN 
inhibitors (Li et al., 2010; Adhikari et al., 2012). By last, granulosa cells -derived anti-
Müllerian hormone mediated dialogue also inhibits follicle activation (Carlsson et al., 
2006). On the other hand, primordial follicle activation is initiated by molecules in 
primordial follicle granulosa cells (Zhang et al., 2014), activated by mTORC1 complex 
(mammalian target of rapamycin complex) (Cheng et al., 2015; Sun et al., 2015; Zhang 
and Liu, 2015) that lead to diferenciation and proliferation of granulosa cells of recruited 
follicles. Transcription of some genes into germ cells such as Folliculogenesis Specific 
BHLH Transcription Factor (FIGLA), Newborn ovary homeobox-enconding gene 
(NOBOX), KL and neurotrophic Receptor Tyrosine Kinase 2 (NTRK2), as well as 
forkhead box protein L2 (FOXL2), kernel independent transport layer (KITL) and nerve 
growth factor (NGF) have also been observed, which are expressed in somatic cells and 
play a critical role during early folliculogenesis (Choi and Rajkovic, 2006). Many growth 
factors play a role as upstream regulators of primordial follicle activation, including 
leukemia inhibitory factor (LIF) (Nilsson et al., 2002), basic ﬁbroblast growth factor (β-
FGF) (Nilsson et al., 2001), platelet-derived growth factor (PDGF) (Nilsson et al., 2006), 
stem cell factor (SCF), stromal derive factor-1 (SDF-1), and bone morphogenetic protein 
4 (BMP-4) (Nilsson and Skinner, 2003; Williams and Erickson, 2014). This growth factor 
network is supported by surrounding stromal cell derived mediators, such a keratinocyte 
growth factor, BMP-4 and BMP-7 (Nilsson and Skinner, 2003). However, mTORC 
provokes KITL secretion in granulosa cells which binds kit in the oocyte so PI3K pathway 
activates, awaking the quiescent oocyte and starting their development.  
 
In primary follicle the oocyte increase in size and the single layer of granulosa cells 
change to cuboidal shape and proliferate mitotically enclosing and surrounding the 
oocyte (Knight et al., 2012; Orsi et al., 2014). The growing oocyte secretes a glycoprotein 
called the zona pellucida (ZP) that assembles into an extracellular layer and physically 
separates the oocyte from the adjacent granulosa cells (El-Hayek and Clarke, 2016). 
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Although follicle growth is gonadotrophin independent in this stage, upregulation of FSH 
receptor expression by the action of granulosa cells is described (Oktay et al., 1997; 
Findlay and Drummond, 1999) and is required for primary follicle development to the 
preantral stage (Oktay et al., 1997). Then, stimulators of FSH receptor expression such 
activin, cyclic adenosine monophosphate (cAMP), and transforming growth factor-beta 
(TGFβ) family, mainly BMP-15 and growth derived factor 9 (GDF 9) are secreted (Findlay 
and Drummond, 1999). In primary follicles, granulosa cells continue to secrete KL, the 
oocyte is transcriptionally active and must generate sufficient proteins and mRNA 
(messenger ribonucleic acid) transcripts to support its own growth as well as oocyte 
maturation, fertilization and early embryo development (Williams and Erickson, 2014). 
The oocyte and granulosa cells come into contact through by intercellular connections 
denominated transzonal projection (TZP), that traverse the ZP and form adherents 
junction between oocyte surface and gap junctions from granulosa cells (Albertini et al., 
2001). Finally, gap junctions, ((formed by connexins (Cx)), established in this area to 
give cell-to-cell contact, facilitate the diffusion of metabolites, ions and signaling 
molecules (Bruzzone et al., 1996). Between the oocyte and GC, gap junctions are form 
by Cx37 synthesized by the oocyte and Cx43 synthesized by the GC (Simon et al., 1997; 
Grazul-Bilska et al., 1997), so in granulosa cells gap junctions are only formed by Cx43. 
 
The next stage of development is the secondary follicle. This is usually situated deeper 
in the ovarian cortex and its development begins with the acquisition of the second layer 
of granulosa cells. Active granulosa cells changes from a simple cuboidal epithelium to 
a stratified or pseudostratified columnar epithelium surrounding the oocyte (Williams and 
Erickson, 2014; Orsi et al., 2014). This granulosa cells makes possible the change of 
nutrients and their transport to the oocyte (Herlands and Schultz, 1984). In addition, 
theca development layer occurs in this phase differentiating into two layers: internal 
theca comprising rounded interstitial cells and external theca, which differentiates into 
smooth muscle cells (Erickson et al., 1985). Theca external development is accompanied 
of the perifollicular vascular development through angiogenesis (Orsi et al., 2014; 
Williams and Erickson, 2014). Secondary follicle can be described by an active 
autocrine/paracrine system which depends of oocyte-derived cytokines (Orsi et al., 
2014). Studies in animal models suggest a crucial role of Growth differentiation factor-9 
(GDF-9) and BMP-15. In its absence follicle growth and development stop at the primary 
stage (Chang et al., 2002). The oocyte not only controls the follicular growth but also its 
own growth (Eppig, 2001; Matzuk et al., 2002). In this phase, the gap junctions continue 
to develop between the granulosa cells for promoting the cellular communication. 
Studies in mice demonstrated that folliculogenesis arrests at the primary/secondary 
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transition in Cx43-deficient animals, so conexins play an indispensable role in secondary 
follicle formation (Juneja et al., 1999). Angiogenesis is also crucial in this phase and is 
promoted by the FGF-β and vascular endothelial growth factor (VEGF) (Brown et al., 
1997). The blood now circulates around the follicle, bringing nutrients, gonadotropin, 
waste and secretory products from, the developing follicle. At the completion this phase 
of folliculogenesis, the secondary follicle is formed by interacting structural units: a fully 
grown oocyte surrounded by a zona pellucida, several layers of granulosa cells, a basal 
lamina, and internal and external theca with a capillary net (Williams and Erickson, 2014). 
 
The antral follicle is formed when a full-filled cavity with follicular fluid (FF) are developed 
inside follicle. FF is a plasma exudates and protein concentration is generally lower than 
in plasma. It is conditioned by secretory products from the oocyte and granulosa cells 
(Hutt and Albertini, 2007) and creates a microenvironment where regulatory molecules 
must pass to and from (Williams and Erickson, 2014). Once the antrum expands, it 
separates the granulosa cells into two populations: the mural granulosa cells that line 
the inside of the follicular wall (with sterodogenic action) and the Cumulus Cells (CCs) 
that surround the oocyte. Now, follicle is dependent of gonadotropins it is regulated by 
FSH, LH, and an extensive array of growth factors (Orsi et al., 2014). FSH receptors are 
located on the granulosa cells and is essential for the maturation of ovarian follicles and 
induces granulosa cells proliferation and antrum formation. Gonadotropins can increase 
intracellular cAMP; studies showed, that the oocyte is able to synthesize cAMP through, 
the activity of a G protein related receptor, (GPR3) (Mehlmann et al., 2002, 2004). Antral 
follicle are heterogeneous in size, as their size is determined by FF volume in the antrum 
(Erickson and Shimasaki, 2000). As an antral follicle develops, GDF-9 and BMP-15 
function as gradient signals for the generation of distinct classes of granulosa cells. 
These differences become important as the follicular cells and the oocyte are prepared 
for formation of preovulatory follicle (Graafian follicle) and its ovulation (Williams and 
Erickson, 2014). When the theca and granulosa cells proliferate and at the same time 
grows the antrum, the antral follicle becomes a preovulatory follicle. Also, some factors 
implied in angiogenesis as Insulin-like growth factor-1 (IGF-1) and VEGF intervene in the 
improvement of vascularization in selected follicles, which lead to more FSH support in 
these follicles and more LH receptors development. In addition, as estrogens level 
decreased in the recruited follicles, TGF-β factors modulate FSH secretion (Aerts and 
Bols, 2010). 
 
As mentioned, in the preovulatory follicles the granulosa cells are of different types and 
according to their position have different responses to the stimulus of FSH. For example, 
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the granulosa cells membrane express P450 and LH receptor whereas CCs only have 
FSH receptors. The way in which granulosa cells differentiate may be controlled by the 
oocyte (Erickson and Shimasaki, 2000; Hutt and Albertini, 2007). The theca external is 
innervated by autonomic nerves, concentrically organized (Erickson and Shimasaki, 
2000). The physiological significance of the theca external is unknown but it has been 
suggested that they may play a role in subsequent ovulation (Orsi et al., 2014). The theca 
internal is formed by large epithelioid cells whose cytoplasm is ﬁlled with lipid droplets, 
smooth endoplasmic reticulum, and mitochondria (Young and McNeilly, 2010). These 
cells possess receptors for LH and insulin (e.g. produce androgens such 
androstenedione) (Orisaka et al., 2006). In this follicle, FSH plays a vital role in LH 
receptor induction in the granulosa cells necessary to respond to LH surge and 
undergoes ovulation process. The expression of LH receptors remain suppressed until 
late in the follicular phase of the cycle (Erickson and Shimasaki, 2000; Eppig, 2001) and 
is completely dependent of FSH as mentioned. LH surge causes resumption of meiosis 
of the oocyte at the end of the follicular development in the preovulatory follicle (Figure 
3). 
 
 
 
 
Figure 3. Follicular stages and their endocrine and paracrine control in guinea pig. Adapted from 
Pangas and Rajkovic, 2015. 
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1.3.2.1. Endocrine, paracrine and autocrine control of folliculogenesis 
 
The follicular development is regulated by the hypothalamic-pituitary-ovarian axis, where 
the specialized hypothalamic neurons secrete pulses of gonadotropin-releasing 
hormone (GnRH) into the blood vessels regulated by the kisspeptin system (Messager 
et al., 2005; Okamura et al., 2013; Kanasaki et al., 2017). The anterior pituitary secretes 
gonadotropins FSH and LH and the ovary itself produce steroid (e.g., androgens, 
estrogen and P4) and peptide hormones (e.g., inhibin). The frequency of GnRH pulsatility 
determines the FSH secretion (slower pulses) or LH secretion (rapid pulses) that 
explains their differential predominance in the follicular phase and luteal, respectively 
(Mermillod et al., 2008). Steroidogenesis in the ovary, occur via the two cell/two 
gonadotropin model describing cooperation between the granulosa and theca cells as 
follows: the androgens are synthesized from cholesterol in LH-stimulated theca cells, 
followed by conversion to estrogens by FSH in granulosa cells (Richard et al., 2002). 
The cholesterol is imported by steroidogenic acute regulatory protein (StAR) (Stocco, 
2001) and cleaved by cytochrome P450 (CYP) (Young and McNeilly, 2010). Both are 
mitochondrial enzymes. LH receptors and the enzyme CYP17, which converts 
pregnenolone and P4 to dehydroepiandrosterone (DHEA) and androstenedione, 
respectively, are expressed primarily in theca cells, while FSH receptors and aromatase 
(CYP19), which converts androgens to estrogens, are expressed mainly in granulosa 
cells (Peter and Dubuis, 2000). Androgens diffused to granulosa cells where they play a 
dual role: are substrates for enzyme aromatase and also increase the activity of this 
enzyme, thereby increasing estrogen production (Taubøll et al., 2003). Regulation of 
both GnRH pulsatility and gonadotropin production is due of the feedback to the pituitary. 
P4 decrease GnRH pulse frequency and therefore LH secretion, while E2 has positive 
feedback for the production of proges P4 (Orsi et al., 2014). On the other hand, as has 
been mentionated granulosa and theca cells are capable of making pregnenolone and/or 
P4 from cholesterol. In the follicular phase, the relatively avascularized granulosa cells 
have limited oxygen (O2) or cholesterol, thus low amounts of these steroids are 
produced. In contrast, after exposure to gonadotropins, the granulosa cells become 
“luteinized,” and are then able to synthesize large amounts of pregnenolone and P4 from 
cholesterol substrate (Wood and Strauss, 2002; Havelock et al., 2004). 
 
Although gonadotrophins are important in regulating folliculogenesis, to obtain 
competent oocytes is necessary to have a perfect interaction between follicular somatic 
cells and the oocyte, which is potentially regulated by paracrine factors produced in the 
ovary and autocrine produce by both granulosa cells and oocyte. One of the more 
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amazing event discovered in last decade is that local produced oocyte factors can drive 
follicle to success or atresia (Hutt and Albertini, 2007; Mermillod et al.; 2008). Oocyte 
plays an active role in the follicle growth by regulation of proliferation, differentiation of 
granulosa cells and by the secretion of extracellular matrix components, ensuring an 
adequate environment for follicular development (Eppig et al., 2002; Hussein et al., 
2005). Then the oocyte has the ability to regulate LH receptors, steroids and hyaluronic 
acid secretion stimulating follicle growth and survival as well as cumulus expansion; also 
inhibits luteinization by suppressing P4 production until it is released at ovulation (Hutt 
and Albertini, 2007). All these processes are supported by TGF-β superfamily factors, 
mainly GDF-9 and BMP-15 (Young and McNeilly, 2010). Evidence suggests that both 
oocytes and CCs produce and secreted proteins and cell surface receptors that are 
involved in an oocyte granulosa cell regulatory loop (Taft et al., 2002). 
 
In addition, other paracrine and autocrine factors are responsible for ensuring the 
success of follicular and oocyte developmentsuch as growth factors (Erickson et 
al.,1985). The intrinsic growth factors interact with the endocrine system to evoke the 
physiologic control of folliculogenesis including recruitment, preantral follicle growth, 
selection, stereiodogenesis, atresia and ovulation. Among these factors, we highlight the 
Epidermal Growth Factor (EGF) and IGF family ((IGF-1 and their IGF- Binding Proteins 
1-6 (IGFBPs)) that describe below, for their important participation in follicular 
development, maturation and early embryo development. And also by their implication 
insome pathologies as polycystic ovarian syndrome (PCOS). Some authors have 
signaling growth factors EGF and IGF systems as one of the major factors that causes 
the multietiology syndrome PCOS, since development of follicles are stopped and also 
impaired steroidogenesis and hyperinsulinemia has been described (Guidice, 1995; 
Homburg, 1998). 
 
i. EGF system 
 
EGF is member of a large family of closely related proteins that includes amphiregulin 
(AREG), epiregulin (EREG), β-cellulin (BTC) and transforming growth factor-α (TGFα). 
All of these EGF-like ligands act by binding with high affinity to the cell surface receptor, 
EGF-R (Goodsell, 2003; Herbst, 2004; Citri and Yarden, 2006). EGF is an important 
regulator of physiological ovarian function since it acts via endocrine, autocrine and 
paracrine manner as a potent mitogenic factor but also can exert inhibitory actions. In 
general, EGF and EGF-like ligands are associated with cell growth, proliferation and 
differentiation. Notably, EGF cannot directly trigger maturation of denuded oocytes, 
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suggesting that secondary messengers induced by EGF-R signaling in the CCs are 
required for meiotic progression (Jamnongjit et al., 2005). So, EGF has the ability to 
stimulate the proliferation of granulosa cells (Gospodarowicz and Birdwell, 1977; May et 
al.,1987) germinal vesicle breakdown (GVBD), polar body formation (Das et al.,1991), 
and cleavage of oocytes (Coskun et al.,1991). LH triggers secretion of EGF molecules, 
that in a paracrine signal through the EGF-R stimulates cumulus-cell expansion and 
oocyte maturation. In CCs, EGF promotes calcium (Ca2+) efﬂux and improves their 
expansion during maturation (Hill et al., 1999; O’Donnell et al., 2004). 
 
EGF-R is a growth factor dependent of tyrosine kinase activity and is considered to be 
the primary mechanism for the generation of intracellular signals that culminates in 
meiosis re-activation and maturation of the oocyte. It belongs to family of transmembrane 
receptor tyrosine kinases (RTKs) consists of the EGF-R (ERBB1), HER2 (ERBB2), 
HER3 (ERBB3), and HER4 (ERBB4). Each ErbB receptor comprises a large extracellular 
region (ER) a single spanning transmembrane domain (TM) an intracellular 
juxtamembrane region (JM), a tyrosine kinase domain and Carboxi-terminal (C-terminal) 
regulatory region (Ferguson et al., 2003; Lafky et al., 2008) (Figure 4). The dimerization 
of two ErbB receptors results in the auto-transphosphorylation of tyrosine residues 
(Ferguson et al., 2003; Citri and Yarden, 2006). 
 
 
Figure 4. ErbB receptor family: the different endogenous ligands are shown and the members of 
each family. 
 
The interaction between EGF and their receptor activates several systems of signal 
transduction implicated in important mechanism for the follicle development and oocyte 
maturation: 
i. Raf/Ras/mitogen-activated protein kinase pathway: regulates cell proliferation and 
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survival. Raf/Ras (Protein superfamily) activation ((Ras-GTP (Guanosine 
triphosphate)) activates Raf-1 that can phosphorylate to activate the dual 
specificity protein kinases MEK1 (Mitogen-activated protein kinase kinase-1) and 
MEK2 (Mitogen-activated protein kinase kinase-2), which in turn phosphorylate to 
activate the serine/threonine specific protein kinases, Extracellular signal-
regulated kinase-1 (ERK1) and Extracellular signal-regulated kinase-2 (ERK2) 
(Liebmann, 2001). Activated MAPKs (Mitogen-activated protein kinases) are 
imported into the nucleus where they phosphorylate specific transcription factors 
involved in cell proliferation (Gaeste, 2006; Citri and Yarden, 2006) and it is 
essential for granulosa cells division. It is also involved in processes such as oocyte 
maturation and embryo development (Walker et al., 1998). 
 
ii. PI3K/Akt pathway: this pathway is involved in cell growth, apoptosis resistance, 
invasion and migration. PI3K is a dimeric enzyme responsible of the anchorage to 
ErbB receptor-specific docking sites and generation of the second messenger 
phosphatidylinositol 3,4,5-triphosphate (IP3) that is responsible for 
phosphorylation and activation of the Akt (Vivanco and Sawyers, 2002).  
 
iii. Signal transducers and activators of transcription (STAT): proteins interact with 
phosphotyrosine residues via their Src homology 2 domains and dimerization, 
translocate to the nucleus and drive the expression of specific target genes 
(Bromberg, 2002).  
 
iv. Src kinase pathways: Src plays a critical role in the regulation of cell proliferation, 
migration, adhesion, angiogenesis, and immune function (Summy and Gallick, 
2006). Src serves as a signal transducer and an enhancer of EGF-R activation 
(Leu and Maa, 2003). 
 
In addition, the mural granulosa cells and cumulus cells both express EGF receptors. 
This suggests that LH could act by transactivating EGF-R signaling. This provides a 
pathway by which the LH signal received by the mural granulosa cells could be relayed 
to the cumulus cells and ultimately the oocyte. EGF is able to induce maturation of 
follicle-enclosed oocytes and expansion of the cumulus layer in the absence of LH 
(Ashkenazi et al., 2005; Downs and Chen, 2008). EGF-like ligands released by the 
granulosa cells in response to LH, as well as EGF, trigger the decrease in follicular cyclic 
guanosine monophosphate (cGMP) independently of LH (Hsieh et al., 2011; Norris et 
al., 2010). In ovarian follicles EGF activates StAR post-translationally through 
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phosphorylation. Since activation of the EGF and LH receptors similarly increase StAR 
activity and steroidogenesis, then perhaps the EGF receptor is signaling downstream of 
the LH receptor (Jamnongjit et al., 2005). 
 
On the other hand, EGF can have a role in pathological situations because excess of 
activity in both EGF and TGFα can prevent aromatase function and disminish apoptosis 
of follicles (Homburg, 1998).  
 
ii. IGF System 
 
The IGF system is denominated the "IGF autocrine/paracrine system" which is 
composed of different elements (Jones and Clemmons, 1995).Two ligands: IGF-1 and 
IGF-2 (Humbel, 1990), two receptors, the type I receptor that mediates most of the 
somatomedin-like actions of both IGF-1 and-2 (Roth and Kiess, 1994) and six IGF 
binding proteins (IGFBPs 1–6) circulatingin addition to proteases that modulate ligand 
availability (Hwa et al., 1999; Paveli´c et al., 2007; Mctavish et al., 2009; Zha and 
Lackner, 2010).  
 
IGF-1 or somatomedin-C is a 70 amino acid hormone that is structurally similar to pro-
insulin and is synthesized in the liver and fibroblasts (Hwa et al., 1999; Laviola et al., 
2007) but also in the ovary (Adashi, 1998). This peptide of low molecular weight 
promotes cellular mitosis and differentiation in a variety of systems (Giudice, 1992) and 
IGF system is considered as intraovarian regulator of folliculogenesis by endocrine, 
autocrine and paracrine pathways (Kooijiman, 2006). It plays an important role in the 
regulation of cell proliferation, differentiation and protein synthesisas well as in the 
protection of multiple tissues from apoptosis (Laviola et al., 2007). In the ovary, IGF-1 is 
important in the follicular development process by enhancement of cell proliferation and 
differentiation of granulosa cells (Hernández et al., 1988), acts as a biological amplifier 
by the action of FSH in the ovary (Hsu and Hammond, 1987) by increasing the aromatase 
activity and biosynthesis of estrogen (Young and McNeilly, 2010), induces antrum 
formation (Baker et al., 1996; Zhou et al., 1997; Adams et al., 2000; Martins et al., 2010; 
Sharma et al., 2010), increases P4 level and keep resistance to apoptosis events (Ewton 
et al., 1994; Spicer and Echternkamp, 1995; Gutierrez et al., 1997; Mani et al., 2010). 
Figure 5 show the main effects of IGF-1 in the ovary of different mammalian speciesat 
different stages of follicular development. 
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Figure 5. Influence of IGF-1 on the development of primordial to preovulatory follicles in 
mammalian species. By Silva et al. (2009). GC (Granulosa cells) 
 
The biological actions of IGF-1 are mediated by the Insulin-like growth factor-1 Receptor 
(IGF-1R) (Laviola et al., 2007). It is a transmembrane tyrosine kinase with high homology 
to the insulin receptor (Izadyar et al., 1998) and consists of two extracellular α-subunits 
and two membrane-spanning β-subunits (Figure 6). The α-subunit is extracellular and 
contains the ligand binding domain for IGF-1, IGF-2, and insulin. The β-subunit has a 
hydrophobic domain that traverses the cell membrane, contains an Adenosine tri-
phosphate (ATP) binding site and ligand-activated tyrosine kinase activity, as well as 
sites for autophosphorylation (Liu et al., 1993; Gennigens et al., 2006; Laviola et al., 
2007; Yin et al., 2009). Additional tyrosine residues in the C-terminal domains of the β- 
subunit are also important in signal transduction by the IGF-1 receptor (Yuen and 
Macaulay, 2008). 
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Signalling pathway involve the activation of the PI3K (Le Roith et al., 2001) which cause 
induction of antiapoptotic proteins (Meinbach and Lokeshwar, 2006) and activation of 
the recruitment of Akt (protein kinase B) to the membrane. Activated Akt then mediates 
a host of cell signaling events, including disinhibition of the mTORC1 complex and 
increased protein synthesis and cell growth. Also activated IGF-1R results in stimulation 
of the RAS/MAP kinase pathway, which also leads to increased cell proliferation (Zha 
and Lackner, 2010) (Figure 6). Finally, MAPK/ERK kinase signaling pathways is 
activated (Le Roith et al., 2001). The ligands IGF-1 are both capable of binding and 
stimulating the catalytic activity of the IGF-1R. 
 
 
 
Figure 6. Key components of the IGF-1R pathway. (By Zha and Lackner, 2010). 
 
The IGFs interact on a 1:1 molar ratio with six specific, high-affinity IGFBPs (Rechler, 
1993; Jones and Clemmons, 1995). They are often divided into two classes: the pituitary 
growth hormone (GH)-dependent main serum IGFBPs (IGFBP-3) and the low molecular 
weight, GH-independent IGFBPs 1,2,4,5 and 6 (Binoux et al., 1988; Hardouin et al., 
1987). Less than 5% of IGF is free in circulation whereas almost 90% circulates as a 
complex with IGFBPs. The ligand affinities of the IGFBPs are comparable to or greater 
than the affinity of the cellular IGF receptors but the affinity of IGFBPs for IGFs can be 
reduced when IGFBPs are bound to extracellular matrix or when they undergo 
proteolysis (Spicer, 2004; Clemmons, 2016). Thus, IGFBPs modulate IGF bioactivities 
both in the circulation and in the extracellular environment (Hwa et al., 1999), regulating 
the ability of the IGFs to interact with their receptors. IGFBPs 1-6 can both inhibit and 
potentiate IGF action at the target cells, depending on particular post transductional 
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changes, including phosphorylation, proteolytic degradation, and binding to the 
extracellular matrix (Rajaram et al., 1997). All of them are known to inhibit IGF actions 
(Yu and Rohan, 2000; Puche and Castilla-Cortázar, 2012). Also, IGFBP-1, IGFBP-3 and 
-5 can potentiate IGF action (Conover, 1992; Baxter, 2000; Firth and Baxter, 2002; Kiepe 
et al., 2002). In general, the IGFBPs have four essential functions in the regulation of 
IGF activities: (1) they act as transport proteins in plasma; (2) they leng then the half-
lives of IGFs by regulating their metabolic clearance; (3) they provide a means of tissue 
and cell type-specific targeting and (4) they directly modulate interaction of the IGFs with 
their receptors and thereby indirectly control their bioreactivity (Silva et al., 2009). 
However, there is increasing evidence that the IGFBPs possess IGF-1 independent 
effects (Guler et al., 1989; Zapf et al., 1995; Firth and Baxter, 2002; Clemmons, 2016). 
In this sense, IGFBP-3 and -5 can induce apoptosis or modulate cell survival in the 
absence of the ligand (Schedlich et al., 2000; Torng et al., 2009; Beauchamp et al., 2010; 
Kim et al., 2011; Gullu et al., 2012; Baxter, 2013, 2015), possibly by sequestering 
extracellular IGF and thereby limiting peptide access to specific cell surface receptors.  
 
IGFBPs for IGF are expressed in different species in specific ovarian cell types. Their 
expression appears to be independently regulated during the reproductive cycle (Spicer, 
2004; Chen et al., 2010). The amount of mRNA for all six IGFBPs in follicles has distinct 
patterns and these IGFBPs have distinct functions in cattle (Schams et al., 2002; 
Rodríguez et al., 2013) and anoestrous sheep (Hastie et al., 2004), but they participate 
as the rest of IGF system the important biological function in follicles such as cellular 
growth, proliferation, differentiation, survival against apoptosis and migration 
(Khandwala et al., 2000).The IGFBPs are inhibitory to gonadotrophin-induced follicular 
growth and differentiation and inhibit the actions of IGF at the level of target cells (Spicer 
and Echternkamp, 1995). Thus changes in intrafollicular IGFBPs lead to changes in IGF 
bioavailability and the up or down regulation of gonadotropin actions on follicular cells 
(Spicer, 2004). 
 
 IGFBP-1 
 
IGFBP-1 was the first member of a IGFBPs family to be characterized. This family is 
involved in modulating the effects of the IGF-1 and 2 whit roles in growth and apoptosis, 
metabolism and development (Lee et al., 1993). The IGFBP-1 primary amino acid 
sequence contains 12 N- terminal and 6 C- terminal cysteine residues which are 
conserved in other mammalian; these cysteine-rich areas are essential for optimal 
IGFBPs. Availability of IGF-1 in relation to levels of IGFBP-1 (ratio between IGF-1 and 
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IGFBP-1) may be useful as a marker for biological response of the IGF-1 system in 
various treatments or also as marker for mature oocytes (i.e. alterations in the levels of 
IGFBPs may generate the low IGF-1 levels preventing the protein from binding to its 
receptor and altering the normal development of function) (Kawano et al., 1997; 
Donaghy, et al.,1995). The post-translational modifications can be modificate the 
phosphorylation of IGFBP-1, for example during fetal stresses (hypoxemia). IGFBP-1 
can be increased in a sixfold of its afiniity for IGF-1 resulting in fetal growth restriction 
(Abu et al., 2014). Serum IGFBP-1 levels seems to be lower in PCOS (Cataldo, 1997). 
 
 IGFBP-2 
 
The IGFBP-2 was isolated originally from rat liver (Lyons and Smith 1986; Mottola et al., 
1986) and their N- terminal amino acid sequence was reported and isolated from adult 
rat serum (Binkert et al., 1989; Shimonaka et al., 1989) ovine plasm (Walton et al., 1990) 
and pig ovarian FF (Shimasaki et al., 1990). The IGFBP-2 precursor is 36- kilo daltons 
(kDa) (328 amino acid residues) in size and consists of three distinct regions: The N-
terminal (Amino-terminal) region (amino acid residues 43-136); the C-terminal region 
(amino acid residues 229-309) (Bunn et al., 2003; Mark et al., 2005). The N-terminal and 
C-terminal domains are cysteine-rich. The cysteine distribution in IGFBP-2 is highly 
similar to that of IGFBP-1. Studies have indicated that IGFBP-2 may be important during 
early stages of follicular development (Giudice, 1992), supporting the role for the IGF 
system in oocyte maturation. Also IGFBP-2 is expressed in fetal tissues that are highly 
proliferative as the apical ectodermal ridge and after birth in the glial cells (Fuller et al., 
1999; Fukushima and Kataoka, 2007). The expression of IGFBP-2 decreases 
significantly after birth, but gradually increases again and found in seminal plasma, milk 
and cerebrospinal fluid (Blum et al., 1993; Schwander and Mary, 1993; van den Beld et 
al., 2003). Other studies have also shown that IGFBP-2 bind to glycosaminoglycans on 
the cell surface and extracellular matrix through its heparin-binding domain (HBD) 
(Russo et al., 2005). IGFBP-2 down regulates phosphatase and PTEN expression, but 
has not yet been determined the receptor that mediated this process and the signaling 
elements (Perks et al., 2007). 
 
 IGFBP-3 
 
IGFBP-3, is the most abundant of the IGFBPs in the circulation in humanand the main 
IGF transports protein in the blood stream, where it carries the growth factors 
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predominantly in stable complexes. The IGFBP-3 primary amino acid sequence contains 
12 N- terminal and 6 C- terminal cysteine residues. The IGF-1/IGFBP-3 ratio has 
sometimes been used as an index of IGF bioavailability in the circulation IGFBP-3 is also 
predominant in FF although, its role in FF has not been clearly demonstrated (Thierry 
van Dessel et al., 1996). It can modulate the actions of insulin-like growth factors (IGF-1 
and -2) also exerts IGF-1 independent actions as suppression of cell proliferation and 
stimulation of apoptosis in a variety of cell lines (Valentinis et al., 1996; Oh et al., 1995; 
Lalou et al., 1996; Butt et al., 1999).  
 
IGFBP-3 also interacts with cell-surface proteins, affecting cell signaling from outside the 
cell or after internallization, and also enters the cell nucleus where it binds to nuclear 
hormone receptors and other ligands (Martin and Baxter, 1986). Studies had 
demonstrated that IGFBP-3 also exerts antiproliferative effects in many cell types by 
blocking the ability of IGF-1 to activate the IGF-1R (which stimulates cell proliferation) 
(Takaoka et al., 2006). A subsequent study showed that IGFBP-3 can activate the TGF-
β1and-β2 receptors, and inhibit the signaling of SMAD (Intracellular proteins) in the 
TGFβ pathway (Fanayan et al., 2002). Other studies showed that IGFBP-3 could 
stimulate sphingosine kinase. IGFBP-3 functions through this mechanism to 
transactivate either the EGF or the IGF receptor, but this mechanism is still unknown. 
IGFBP-3 also binds to caspase 3 and 8 linked to the cell death (Ingermann et al., 2010). 
 
 IGFBP-4 
 
The IGFBP-4 is the smallest among the six IGFBPs and it exists in two forms; non-
glycosylated (24 kDa) and N-glycosylated forms (28 kDa) (Durai et al., 2006). IGFBP-4 
has two extra cysteine residues (Qin et al., 1998) and three domains: N-terminal, C-
terminal and the central domain, of which the N-terminal sequence is important for the 
binding of IGF (Fernandez-Tornero et al., 2005). IGFBP-4 acts as a transport protein for 
IGF-1 and IGF-2 and inhibits IGF-1 induced cellular growth both in vitro and in vivo. 
IGFBP-4 level and expression in various tissues are influenced by IGFBPs protease, 
growth factors and hormones (Durai et al., 2006). Other studies have demonstrated that 
IGFBP-4 has an inhibitory effect on both granulosa and theca cell steroidogenesis 
(Seppälä et al., 1984).  Intrafollicular concentrations of IGFBP-4 strongly decrease during 
the last steps of folliculogenesis (Monget et al., 1996; Stewart et al., 1996). These 
changes are mainly due to an increase in proteolytic degradation of IGFBP-4. However, 
the follicular atresia is associated with the appearance of IGFBP-4 transcripts in rat 
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granulosa cells (Erickson et al., 1992) and increases in IGFBP-2, -4, and -5 in sheep AF 
(Besnard et al., 1996). 
 IGFBP-5 
 
IGFBP-5 is formed by 18 cysteine residues: 12 in the N-terminal and 6 in the C-terminal 
regions of the protein. Initially was report that IGFBP-5 bound to the TGFβ receptor, later 
was determined to be a low-density lipoprotein receptor-related protein 1 (LRP-1) (Kalus 
et al., 1998; Beattie et al., 2006). Studies have demonstrated that IGFBP-5 interacts with 
IGF-1 and IGF-2. It was initially demonstrated that inhibit IGF function in cell growth, 
apoptosis, survival, and differentiation (Lee et al., 2016), by blocking the interaction 
between IGF and the IGF-1R in rat granulosa cells (Kalus et al., 1998). Studies also, 
demonstrated that IGFBP-5 stimulates markers of bone formation and in the humans, 
IGFBP-5 mRNAs were detected in liver, kidney and brain tissues and an osteosarcoma 
(Shimasaki and Ling, 1991). 
 
 IGFBP-6 
 
IGFBP-6 consists of 3 domains: The N- and C-terminal domains, which contain internal 
disulfide bonds, 5 in the N-terminal IGFBPs domain and 3 in the C-terminal domain 
(Neumann and Bach, 1999; Chandrashekaran et al., 2007). IGFBP-6 expression is 
regulated by cAMP, IGF, p53, β-catenin, and TGF-β (Bach et al., 2013). Studies hace 
demonstrated that IGFBP-6 may enter the nucleus and modulate cell survival and 
differentiation (Bach, 2015). A principal role for IGFBP-6 is inhibition of IGF-2 actions, 
angiogenesis and promotion of cancer cell migration. This type of IGFBPs has a binding 
preference for IGF-2 over IGF-1. It is antiproliferative and proapoptotic in a number of 
cell lines in vitro (Bach, 2005; Bach et al., 2013). It has also been reported to have IGF-
1 independent actions, such as angiogenesis (Zhang et al., 2011). It has been reported 
in humans to be a tumor suppressor through regulation of EGR-1 expression (Kuo et al., 
2010). IGFBP-6 has been isolated from FF or ovarian tissue. Studies indicate that 
IGFBPs expression and production in the developing follicle is dependent on both cell 
type and follicle size and is regulated by IGF-1 and gonadotropins. Singh et al. (2015) 
describe in buffalo that the expression of IGFBP-6 is greater in preovulatory follicles that 
other binding proteins.  
 
Regarding, the role of IGF system in pathogenesis of PCOS IGFBPs concentrations are 
decreased, thus it will be more active IGF-1 that induces LH receptors and activation of 
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P450 which leads to hyperandrogenism due to the excess of androgen produced in the 
theca cells (Guidice, 1995; Homburg, 1998). 
  
1.3.2.2. Follicular atresia 
 
Apoptosis or programmed cell death is cell self-destruction under physiological control 
(Ameisen et al., 2002). It is a complex process that involves a variety of different signaling 
pathways and regulatory networks caused by extrinsic and intrinsic factors (Quirk et al., 
2006; Sirotkin et al., 2010) and give as results multitude of morphological, histological 
and biochemical changes in the dying cell. The cell undergoes shrinkage, chromatin 
margination, nuclear condensation, segmentation, and division into apoptotic bodies that 
may be phagocytosed (Hussein, 2004; Matsuda-Minehata et al., 2006). This event plays 
an important role in the normal function of all tissues including the follicle (Amsterdam et 
al., 2003). In mammalian and human follicular development, apoptosis can be initiated 
in different follicular stages and cell compartments, i.e., theca and granulosa cells 
(Sharma, 2003; Sharma and Bhardwaj, 2007, 2009), CCs, the oocyte itself (Hussein, 
2004) and corpus luteum (Sharma and Batra, 2005). However, mainly apoptosis signals 
in the follicle are seen in granulosa cells.  
 
Many studies have shown that apoptosis in granulosa and germ cells of diverse species 
is precisely regulated by a cohort of intracellular signals and gene products conserved 
through evolution (Tilly, 1996; Tilly et al., 1997; Quirck et al., 2006). The complex range 
of molecular mechanisms (Hussein, 2004; Manabe et al., 2004; Inoue et al., 2011) and 
signaling pathways are mainly regulated bya type of non-coding RNA (Ribonucleic Acid) 
molecule microRNAs (miRNA) (Liu et al., 2014; Nie et al., 2015; Xiong et al.,2016; Worku 
et al., 2017). Some miRNAs regulating apoptosis in granulosa cells are miR-22, let-7 
family (lethal-7), miR-26b. Also, apoptosis is activated by the binding of the death 
receptors (Fas, tumour necrosis factor receptor (TNFR), interferon (IFN) and TNF-related 
apoptosis-inducing Ligand (TRAIL) receptors) to their ligands. The expression of these 
proteins is closely linked with gonadotrophin levels. Low levels of gonadotrophin are 
associated with disappearance of FasL/Fas and p53 (in the granulosa cells) (Hu et al., 
2001). The FasL-Fas signaling pathway in the granulosa cells can be suppressed by 
IGF-1 or EGF mediated by the PI3K/Akt pathway (Quirk et al., 2000; Hu et al., 2001). It 
also modulates the apoptotic role of miR-23a and -27a (Nie et al., 2015). Similarly, the 
TGF-β1 signaling pathway has been found to be involved in granulosa cells apoptosis 
and follicular atresia by down regulating miR-26b, in which case SMAD4 is the target 
gene (Liu et al., 2014). Finally, several intracellular molecules as: B-cell lymphoma 2 
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(Bcl-2), Bax and caspases (Kim and Tilly, 2004) can regulate this process. Bcl-2 (pro-
survival factor) is found in the developing follicles while Bax (pro-apoptotic) is seen in the 
atretic follicles (Hussein, 2004). This expression is related to gonadotrophin levels again; 
higher levels of gonadotrophins increase the expression of Bcl-2 and decrease the 
expression of Bax (Sugino et al., 2000). Caspases are the main effector molecules in 
ovarian apoptosis. They are activated by cell surface receptors or members of the Bcl-2 
family of proteins. In the ovary, caspase- 3 is expressed in luteal and thecal cells of 
healthy corpus luteum as well as in the granulosa cells of follicles. This expression is 
regulated by gonadotrophin and may be altered as part of the apoptotic process in the 
granulosa cells (Hussein, 2004).  
 
In guinea pig, various factors can influence follicular atresia as age, nutrition, X-
irradiation (Jacquet et al., 2001) and phases of the ovarian cycle. During the second half 
of the ovarian cycle, the atresia can occur in the early stages of development of follicles 
as a process of degeneration of the granulosa cells and phenotypic transformation of 
theca cells (Logothetopoulos et al., 1995; Sun et al., 2014). 
 
1.3.3. Oocyte maturation 
 
The events that arise during oocyte maturation depend not only on the correct dynamics 
of chromosome separation during nuclear maturation (known as nuclear maturation) but 
also to the redistribution of cytoplasmic organelles and the previous storage of mRNA 
proteins, and transcription factors during oogenesis (known as citoplasmic maturation). 
Therefore, nuclear maturation events are accompained by cytoplasmic maturation 
processes. A complete nuclear maturation does not guarantee the complete cytoplasmic 
maturation. Then, when oocyte has not completed cytoplasmic maturation it shows poor 
quality and is unable to successfully complete normal developmental progression 
(Krisher, 2004). Therefore, both processes are essential to obtain a competent oocyte. 
Changes to nuclear and cytoplasmic level are also dependent on maternal genetic 
background and may be responsible for maternal effects on de-novo methylation, gene 
expression and congenital aberrations (Picard et al., 2001). Selection of good quality 
oocytes is particularly important for the improvement of assisted reproduction techniques 
(Marteil et al., 2009). 
 
Estrogen act at the oocyte surface by producing changes in reactivity of Ca2+ that play 
an important role in intracellular signaling. It is essential for oocyte activation during 
fertilization including the block to polyspermy and the completion of meiosis, cortical 
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granule exocytosis and the transition into the embryonic mitotic cell cycle (Machaca, 
2007; Ullah et al., 2008; Ferreira et al., 2009). In immature oocytes Ca2+ release is 
activated by protein kinase C (Tesarik and Mendoza, 1995). Only when the oocyte 
grows, it becomes competent and need to release cortical granules the oocyte first 
generates spontaneous Ca2+ transients (Carroll and Swann, 1992; Carroll et al., 1994) 
and the ability to generate Ca2+, is acquired in the oocyte at metaphase II (M-II), since it 
is possible that in this phase that Ca2+ channels are regulated by mitotic cell cycle control 
proteins or by factors released from the nucleus that control Ca2+ release during mitosis 
(Kono et al., 1995; Carroll et al., 1996; Ullah et al., 2008). 
 
1.3.3.1. Nuclear maturation 
 
The MI which consists of prophase I, metaphase I, anaphase I and telophase I are 
denominate “reductional” because it results in daughter cells that contain only half of the 
number of chromosomes that existed in the originating parent cell. In this process, 
homologous chromosomes pair during prophase I are separated at metaphase I, 
resulting in the formation of two daughter cells each containing just one homologous 
chromosome. Homologous chromosomes come together and pair in a process known 
as synapsis and then exchange genetic information through crossing over by 
recombination (Tankimanova et al., 2004). Synapsis and recombination events are 
necessary to keep homologous chromosomes tightly associated with each other to be 
equally segregated to daughter cells. Daughter cells now consist of paired chromatids 
(Storlazzi et al., 2003) and must then enter MII that consisting of prophase II, M-II, 
anaphase II, and telophase II (Figure 7) (Cohen and Holloway, 2015). This division is 
called “equational” because overall number of chromosomes in the daughter cells is the 
same as in the parental cell at the end of MI (Cohen and Holloway, 2015). 
 
Regarding to metaphase I, the first substage of prophase I is known as leptonema. This 
occurs immediately after DNA replication and involves the initial assembly of a proteinic 
structure, termed the synaptonemal complex. This complex begins to form a scaffold 
along each homologous chromosome. The second substage of prophase I, termed 
zygonema, consists of pairing of homologous chromosomes chromatids; then occurs the 
synapse (Liu and Keefe, 2008). Simultaneously, the DNA begins to condense, making 
the chromosomes more visible cytologically. Once the homologs have been completed 
the synapsis, the cell enters the third substage of prophase I, known as pachynema. 
Now the chromosomes are fully condensed and have a short, flat cytological 
appearance. After pachynema, the central constituent of the synaptonemal complex 
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break down, and the chromosomes keep away each other (Kouznetsova et al., 2011). 
This fourth substage is known as diplonema, when the two homologs become clearly 
visible again. The homologs remain joined at the location of meiotic crossover, called 
chiasmata even if the central element was broken down and the synaptonemal complex 
disassembled. The fifth and final substage of prophase I is diakinesis which means 
“moving through”. At this point, the homologs are connected only by the remnants of the 
synaptonemal complex of the centromeres and at the crossover sites (Cohen and 
Holloway, 2015). 
 
During MI, the chiasmata form the tension necessary to ensure stable the microtubules 
which maintain homolog interactions. In following stage, Anaphase I, chromosomes 
containing a pair of chromatids joined solely by cohesin at the centromeres (Liu and 
Keefe, 2008), are separated to the opposite poles. Then in telophase I, a clearly 
asymmetric division is produced and a rudimentary structure called the first polar body, 
which contains the excess of chromosomes, is formed and extruded to the periphery. 
There is no intervening S-phase before entry into MII, and oocytes progress to M-II 
rapidly, only to arrest again under the influence of cytostatic factor (CSF). It induces 
stabilization and reaccumulation of meiosis promoting factor (MPF). (Rieder et al., 1994; 
Lara-Gonzalez et al., 2012). Inhibition of anaphase promoting complex (APC/C) action 
avoid CSF binding to MPF (Hunt et al., 2012) resulting in the second meiotic arrest at M-
II. MII resumption only occurs upon fertilization by the influx of Ca2+ ions triggered by 
sperm penetration (Madgwick and Jones, 2007). 
 
 
 
 
Figure 7. Meiotic division. Adapted from Cohen and Holloway, 2015 
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Nuclear maturation covers chromatin changes during oocyte maturation from GVBD 
throughout MI to MII. Morphologically the nuclear stages displayed during oocyte meiotic 
maturation (Marteil et al., 2009; Li and Albertini, 2013) are: 
 
i. GV (germinal vesicle): the nucleus of the oocyte is arrested in prophase of 
meiosis with a nucleus surrounded by a nuclear membrane wherein the nucleus is 
characterized by the presence of chromatin filaments. 
 
ii. GVBD: In this stage the nuclear envelope of the GV will break down in a process 
known as GVBD, when the oocyte resumes meiosis in response to the LH surge 
that occurs prior to ovulation. 
 
iii. MI (Meiosis I): The first meiotic division leads thanks to crossing-over to the 
formation of daughter cells with distinct genetical compositions.  
 
 Prophase I: Chromosomes start to condense, crossing-over between pairs of 
homologous chromosomesand form chiasmata. 
 
 Metaphase I: Homologous pairs of chromosomes (bivalents) arranged as a 
double row along the metaphase plate.  
 
 Anaphase I: The homologous chromosomes in each bivalent pair are separated 
and move to the opposite poles of the cell.  
 
 Telophase I: The chromosomes become diffuse and the nuclear membrane 
reforms. 
 
iv. MII (Meiosis II): An haploid number of chromosomes condense again. The 
nuclear membrane and nuclei break up while the spindle network appears. The 
chromosomes move again to the equatorial plane. The sister chromatids are 
pulled apart to opposite poles by the spindle and begin moving to opposite ends 
(poles) of the cell. A nuclear envelope is formed around each nucleus. Distinct 
nuclei form at the opposite poles and cytokinesis occurs. At the end of M-II, each 
cell has one half the numbers of chromosomes (Marteil et al., 2009). 
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The resumption of meiosis is marked by the breakage of the nuclear membrane VG, the 
disappearance of nucleolus, formation of meiotic spindle and chromatin condensation in 
homologous chromosomes reaching metaphase I, then the pairs of chromosomes are 
separated homologues and progresses to metaphase of the second meiotic division (M- 
II) accompanied by extrusion of the first polar body. The oocyte remains M-II stage in the 
oviduct until fertilization. At that time occurring meiosis complete extrusion of the second 
polar body (Figure 8) which is located between oocyte cell membrane and perivitelline 
space. 
 
 
 
 
Figure 8. Schematic overview of the nuclear maturation. Redrawed figure adapted from Ferreira 
et al. (2009) 
 
As it has been indicated before, the beginning of oocyte maturation is determined by 
influence of LH in the granulosa cells (Eppig et al., 2004; Norris et al., 2010). The 
presence of gap junctions between granulosa cells and oocyte provide the cGMP 
necesary to keep the meiotic arrest after entering the oocyte (Norris et al., 2009). The 
process by which LH activates the pathways that reduce cGMP is not known. cAMP is 
synthesized by follicular somatic cells and is transported into the oocyte also through 
gap junctions (Adhikari and Liu, 2014). Then, LH increase provokes activation of cAMP 
and cGMP lowering in the COCs. Oocytes arrest under the influence of CSF. Activity of 
CSF induces stabilization and reaccumulation of MPF, which keeps the prophase I arrest 
in the oocyte. MPF is a complex of a catalytic kinase, consisting of the regulatory subunit 
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cyclin B1 and thecatalytic subunit p34cdc2 (cyclin dependent kinase 1 (CDK1) or Cdc2) 
and CDK1 in the nucleus. It regulates the passage of prophase to-metaphase restarting 
the meiosis in immature oocytes (Brunet and Maro, 2005; Santamaria et al., 2007; Oh et 
al., 2010; Adhikari et al., 2012). 
 
 
1.3.3.2. Cytoplasmic maturation  
 
During cytoplasmic maturation fully grown oocytes undergo structural and functional 
modifications that allow them to be fertilized and to continue embryo development 
(Duranthon and Renard, 2001; Sirard et al.,2006). Some of these changes include the 
redistribution of cell organelles like cortical granules, mitochondria, golgi apparatus and 
endoplasmic reticulum and the ability to undergo cortical granules exocytosis (Ducibella 
et al.,1993; Yoshida et al., 1993). Trafficking of cytoplasmic organelles during maturation 
occurs through the actions of cytoskeletal microfilaments and microtubules and 
repositioning of the organelles depends on the needs of the cell during each stage of 
development (Ferreira et al., 2009). The microtubules of cytoskeleton play an important 
role in the separation of chromosomes, extrusion of the first and second polar body and 
migration of cortical granules (Adams and Hertig, 1966; Adona et al., 2008). Although 
migration of cortical granules and mitochondria has been assessed as an indicator of 
cytoplasmic maturation, the ultimate sign of cytoplasmic maturation is the ability of the 
oocyte to undergo fertilization (Ducibella et al., 1988; Ferreira et al., 2009). Other 
morphological changes include cumulus cell expansion, expulsion of the polar body and 
the increase in the perivitelline space (Motlik et al., 1990; Kastrop et al., 1991). 
 
In addition, mRNA transcription (Kastrop et al., 1991; Farin and Yang, 1992), protein 
translation (Sirard et al., 1989) and post-translational modification of proteins (Levesque 
and Sirard, 1995; Chian et al., 2004) take place.  
 
 
i. Cortical granules migration 
 
Cortical granules are organelles exclusively found in oocytes and their composition 
includes a diverse population of proteins, structural molecules, enzymes and 
glycosaminoglycans. Cortical granules are derived from the Golgi complex (Wessel et 
al., 2002) and endoplasmic reticulum (Lucidi et al., 2003) in a continuous process until 
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ovulation. These are considered vesicles that once released its contents after the cortical 
reaction, they do not re-synthesized. 
 
They are considered the most important organelles in the cytoplasm to prevent 
polispermia. They increase during early stages of maturation synchronously with the 
increased size of the oocyte. In nuclearly mature oocytes cortical granules migrate to the 
periphery (Figure 9), through its binding to anchoring proteins to the cytoskeleton and 
are located in the arranged cortical cytoplasm monolayer just below the oolema (Wessel 
et al., 2002), close to their site of action (the ZP) but their translocation is necessary for 
fertilization. All these modifications establish an extracellular blocking to polyspermy 
(Hosoe and Shioya, 1997). A failure during oocyte maturation causes the impossibility of 
correct fertilization and inactivating specific receptors that recognize and bind to 
spermatozoa (Ducibella et al., 1994). In many vertebrate and invertebrate species, 
exocytosis of cortical granules after spermatozoa penetration into the oocyte triggers a 
rapid modification of extracellular matrix of oocytes because cortical granules are not 
produced at the site of their final localization (Ducibella et al., 1994; Wessel et al., 2002). 
 
Cortical granules distribution have been used as a reliable indicator for the cytoplasmic 
maturation of oocytes (Damiani et al., 1995). For oocytes in the GV stage, cortical 
granules are distributed throughout the cytoplasm (Hosoe and Shioya, 1997). Partially 
matured oocytes show cortical granules localized in the ooplasm and distributed as 
individual particles as well as small aggregates (Bevers and Izadyar, 2002). At the end 
of the maturation period (M-II) the granules are distributed more or less dispersed in the 
cortical ooplasm aligning the oolemma (Conner et al., 1997; Wang et al., 1997). During 
oocyte maturation a reorganization of cortical granules is observed in various species. 
In immature mouse and hamsters oocytes, cortical granules are found in the whole 
cytoplasm (the cortex cytoplasm and the inner cytoplasm) (Ducibella et al., 1988). In 
matured porcine and bovine oocytes showed asymmetric distribution of cortical granules 
(Hosoe and Shioya, 1997, Wang et al., 1997). 
 
 
ii. Mitochondrial distribution 
 
Mitochondria and their distribution play an extremely important role since they are a key 
component of the metabolic machinery responsible for the supply of energy required for 
the maturation process, chromosomal condensation and segregation (Calarco, 1995; Liu 
et al., 2001; Brevini et al., 2005; Nagai et al., 2006; Shoubridge and Wai, 2007; Yu et al., 
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2010), spindle formation and first polar body extrusion (Krisher and Bavister, 1998; 
Stojkovic et al., 2001) in the oocyte as has observed in several species as: mouse (Nagai 
et al., 2006; Yu et al., 2010), pig (Sun et al.,2001; Torner et al., 2004; Brevini et al., 2005), 
cow (Krisher and Bavister, 1998; Stojkovic et al., 2001; Ferreira et al., 2009), dog 
(Valentini et al.,2010; De los Reyes et al., 2011), hamster (Barnett et al., 1996) and 
human (Van Blerkom, 2004; Dell´Aquila et al., 2009; Liu et al., 2010). Mitochondria 
produce most of the ATP by oxidative phosphorylation (Stojkovic et al., 2001) and may 
serve to supply energy directly to the nucleus. During oocyte maturation, breakdown of 
the nuclear membrane requires elevated ATP levels (Yu et al., 2010). Also, the 
mitochondria around the nuclei might serve to reduce the O2 concentration around the 
nucleus, thus playing a role in protection from O2 radicals (Dumollard et al., 2007). For 
these reason, mitochondria density increases at specific stages of oocyte maturation 
accompanied by concomitant focal bursts of ATP production (Yu et al., 2010). Number 
of mitochondria presents in the cytoplasm of mammalian oocytes varies according to the 
stage of development of the cell (Krisher and Bavister, 1998). During the pre-migratory 
stage of germ cells, the number of mitochondria increasing in the oogonium stage. The 
number of mitochondria in primary oocytes increases during oocyte maturation 
(Cummins, 2001; Shoubridge and Wai, 2007).  
 
On the other hand, mithocondria is reallocated to supply the high demand for ATP and 
Ca2+ needed during cytoplasmic maturation (Van Blerkom and Runner, 1984; Calarco, 
1995). A translocation of mitochondria to the perinuclear region is observed in the GVBD 
in mouse (Van Blerkom and Runner, 1984; Calarco, 1995; Nishi et al.,2003), bovine 
(Stojkovic et al., 2001) and pig (Sun et al., 2001). The aggregation of mitochondria 
around the nucleus is correlated with the acquisition of maturation and developmental 
competences (Nishi et al., 2003; Nagai et al., 2006). The abnormal distribution of 
mitochondria is related to the inappropriate formation of the cytoplasmic microtubule 
network, which can lead to the retardation or arrest of oocyte development due to the 
abnormal ATP distribution (Nagai et al., 2006).  
 
In addition, mithocondria are important in regulating apoptosis (Torner et al., 2004), Ca2+ 
signaling (Krisher, 2004; Dumollard et al., 2007), reactive oxygen species, and 
production of intermediary metabolites (Liu and Keefe, 2008, Liu et al., 2000; Dumollard 
et al., 2003). 
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Figure 9. Schematic overview of the distribution of cytoplasmic organelles during maturation and 
fertilization. Redrawed figure adapted from Ferreira et al. (2009). 
 
1.3.4. Ovulation and corpus luteum formation 
 
Ovulation is a biological process that is regulated by intraovaric connections between 
theca, granulosa, CCs and the oocyte. It depends upon specific cellular and molecular 
events that occur sequentially during follicular development and is a slow extrusion 
process that occurs by degradation of the follicle wall (Richards, 2007; Richards et al., 
2015). Before the ovulation there is an increase of gonadotropins that promove 
production of hyaluronic acid that binds CCs and expands spaces between the cells 
(Eppig, 2001). In addition, a normal ovulation requires prostaglandins (PG) production y 
GDF9 (Elvin et al., 1999) and is induced by the LH. After the ovulation, the CCs continue 
associated with the oocyte, facilitating the capture of the COCs by the ciliated cells of 
the infundibulum and its transport along the oviduct (Lam et al., 2000; Tanghe et al., 
2002; Kôlle et al., 2009). On the ovarian surface, the ovulation involves the dissolution 
of collagen fibers in theca layer; the PG and cytokines permit the release of the expanded 
COCs. The COCs are then picked up by the ciliated cells of the fimbria and transported 
to the oviduct, where fertilization occurs. If the oocyte is not released before to 
luteinization it will be trapped in the corpus luteum (Richards et al., 2015). 
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Luteinization begins prior to ovulation and continues until the fully corpus luteum are 
formed. It involves the proliferation and differentiation cellular (Murphy, 2004). Some 
morphological events must occur: breakdown of the basement membrane separating the 
granulosa and theca layers, invasion of microvascular cells into the granulosa layer and 
theca cells are transported toward the center of the follicle cavity (Redmer et al., 2001). 
In many species, including rodents theca-derived luteal cells appear to disperse 
throughout the parenchyma of the corpus luteum (Stocco et al., 2007). However, the fate 
of theca cells may depend upon their differentiated state or proximity to luteinizing of 
granulosa cells at ovulation (Stouffer and Hennebold, 2014). In addition, a volume of 
granulosa cells increases of up to 10-fold by hypertrophy (Smith et al., 1994), gap 
junctions between granulosa and theca cells disappear and changes in the cytoskeleton 
play an important role in optimizing cell size (Stouffer and Hennebold, 2014). Also 
changes in the extracellular matrix (ECM) and integrins and serine proteases ((e.g. 
matrix metalloproteinases (MMPs)) (Liu et al., 1997), appear to be critical in the corpus 
luteum development. The granulosa and theca cells which initially produced estradiol-
17β, are differentiate into luteal cells that produce P4 after the LH surge (Reynolds et al., 
2000). The principal function of corpus luteum is to synthesize and secrete steroid and 
P4 to permit implantation of the embryo in the endometrium and maintenance of 
pregnancy in mammals (Reynolds and Redmer, 1999). In some species the luteinization 
may occur in response to pregnancy and the angiogenic process in the corpus luteum is 
remarkable (Murphy, 2004; Stouffer and Hennebold, 2014). 
 
Corpus luteum function is controlled by several hormones secreted by the pituitary, 
decidua and placenta (e.g. prolactin (PRL) and GH have crucial role for corpus luteum 
development (Risk and Gibori, 2001; Bachelot and Binart, 2005 a, b). However, corpus 
luteum has some level of autonomy by its own P4 production and the PG, oxytocin and 
noradrenaline play a role in regulation of P4 synthesis (Devoto et al., 2009) that protect 
these cells from apoptosis (Kliem et al., 2009). miRNAs may be regulators of ovarian 
function, including the follicular-luteal transition (Donadeu et al., 2012; McBride et al., 
2012) and also have demonstrated an interaction between the Notch signalling pathway 
and P4 that maintains the functionality of the corpus luteum (Sugino et al., 2005). In vitro 
Notch induces P4 production through the activation of CYP P450 cholesterol side chain 
cleavage enzyme (P450scc). Also the P4 might be interacting with the Notch/PI3K/Akt 
signalling pathway for the survival of luteal cells (Stouffer and Hennebold, 2014). 
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In absence of uterine and embryonic signals, P4 production GnRH and VEGF (molecules 
that promote endothelial cell survival and blood vessels are diminished) decreases 
(Fraser et al., 2005), Prostaglandin F2 alpha (PGF2α) induces a decrease in secretion of 
P4, blood flow and induces DNA fragmentation and apoptosis by effects of the protein 
kinase (PKC) system (Davis and Rueda, 2002; Stouffer and Hennebold, 2014). PGF2a 
decreases luteal concentrations of mRNA encoding receptor for LH, low-density 
lipoprotein (LDL) and StAR. Finally, lipid peroxidation (induces membrane damage) and 
the loss of gonadotropin receptors contributing corpus luteum regression and the 
decrease of steroidogenic capacity. 
 
Guinea pig show spontaneous ovulation that occurs late in the period of estrus or shortly 
after its end (Blandau and Young, 1939). Rowlands in 1957 shows that ovulation in the 
guinea pig occurs about 12 h after the onset of mating behavior. Ovulation usually takes 
place after the opening of the vaginal membrane for more than 1 day and always before 
the membrane is regenerated. On average, only 3 or 4 matured follicles ovulate. If 
fertilization does not occur, 13 days after ovulation the level of P4 decreases and FSH 
secretion by theca cells increase (Reed and Hounslow, 1971). The formation of a 
functional corpus luteum is the most outstanding feature that differentiates the guinea 
pig estrous cycle from that of the rat or hamster. Its luteal cells develop from the follicular 
cells surrounding the ovarian follicle after the ovulation process. The theca cells luteinize 
into small luteal cells (thecal-lutein cells) and granulosa cells luteinize into large luteal 
cells (granulosa-lutein cells). In guinea pigs, luteal cells secrete P4 that begins around 
day 10 post ovulation and reaches a peak on day 15 or 16, in the proestrus period (Joshi 
et al., 1973; Sadeu et al., 2007; Gregoire et al., 2012). In addition, in other studies has 
been found that the P4 concentrations increase in the ovaries, placenta and uterus, 
becoming an essential factor to maintain the early embryo development and gestation 
(Heap and Deanesly, 1966; Csapo et al., 1981; Sun et al., 2014). Several studies have 
proposed that FSH, estrogen and prostaglandin F25 can be an essential component of 
luteotropic complex in the guinea pig (Choudary and Greenwald, 1969; Blatchley et al., 
1971; Grégoire et al., 2012). 
 
1.3.5. Preimplantation embryo development 
 
Preimplantation embryonic development is a complex series of steps that begins just 
after fertilization when the zygote is formed and finalizes in the blastocyst stage, before 
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implantation. This period takes place in the guinea pig 6 to 7 days as it showed in the 
Figure 10. 
 
 
 
 
Figure 10. Preimplantation embryonic development in guinea pig compared to mouse, and 
human. Day 0.5 to 1: zygote; Day 1.5 to 2: 2 cell embryo; Day 3 to 3.5: 4 to 8-cell embryos; Day 
4: 16 to-32-cells embryo and compact morula; Day 5: early blastocyst; Day 6: late blastocysts. 
Figured adapted from Cockburm and Rossante (2010) with guinea pig data recovered from 
several authors (Blandau, 1949; Hunter et al., 1969; Dorsch et al., 2008). 
 
The fertilized oocyte is called zygote and the male and female pronucleus are identified 
at the pole of the egg opposite the place of expulsion of the polar bodies. Blastomeres 
start to divide evenly and after cleavage division, embryos reach 16-cells stage where 
an increase in intercellular adhesion (compactation) takes place. This event is associated 
with the formation of gap junctions; E-cadherin becomes localized in regions of cell-cell 
contact (Cockburn and Rossant, 2010), as well as β-catenin and Rho family GTPases 
(Natale and Watson, 2002). From the 32-cell stage, cells on the outside of the embryo 
form the trophectoderm (TE), while inner-cells contribute to the formation of inner cell 
mass (ICM). In the TE the polarity and transcription factor caudal type homeobox2 
(Cdx2) (Cdx2mRNA) are important for determining cell fate (Jedrusik et al., 2008), 
whilethe pluripotency markers Oct4 (Octamer-binding transcription factor), Nanog and 
SRYbox (Sox2) are involved inestablishing the ICM fate. When the TE is formed a fluid-
filled cavity known as the blastocele also begins to form. The blastocele is essential for 
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development of the ICM. During blastocele formation water movement is facilitated by 
aquaporins, which are present in the TE (Watson and Barcroft, 2001). Finally, with the 
formation of the blastocele the embryo is considered a blastocyst. In rodents normal 
embryonic development to the blastocyst stage requires the ovarian estrogen and P4 
(Tazuke and Giudice, 1996; Dey et al., 2004). 
 
In guinea pig, blastocyst reaches the uterine cavity and attaches to the endometrium at 
Day 6 -7 p.c. Penetration of the zona pellucida is performed by projections of the 
embryonic trophoblastic cells is one of the characteristic of implanting guinea-pig 
embryos (Hunter et al., 1969; Suzuki et al., 1993). In order to complete this process, 
there is an embryonic-maternal dialogue, in which the embryo and the endometrium 
induce changes in each other to promote embryonic development and endometrial 
receptivity (Tazuke and Guidice, 1996). Studies in rodents have demonstrated that this 
process is controlled by the action of hormones (estrogen and P4), cytokines and growth 
factors as EGF and IGF-1, glycoproteins and carbohydrate ligands (that are expressed 
in the uterine luminal epithelium and blastocyst cell surfaces), primary adhesion 
molecules (selectins, heparan sulfate, proteoglycans, Muc-1, integrins and cadherins) 
(Kimber and Spanswick, 2000; Dey et al., 2004; Cockburn and Rossant, 2017) These 
factors mediate interactions between trophoblast with the ECM (Dey et al., 2004; 
Eftekhari-Yazdi et al., 2006; Ramathal et al., 2014), allow the initial attachment phase of 
implantation, bind to specific cell surface receptors, resulting in cellular mitosis or 
differentiation by autocrine, paracrine, juxtacrine, or endocrine mechanisms. All these 
effector molecules participate in the attachment and invasion phase (Tazuke and 
Giudice, 1996) that activate some signaling pathways as COX-2, Hippo and TGFβ 
superfamily (TGFβ/activin/nodal) among other, that are essential for controlling celll fate 
during the embryo development and implantation. Finally, early stages of placental and 
yolk sac development involve some mechanisms specific to caviomorph rodents (e.g. 
yolk sac involution, development of a subplacenta) (Kaufmann and Davidoff, 1977; 
Uhlendorf and Kaufmann, 1979). 
 
1.4. SYSTEMS OF OOCYTE MATURATION IN VITRO 
 
1.4.1. Definition and importance of in vitro maturation (IVM) in ARTs 
 
In vitro maturation (IVM) of mammalian oocytes is an efficient method to produce II- 
mature oocytes for their use in the ARTs (Mahmoudi et al., 2005). It consists in maturing 
oocytes from ovarian follicles in culture. Although this technique was described in the 
Introduction 
36 
 
early past century (Pincus and Enzman, 1934), efficiency is satisfactory only in some 
species but not in others. Indeed, in guinea pig scarce studies in this area has been 
developed. 
 
IVM has been proposed as an alternative ARTs and it is the most important step before 
successful monospermic fertilization and proper embryo growth. In contrast to standard 
techniques usually employed in human as in vitro fertilization (IVF) or intracytoplasmatic 
inyection of sperm (ICSI), the IVM is a technique that avoids hormonal stimulation 
because immature oocytes will be matured in vitro after collection (Strowitzki, 2013). In 
animals, use of ARTs allows accelerate genetic improvement toward type of production 
and permit maximizing the benefits of outstanding individuals with reproductive problems 
(Hafez and Hafez, 2013). In laboratory animals reduce the number of animals required 
in the lab and subjected to hormonal treatments to obtain MII-oocytes in vivo by replacing 
them with in vitro alternatives. Then, IVM is a useful tool in ARTs in both human and 
animals so studies in animal models like guinea pig could be a remarkable approach to 
improve IVM system. Thus, the guinea pig is a valuable laboratory animal model for 
reproductive studies; however, female produces 2 to 4 oocytes in each ovarian cycle 
(Logothetopoulos et al., 1995; Harkness et al., 2016) and shows little ovarian response 
to exogenous FSH and equine chorionic gonadotrophin (eCG) (Reed and Houstaw, 
1971). Superovulation was scarcely studied in this species (Shi et al., 2000; Dorsh et al., 
2008) so an IVM system could be an alternative method to the use of superovulation 
protocols in assisted ARTs.  
 
1.4.2. IVM system 
 
1.4.2.1. Ovary collection and oocyte selection 
 
IVM consist of several steps. The first one is the collection of ovaries and selection of 
oocytes. The availability of enough number of oocytes is the pre-requisite to any 
investigation for the development and optimization of reproduction techniques. Ovaries 
of the slaughtered animals are the cheapest and the most abundant source of primary 
oocytes for large scale production of embryos through IVM and IVF (Agrawal et al., 
1995). Transport may be performed in physiological solution or phosphate-buffered 
saline (PBS) with or without antibiotics at anuniformily temperature above 30°C. The 
shelf-life of the collected ovaries should not exceed 5 h as it could diminish the 
developmental capacity and viability of the oocytes. Moreover, an important aim of an 
oocyte recovery method is to maximize the total number of oocytes and the yield of high-
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quality oocytes recovered per ovary, which can be used for in vitro technologies (Shirazi 
et al., 2005). However, no enough reports evaluating the relative efficacy of the methods 
have been published in the guinea pig. The development of an efficient oocyte collection 
procedure is, therefore, very significant.  
 
The oocyte collection methods actuality used are slicing, puncture and aspiration. In the 
slicing method, the whole ovarian is chopped into small pieces with a surgical blade. In 
the puncture method, the whole ovarian surface is punctured by needle. In aspiration 
methods, the oocytes are collected by aspirating from the visible follicles using diameters 
different needle attached to a syringe or using a constant negative pressure with a 
vacuum pump (Wang et al., 2007) depending each species. In any case, a close 
association between CCs and the oocyte is crucial in the production of developmentally 
competent IVM mammalian oocytes (Zuelke and Brackett, 1990; Saeki et al.,1991; 
Kidder and Mhawi, 2002; Gittens et al., 2003). 
 
On a routine basis, oocyte quality is evaluated immediately after recovery by non-
invasive visual assessment of the morphology of COCs. Homogeneity of the ooplasm 
and number of compact granulosa layers surrounding the oocyte (so-called CCs) are 
assessed, enabling the elimination of oocytes in which maturation has initiated in vivo or 
those that have any signs of atresia in either the oocyte cytoplasm or CCs (Wasielak and 
Bagacki, 2007). For the IVM process COCs are classified in different categories based 
on the following criteria according to De Loos et al., (1989) (Table1): 
 
Table 1. Morphological classification of COCs. By: De Loos et al. (1989) 
Category COCs 
1 
- Compact multilayered cumulus investment  
- Homogeneous ooplasm  
- Total COCs light and transparent  
2 
- Compact multilayered cumulus investment 
- Homogeneous ooplasm but with a coarse appearance, and a darker 
zone at the periphery of the oocyte 
- Total COCs slightly darker and less transparent  
3 
- Less compact cumulus investment 
- Ooplasm irregular with dark clusters 
- Total COCs darker than categories 1 and 2 
4 
- Expanded cumulus investment 
- Cumulus cells scattered in dark clumps in a jelly matrix  
- Ooplasm irregular with dark clusters 
- Total COCs dark and irregular  
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1.4.2.2. Maturation media 
  
Choosing a specific medium for IVM of immature oocytes was derived by adapting 
methods developed from culturing other cell types and mimicking the composition of 
ovarian microenvironment of the enclosed oocyte in the follicle. Complex culture media 
such as tissue culture medium 199 (TCM-199), Ham’s-F10 and Whitten’s medium 
buffered with bicarbonate or 4-(2-Hydroxyethyl)-1-piperazine-ethanesulphonic acid 
(HEPES) among others has been used in rodent IVM culture. Numerous supplements 
can be added (Bevers et al., 1997; Trounson et al., 1998) to provide the necessary 
nutrients for the process of oocytes maturation. 
 
The biophysical parameters must be controlled in the culture media as pH (potential 
hydrogen), carbon dioxide (CO2) and osmolarity.  Most in vitro culture media develops a 
neutral or slightly alkaline pH, being the best results between 7.2 and 7.6. For the CO2, 
the gas phase used consists of 5% CO2 in air to mimick the follicle and oviduct of 
mammalian females or 20% of CO2 as in air. Osmolarity ranges between 275 and 290 
mOsm. 
Despite many supplements can add to the maturation media, normally energy substrates 
and protein source, as well as different hormones and growth factors are added. Different 
energy substrates are provided due to the influence on oocyte meiotic and cytoplasmic 
maturation (Rose-Hellekant et al., 1998; Chung et al., 2007; Garner and Lane, 2013). 
This energy source used in most culture media is generally lactate, pyruvate and glucose 
because they are the main substrates for energy metabolism of oocytes (Gardner and 
Lane, 2013). Oocyte utilization of pyruvate is dependent upon CCs that can convert 
glucose or lactate into pyruvate to be used by oocytes (Pool, 2004). Furthermore, 
glutamine can serve as an energy substrate to improve in vitro nuclear maturation of 
oocytes. On the other hand, protein source are essential and non-essential amino acids 
that would be used by protein synthesis, but also can be utilized as an energy source 
and intracellular buffer. Essential and non-essential amino acids are added to culture 
media serum-supplemented or serum-free culture media (Gardner and Lane, 1998; 
2014; Rezaei et al., 2003). Also Fetal calf serum (FCS) and bovine serum albumin (BSA) 
are the most used protein sources for in vitro culture (Carolan et al., 1995; Lazzari et al., 
2000). FCS contains a complex array of protein components that are required by many 
cells to grow; it provides a wide variety of macromolecular proteins, low molecular weight 
nutrients, carrier proteins for water-insoluble components and other compounds 
necessary for in vitro growth of cells, such as hormones, growth factors, vitamins and 
attachment factors (Chung et al., 2007; Chian et al., 2004). However, large offspring 
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syndrome (LOS) has been described mainly in ruminants with the adition of serum (Farin 
et al., 2001). Efforts to avoid FCS and BSA as indeterminant compounds in the medium 
are done in the last decade. Synthetic compounds as polyvinyl alcohol (PVA) and 
polyvinyl pyrrolidone (PVP) can be substitute as well as BSA. 
 
As gonadotrophins (FSH and LH) play an important role in the physiological development 
and function of follicles in vivo and oocyte maturation as we explained before, some 
medium includes these supplements. LH probably acts to induce GVBD by an indirect 
action mediated by CCs because it is believed that there are no LH receptors on oocytes 
(Yadav et al., 2010; Sha et al., 2010). Besides, E2 may be important in regulating oocyte 
maturation (Lonergan, 2011) and also is used in some laboratories. 
 
Finally, growth factors are usually present in the culture media. The most used are EGF, 
IGF-1, TGFα and TGF-β.  
 
EGF has been shown to stimulate in vitro oocyte maturation thus resulting in an 
increased developmental competence of oocytes in different species (mouse: Das et al., 
1991; Smitz et al., 1998; Merriman et al., 1998; De La Fuente et al., 1999; sheep: Guler 
et al., 2000; cattle: Lonergan et al., 1996; Sakaguchi et al., 2002; pig: Reed et al., 1993; 
Coskun and Lin, 1995; Singh et al., 1997; Prochazka et al., 2000, 2003; rat: Dekel and 
Sherizly, 1985; rabbit: Lorenzo et al., 1996; buffalo: Kumar and Purohit, 2004 and 
human: Gómez et al., 1993; Goud et al., 1998). It was reported that EGF stimulates 
granulosa cells proliferation in vitro (pig: May et al., 1992) and estrogen production 
through aromatase activation (human: Misajon et al., 1999; goat: Behl and Pandey, 
2001); modulates steroidogenesis and estrogen production (Hsueh et al.,1981; human: 
Misajon et al., 1999). Also EGF is particularly important in controlling oestrogen receptor 
function (Ignar-Trowbridge et al., 1996) and alone or associated with gonadotropins 
induces cumulus expansion and promotes nuclear and cytoplasmic maturation of 
immature oocytes during culture in vitro (Lorenzo et al., 1994; Wang and Niwa, 1995; De 
La Fuente et al., 1999). 
 
In vitro studies have also shown that EGF maintains follicular survival (Wandji et al., 
1996), promotes follicular growth (bovine: Wandji et al., 1996; caprine: Kajarajan et al., 
2006; Silva et al., 2013; hamster: Roy, 1993; mouse: Boland and Gosden, 1994 and 
human: Roy and Kole, 1998), proliferation of granulosa cells obtained from preantral 
follicles Morbeck et al., 1993) and stimulates antrum formation (Silva et al., 2013). 
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IGF-1 promoted nuclear maturation of oocytes, stimulated proliferation and inhibited 
apoptosis in the surrounding CCs, increased developmental competence of oocytes 
(Lorenzo et al., 1996; Patiño et al.,2001; Sirotkin et al., 2003; Hunter et al., 2004; 
Velazquez et al., 2009). Likewise, IGF-1 is known to stimulate protein synthesis when 
added to medium for mouse embryos in vitro (Simmen et al., 1993) and known to 
increase E2 production by the theca granulosa cells in serum free culture (Shores et al., 
2000). 
 
In some studies, it have been shown that EGF and IGF-1 in combination act 
synergistically and accelerate the cumulus expansion and the progression of meiosis 
(Lorenzo et al., 1996; Sakaguchi et al., 2000; Purohit, 2001; Sakaguchi et al., 2002; Isobe 
and Terada, 2001). In bovine oocyte activation is known to be associated with Ca2+ 
dependent electrical events (Tosti et al., 2002). A combination of EGF and IGF-1 under 
conditions in vitro stimulates a cascade of events including protein synthesis which 
generate positive signals for mitotic resumption (Spicer and Chamberlain, 2000). On the 
other hand, the addiction the protein sources how FCS or BSA could neutralize the 
accelerating effect of EGF and IGF-1 of the meiosis of in vitro (Sakaguchi et al., 2000) 
stimulating cytoplasmic oocyte maturation. 
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OBJETIVE AND THESIS OUTLINE 
 
Guinea pig (Cavia porcellus) has been widely used as a laboratory animal and due to its 
reproductive characteristics can be considered an excellent animal model for the study 
of ovarian physiology in woman. However, IVM protocols are rarely developed in this 
specie, and cellular mechanisms that occur during oocyte maturation are unknown. 
Replacement of animal models with in vitro alternatives, such as IVM to obtain M-II- 
oocytes, involves a reduction of animals used in the lab, avoid the application of 
hormonal treatments and give us a tool to develop a useful IVM system to study the 
oocyte maturation processes in these species for biomedical research in the ARTs and 
for conservation of valuable genetic pool. 
 
Growth factors, such as EGF and IGF-1 systems are implicated in a wide range of events 
in the ovary. The EGF throgouth the EGF-R is involved in the ovulation process, oocyte 
maturation, granulosa cell proliferation, apoptosis and steroidogenesis of follicle and, 
luteinization of corpus luteum in human and several animal species. On the other hand, 
IGF-1 regulates luteal steroidogenesis by an increase in E2 and P4 production and acts 
as anti-apoptotic factor during oocyte maturation. Moreover, IGF-1 system is implied in 
the development of PCOS in woman, and the gene expression of IGFs and IGFBPs differ 
from women with normal ovaries and those with PCOS. 
 
In this context, there is a clear evidence that the role of the components of EGF and IGF-
1 system in relation to follicular health needs to be investigated in animal models, to 
increase our understanding of the relationship between the constituents and the 
processes involved in the ovarian health or failure; as well as to develop useful IVM 
defined system for this species in order to obtain competent oocytes for ARTs and for 
genetic conservation of resources. 
 
MAIN OBJETIVE 
 
The main objective of this Thesis was to characterizethe EGF and the IGF-1 systems in 
different structures of the guinea pig ovary, to use the guinea pig as a possible animal 
model for the study of ovarian physiology. Furthermore, we studied the effect of both 
growth factors (EGF and IGF-1) alone or in combination on in vitro oocyte maturation as 
a possible way to set up an in vitro defined maturation system in this specie. To achieve 
this main objective, a total of three specific objectives have been proposed and 
developed in different experiments: 
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EXPERIMENT 1. Characterization of gene expression patterns of EGF (EGF and 
EGF-R) and IGF-1 system (IGF-1, IGF-1R and IGFBPs 1-6) in ovarian follicles, 
corpus luteum and cumulus-oocyte complexes (oocyte and cumulus cells) in the 
guinea pig model 
 
The objective of this experiment was to describe the gene expression patterns of EGF 
and IGF-1 systems in the ovary of the guinea pig as a possible animal model for human. 
The basis of the physiological mechanism of action of both growth factors during the final 
oocyte growth, oocyte maturation and early embryo development was elucidated. For 
this purpose, in current experiment was analyzed: 
 
Experiment 1.a. The gene expression patterns of EGF, IGF-1, their receptors (EGF-R 
and IGF-1R), and the IGFBPs 1-6 in: 1) the preovulatory follicle and, 2) the ovarian 
structure mainly involved in the early embryo development, such as the corpus luteum.  
 
Experiment 1.b. The mRNA transcripts for EGF and IGF-1 system in cumulus-oocyte 
complexes to reveal the possible direct implication of both growth factors during oocyte 
maturation in the guinea pig model and their autocrine and/ or paracrine response. 
 
EXPERIMENT 2. Immunolocalization of EGF-R and IGF-1R and their ligands 
(IGFBPs 1-6) in follicles, corpus luteum, cumulus-oocyte complexes and early 
embryos in the guinea pig model 
 
In line with the expression study, the objective of this experiment was to characterize the 
possible pattern of distribution for the EGF-R and IGF-1R and IGFBPs 1-6 proteins to 
establish the possible respond of the follicles, corpus luteum, cumulus-oocyte complexes 
and early embryos to both growth factors and the role of IGFBPs. For this purpose, in 
current experiment was analyzed: 
 
Experiment 2.a. The diferential localization by immunohistochemistry of EGF-R, IGF-
1R and their ligands (IGFBPs 1-6) in guinea pig ovaries. 
 
Experiment 2.b. The differential and temporal distribution by immunocytochemistry of 
EGF-R and IGF-1R and their ligands (IGFBPs 1-6) in cumulus-oocyte complexes and in 
the early embryos of guinea pig. 
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EXPERIMENT 3. Study of the effect of EGF and IGF-1 on nuclear and cytoplasmic 
in vitro oocyte maturation, apoptosis and steroidogenic production by the 
cumulus-oocyte complexes in the guinea pig model. 
 
The specific objective of this experiment after the immunolocalization of the EGF-R and 
IGF-1R in the oocytes and CCs was to investigate the direct role of different 
concentrations of EGF and IGF-1 during the in vitro oocyte maturation process in the 
guinea pig, to set up a possible defined medium useful in this specie. Furthermore, the 
description of patterns of cortical granules and mitochondrial distribution was done, due 
to their importance in the cytoplasmic maturation of the oocytes and the acquisition of 
their developmental competence. For these purpose in current experiment was 
performed: 
 
Experiment 3.a. Characterization of cortical granules and mitochondrial distribution 
patterns during in vitro oocyte maturation in the guinea pig. 
 
Experiment 3.b. Dose response study by supplementation of EGF on in vitro oocyte 
maturation system of guinea pig by assessment of nuclear and cytoplasmic oocyte 
maturation, apoptotic rate in CCs and steroidogenic response of cumulus-oocytes 
complexes. 
 
Experiment 3.c. Dose response study by supplementation of IGF-1 on in vitro oocyte 
maturation medium of guinea pig evaluating of nuclear and cytoplasmic oocyte 
maturation, apoptotic rate in CCs and steroidogenic response of cumulus-oocytes 
complexes. 
 
Experiment 3.d. Study of the effect of combination of EGF and IGF-1 on in vitro oocyte 
maturation of guinea pig by the study of nuclear and cytoplasmic oocyte maturation, 
apoptotic rate in CCs and steroidogenic response of cumulus- oocytes complexes. 
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Unless otherwise stated, all chemicals were purchased from Sigma Chemical Company 
(Alcobendas, Madrid, Spain). 
 
3.1. Animals and facilities 
 
All the animals used in the experiments were adult (3-4 months) female guinea pigs 
(Cavia porcellus), sexually mature with body weights ranged 450-550 g (Figure 11). 
 
 
 
 
Figure 11. Adult guinea pig of Peruvian breed 
 
Ovaries and reproductive tract were obtained from animals that were purchased from a 
breeding farm and maintained in the Agroecological station of the Department of 
Biological Sciences of the Universidad Técnica Particular de Loja (UTPL) or from a 
commercial farm (Sivisapa Farm, Chuquiribamba-Loja, Ecuador). In both facilities the 
animals were kept under the following environmental conditions: temperature (18-22 °C) 
and humidity (60 ± 5%); photoperiod constant with 12-h light/12 h darkness. They were 
caged in groups of eight to ten animals and were fed guinea pig pellets (vitamin C 
enriched) (Pronaca, Quito, Ecuador) and watered ad libitum. The experimental 
procedures described were approved by the Ethics Committee for Animal 
experimentation of the UTPL. All the animals were sacrificed according to ethical 
guidelines on Animal care (Close et al., 1997). 
 
3.2. Ovarian collection and transport  
 
The ovaries (Figure 12) were obtained from slaughtered animals by ventral midline 
laparotomy and transported to the laboratory in a flask desk with PBS + antibiotic (100 
IU (International Unit), 100 IU/mL) (A5955, antibiotic antimicotic, lyophilized ϒ- sterilized 
by irradiation, cell culture tested) at 37 °C. 
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Figure 12. A) Measurement in mm of guinea pig ovary, B) Guinea pig ovaries with follicles of 
different sizes visualized under stereoscopic microscope. 
 
 
3.3. Gene expression of EGF, IGF-1 and their receptors (EGF-R and IGF-1R), and 
IGFBPs 1-6 in ovaries, follicles and corpus luteum, and COCs in the guinea pig 
model 
 
A total of 19 non-synchronized females were used to collect ovaries and their structures 
for the study of the gene expression of EGF, IGF-1 and their receptors (EGF-R and IGF-
1R), and IGFBPs 1-6 by RT-PCR according with the procedures described below. 
 
3.3.1. Collection of ovaries, follicles and corpus luteum 
 
A sum of 13 ovaries was used to obtain total RNA from the ovary, follicles and corpus 
luteum. Ovaries (n=8) were collected and rinsed in PBS + 0.1% BSA (A9647; Bovine 
Serum Albumin, Fraction V, ≥ 96%) and embedded in RNAlater (Life Technologies, 
Gaithersburg, MD, USA) where they were maintained at 4 ºC overnight. Then the 
supernatant was removed and the ovaries were stored at -80 °C until RNA extraction. 
The rest of the ovaries (n=18) were used to obtain the follicles and corpus luteum. Then, 
ovaries were dissected into two halves and follicles were isolated in sterile conditions in 
laminar flood cabin by microdissection under a stereoscopic microscope. First, the 
connective tissue around the follicles was removed using a 26-gauge needle. Isolated 
follicles were categorized in antral (500 - 700 μm) (n=180) and preovulatory follicles 
(>700 μm) (n=90) and were stored at –80 ºC until used. Also all corpus luteum (n=10) 
found in the ovaries were processed by the same technique. 
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3.3.2. Collection and selection of cumulus-oocyte complexes 
 
Cumulus oocyte complexes (COCs) (n= 73) were collected from the rest of the ovaries 
(n=12) by follicular aspiration of the visible antral follicle (≥700 μm) in the ovarian surface 
with a 25 G needle connected to a syringe 2 mL using a stereomicroscope. COCs 
collected were washed several times in PBS+ 0.1% BSA, and CCs were mechanically 
removed by gentle repeated aspiration with a fine-bore pipette to get denuded oocytes 
and their corresponding CCs per separate. Groups of approximately 15 denuded oocytes 
were allocated in eppendorf (n=73) and then snap frozen in liquid nitrogen. The 
remaining CCs from those oocytes was centrifuged at 2000 × g for 5 min and the pellet 
was snap frozen in liquid nitrogen. Both oocytes and CCs were stored at -80 °C until 
RNA extraction process. 
 
3.3.3. Extraction of total RNA, mRNA purification and Reverse Transcription 
 
3.3.3.1. RNA extraction in ovaries, follicles and corpus luteum 
 
Total RNA was extracted using the PureLink RNA Mini kit (Ambion - Life Technologies, 
Gaithersburg, MD, USA) following the manufacturer’s instructions. A total of 750 
μLTRIzol® Reagent (Ambion - Life Technologies, Gaithersburg, MD, USA) was added 
to all samples of ovaries, antral follicles, preovulatory follicles and corpus luteum to 
maintain RNA integrity with inhibition of RNase activity. Mechanic manually 
homogenization with a plastic pestle was performed at room temperature (rt). Then, they 
were incubated for 5 min at rt to allow the complete dissociation of nucleoprotein 
complexes. After that, it was added 150 μL of chloroform (Panreac, Barcelona, Spain) to 
separate the aqueous (RNA-containing) layer from the organic layer (containing DNA 
and proteins), and the tube was vigorously shook by hand for 15 seconds. The samples 
were incubated for 3 min at rt and centrifuged at 12000 × g for 15 minutes (min) at 4 ºC. 
Then, the aqueous phase of the sample was removed by angling the tube at 45 ºC and 
pipetting the solution out to place into a new tube. A volume of 70 % ethanol (Panreac, 
Barcelona, Spain) for DNA precipitation, equal to the sample volume was added and 700 
μL of each sample were transferred to the commercial spin cartridge (with the collection 
tube) supplied in the kit, and centrifuged at 12000 × g for 15 seconds at rt. After that, 700 
μL of wash buffer was added to the spin cartridge and centrifuged for 15 seconds at rt. 
When the supernatant was discarded, the spin cartridge was placed into a new collection 
tube and 500 μL of another wash buffer with ethanol was added. Again, another 
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centrifugation at 12000 × g for 15 seconds at rt and then after throw away the 
supernatant, the empty membrane was dried with bound RNA by a 12000 × g for 2 min 
centrifugation. Finally, 100 μL of RNase-free water was added to the spin cartridge, 
incubated at rt for 1 minute and centrifuged for 2 min at 12000 × g to elute the total RNA 
from the membrane into the recovery tube. At that moment, the purified RNA was 
quantified by Biophotometer plus (Eppendorf, Hamburg, Germany) and stored at -80 ºC. 
 
3.3.3.2. RNA extraction in oocytes and cumulus cells  
 
Total RNA isolation in oocytes and CCs was similar to procedure described for tissues 
with some modifications. For these samples 300 μL of lysis buffer of the PureLink RNA 
Mini kit (Ambion - Life Technologies, Gaithersburg, MD, USA) and 3 μL of 2-
mercaptoethanol was added. The lysate was homogenized through a syringe (1 mL) with 
20-gauge needle; then it was added 300 μL of 70% ethanol (Panreac, Barcelona, Spain) 
and the total volume of the sample was transferred to a spin cartridge (with the collection 
tube) following then the same procedure that described above. The isolated total RNA 
was also quantified and stored at -80 ºC. 
 
3.3.3.3. mRNA purification in ovaries, antral and preovulatory follicles, corpus 
luteum, oocytes and cumulus cells 
 
Specific extraction of mRNA was performed by incubation of the samples (ovaries, antral 
follicles, preovulatory follicles, corpus luteum, oocytes and CCs) with super-
paramagnetic polystyrene beads coated with oligo ((deoxy-thymidine nucleotides (dT)) 
sequence, and processed according to the manufacturer’s protocol for Dynabeads® 
mRNA Purification kit (Ambion - Life Technologies, Gaithersburg, MD, USA) with minor 
modifications. Briefly; 100 μL of the total RNA extracted of each type of sample was 
added to the Dynabeads/Binding Buffer suspension (100 μL). The solution tube was 
mixed thoroughly for 3-5 min at rt to allow mRNA to anneal to the oligo (dT) on the beads 
and it was placed on the magnet until solution was clear; afterward the supernatant was 
removed. The tubes were removed from the magnet and the mRNA-bead complex 
washed twice with 200 μL of Washing Buffer provided by the kit. All the supernatant was 
removed between each washing step with the help of the magnet. Finally, 20 μL of 10 
milimolar (mM)Tris- Hydrochloric acid (HCl) was added and the samples were 
maintained in heat to 75 °C for 2 min in a thermoblock. Finally, the tube was placed 
immediately on the magnet and the eluted mRNA transferred to a new RNase-free tube 
(Ambion - Life Technologies, Gaithersburg, MD, USA). 
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3.3.3.4. Reverse transcription 
 
Reverse transcription reaction was performed using SuperScript™ First-Strand 
Synthesis System for RT-PCR, to synthesize complementary DNA (cDNA) from mRNA, 
using poly(A) RNA, Oligo (dT), random hexamers and SuperScript II™ RT (reverse 
transcriptase Moloney murine leukaemia virus enzyme (MMLV) genetically engineered 
with reduced RNase H activity) (Invitrogen - Life Technologies, Gaithersburg, MD, USA). 
 
First, to get a total volume of 10 μL of mRNA for each reaction the following components 
was combined in a sterile tube: 2 μL of mRNA sample, 1 μL of 10 mM deoxynucleotide 
(dNTP) mix, 2 μL Random hexamers (50 ng/mL), 1 μL Oligo dT primers (0.5 μg/μL), 4 
μL DEPC-treated (Diethyl pyrocarbonate) water. This mixture was heated at 65 ºC for 5 
min in a thermoblock to denature the secondary mRNA structure and then place on ice 
for 1 min. In a separate tube, it was prepared the 2X reaction mix, adding each 
component in the following order: 2 μL of 10X RT buffer, 4 μL 25 mM MgCl2, 2 μL 0.1 M 
Dithiothreitol (DTT) and 1 μL RNase OUT™ (40 U/μL). Then, 9 μL of the 2X reaction mix 
was added to each mRNA mixture tube and the control sample tube. After that, it was 
mixed gently and collected by brief centrifugation. The reactions were incubated at 42 
ºC for 2 min. After added 1 μL of SuperScript™ II RT (1U/ μL) to each tube, they were 
incubated at 42 °C for 50 min in a Thermo-Shaker for microtubes (TS-100, BioSan, 
Latvia) to allow retrotranscription of mRNA, followed by incubation at 70 ºC for 15 min to 
denature the RT enzyme and finally cooled on ice. At the end, a brief spin was performed 
and 1 μL of RNase H (2 U/μL) (Invitrogen - Life Technologies, Gaithersburg, MD, USA) 
was added to each tube. After, incubation for 20 min at 37 °C to get a greater full-length 
cDNA synthesis, the volumen total of cDNA samples (720 μL) were stored at -20 ° C until 
use. Reverse transcriptase negative (RT-) controls containing all the RT-PCR reagents, 
except SuperScript™ II Reverse Transcriptase (RT) were used to check genomic DNA 
contamination. 
 
3.3.4. Polymerase chain reaction  
 
PCR (Polymerase Chain Reaction) reactions were performed with an equal amount of 
cDNA (2 μL) in triplicate in a 0.5-mL thin-walled PCR tube eppendorf following the 
manufacturer’s instructions of Platinum® Taq DNA polymerase (Invitrogen, Carlsbad, 
CA). First, the PCR master mix was prepared to obtain a total volume of 25 μL adding 
the following components to each tube: 2.5 μL of 10 X PCR Buffer (Invitrogen, Carlsbad, 
CA), 0.75 μL of 50 μM MgCl2 (Invitrogen, Carlsbad, CA), 0.5 μL of 10 mM dNTP mix 
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(Invitrogen, Carlsbad, CA), 0.5 μL of each forward and reverse primers, 1 μL of cDNA,0.1 
μLTaq DNA polymerase (Invitrogen, Carlsbad, CA) and 19.15 μL of DEPC-treated water 
to complete a total volume of 25 μL. In the negative control the cDNA was replaced by 
DEPC-treated water. Specific primers were used at a concentration of 10 μM/μL in each 
reaction and are summarized in Table 2. Intron-spanning primers were designed using 
the Primer-BLAST software (www.ncbi.nlm.nih.gov/tools/primersblast/) and validated 
using OligoAnalyser program. Each sample was analyzed in triplicate using eppendorf 
for PCR (Eppendorf, Hamburg, Germany) and template controls (water in place of cDNA) 
were used in each reaction. The RT-PCR (for ovaries, follicles, corpus luteum and COCs) 
was performed in a Mastercycler (Eppendorf, Hamburg, Germany) with the following 
conditions: an initial denaturation and activation of the polymerase for 2 min at 94 °C, 
followed by 40 cycles (94 °C for 30 seconds; specific temperature (see Table 2 for each 
gene) for 30 seconds and 72 ºC for 40 seconds). The final extension at 72 ºC incubation 
was continued for a further 7 min to increase PCR sensitivity. 
 
Table 2. Oligonucleotide primers for amplification of genes of interest in RT-PCR 
analysis of different samples of guinea pig. 
Target gene Primer sequence (5´to 3´) Sense 
Annealing 
temperature (◦C) 
Fragment 
size (pb) 
EGF 
CAGACAGTGGGAAGTCTGT sense 
53 89 
TCGTGGGCGAGAGATATTTT antisense 
EGF-R 
CCTTCCTGAAGACCATCCAG sense 
55 130 
GCCAGAGCATAGGTGTTCTCA antisense 
IGF-1 
GACGCAGAAGGAAGTACATT sense 
56 104 
TGACGTGTCGTTCTTCACC antisense 
IGF-1R 
TGTCCACAGAGACCTTGCTG sense 
53 122 
CTTTCCCTCCTTTCCGGTAG antisense 
IGFBP-1 
AAAGTGGAAGCCGTGCCA sense 
58 11 
CCATTCTTGTTGCAGTTAGG antisense 
IGFBP-2 
GCAGGTTGCAGACAATGGTGA sense 
55 139 
GACAGCCAGTTCCTTCATGC antisense 
IGFBP-3 
CCTCCGCTCCAGGAAATG sense 
55 60 
GGGTCTCCACGCTGCTAGT antisense 
IGFBP-4 
AGCCCGCCGACAAGGATG sense 
58 141 
CCCCGACGACCTTCATCT antisense 
IGFBP-5 
GCCAAGATCGAGAAAGACTC sense 
56 71 
GCGTAGGTCTCTTCGGTCA antisense 
IGFBP-6 
AAGCGGCAGTGTCGATCTTCA sense 
58 112 
GGCAGTGTGAGCTTCTGTCA antisense 
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Gene expression of studied genes was normalized to β -actin expression according to 
Dubey et al. (2015) and Ritter et al. (2015). Normalization is the result of the relative 
expression of each studied genes respect to actin (Table 3). 
 
Table 3. The nucleotide sequences of the β-Actin primer used as target gene in RT-
PCR. 
Target gene Primer sequence (5´to 3´) Sense 
Annealing 
temperature (◦C) 
Fragment 
size (pb) 
β -ACTIN 
AAGATGACCCAGATCATGTTCG sense 
53-58 158 
GCGTAGCCCTCGTAGATGG antisense 
 
 
PCR products of follicle, corpus luteum and COCs, were separated by electrophoresis 
on 2 % agarose gel and visualized by Real safe nucleic acid staining solution (Durviz, 
Valencia, España). The molecular marker used was 100 bp ladder (Biotools, Madrid, 
Spain). The image of all gels was recorded using a Universal Hood II system equipped 
with Gel Doc XR camera with MZL (BIO-RAD Laboratories, Milan, Italy). 
 
Semi-quantitative RT-PCR was chosen to estimate the transcript of EGF, EGF-R, IGF1, 
IGF-1R and IGFBPs. Gene β-actin (housekeeping) was examined in all samples 
(follicles, CCs, oocytes and corpus luteum) to confirm the integrity of the mRNA 
according to Dubey et al. (2015). To normalize different experimental samples, band 
density of β-actin was also calculated, along with band density of targeted genes, using 
densitometry by means of Image J 1.47v software (NIH, Bethesda, Maryland 
(http://imagej.nih.gov/ij)). Relative expression was determined in arbitrary units, defined 
as the ratio of mRNA level to the corresponding β-actin mRNA level. The results were 
expressed as the difference of the densitometric readings for the genes analyzed on β-
actin; therefore, values indicate relative changes in mRNA levels. Mean values of three 
measurements for each gene in each sample band were taken for the analysis. 
 
3.4. Immunolocalization of EGF-R and IGF-1R receptors and IGFBPs 1-6 in the 
guinea pig ovary 
 
3.4.1. Ovary fixation  
 
Ovary samples were fixed in PBS containing 4% wt/vol (weigth/volume) buffered neutral 
paraformaldehyde solution (pH 7.2–7.4) and embedded in paraffin blocks which were 
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cut in 5 μm sections and mounted on glass slides in the Histology Facilities of the 
National Center for Biotechnology (CNB- CSIC, Madrid, Spain).  
 
3.4.2. Immunohistochemistry of EGF-R and IGF-1R in guinea pig ovaries 
 
Immunohistochemical study for EGF and IGF-1 receptors (EGF-R and IGF-1R, 
respectively) was performed in 10 sections of 9 ovaries for each receptor (n=18). 
Immunohistochemical staining was performed by avidin–biotin immunoperoxidase 
system according to a previously described protocol by Arias-Álvarez et al. (2010) with 
some modifications. Sections were deparaffinized in xylene (Panreac, Barcelona, Spain) 
and alcohol (Panreac, Barcelona, Spain) series (100º, 96º and 70º). The endogenous 
peroxidase activity was blocked by incubating the sections with 0.3% v/v 
(volume/volume) hydrogen peroxide (Panreac, Barcelona, Spain) in methanol solution 
(Panreac, Barcelona, Spain) for 30 min, and nonspecific protein-binding sites was 
blocked with normal goat serum (1:10, sc-2043, Santa Cruz Biotechnology, CA, USA) in 
PBS at rt for 30 min. Then, the sections were incubated with EGF-R rabbit polyclonal 
IgG (1:100, sc-03, Santa Cruz Biotechnology, CA, USA) or IGF-1R rabbit polyclonal 
antibody (1:100, sc-7952, Santa Cruz Biotechnology) overnight at 4 °C in a humidified 
chamber. Subsequently, the sections were incubated with a secondary biotinylated anti-
rabbit IgG antibody (1:200, Vector Laboratories, Burlingame, CA, USA) for 30 min at rt 
and then incubated with Avidin-Biotin-Complex (ABC Vector Elite kit, Vector Laboratories 
Burlingame, CA, USA). After the incubation with chromogen (Vector Nova RED substrate 
Kit for Peroxidase, Vector Laboratories Burlingame, CA, USA) for 3 min, the sections 
were counterstained with hematoxylin, dehydrated and mounted in Depex medium. 
Finally, they were observed under a light microscope equipped with a digital camera 
(F550; Leica, Wetzlar, Germany). The intensity of immunohistochemical staining was 
graded as follows: (–) no immunostaining; (+) weak staining; (++) moderate staining and 
(+++) strong staining.  
 
Some of the sections were stained with hematoxylin – eosin and the ovarian follicles 
were previously categorized as primordial, primary, secondary and antral follice 
according to the morphology of the follicular cells described by Sadeu et al. (2007) 
(Figure 13). 
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Figure 13. Follicles in guinea pig ovaries. A) Primary follicle, B) Secondary follicle, C) antral follicle 
and, D) corpus luteum. GC (Granulosa Cells), Oo (Oocyte), T (Theca cells), CL (Corpus luteum), 
p (primordial follicle). Scale is 100 μm. 
 
3.4.3. Immmunohistochemistry of IGFBPs 1-6 in guinea pig ovaries 
 
A total of 12 ovaries from 6 animals were used for the immunolocalization of IGFBPs. 
Each IGFBPs (1, 2, 3, 4, 5 and 6) were analyzed in 4 sections per ovary, therefore a total 
of 288 sections were studied (48 sections per each IGFBPs). 
 
Samples for IGFBPs immunolocalization were processed as described above for the 
immunohistochemical study of EGF-R and IGF-1R with some modifications. The 
sections were incubated with blocking horse serum at a concentration of 1:10 (sc-2483, 
Santa Cruz Biotechnology, CA, USA) in PBS for 30 min. Primary goat polyclonal antibody 
IGFBP-1 (1:200, sc-6072), IGFBP-2 (1:200, sc-6001), IGFBP-3 (1:50, sc-6003), IGFBP-
4 (1:50, sc-6005), IGFBP-5 (1:50, sc-6006) and IGFBP-6 (1:50, sc-6007) (Santa Cruz 
Biotechnology, CA, USA) were diluted in the blocking serum and incubated at 4 °C 
overnight. According to data sheet of products, each specific antibody had shown no 
cross-reactivity with other IGFBPs family. Secondary biotinylated anti-goat IgG antibody 
(Vector Laboratories, Burlingame, CA, USA) was used at a concentration of 1:200 in 
PBS. In all the negative controls, the primary antibody was replaced with blocking serum. 
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Sections were counterstained with hematoxylin, photographed and assessed under a 
light microscope equipped with a digital camera (F550; Leica, Wetzlar, Germany). The 
intensity of immunohistochemical staining was graded as described before in: (–) no 
immunostaining; (+) weak staining; (++) moderate staining and (+++) strong staining. 
 
3.5. Immunolocalization of EGF-R and IGF-1R and IGFBPs 1-6 in cumulus-oocyte 
complexes and early embryos 
 
3.5.1. Collection and selection of cumulus-oocyte complexes  
 
COCs were collected by aspiration of antral follicles (>700 μm diameter) on the ovary 
surface under a stereoscopic microscope (Sadeu et al., 2007), with a 25 G needle 
connected to a syringe 2 mL. Then COCs were washed in 35 mm Petri dishes 
(NunclonTM Surface, NuncTM, Roskilde, Denmark) with PBS (pH 7.4) + 0.1% BSA at 
37 °C and selected for in vitro maturation based on morphological criteria of homogeneity 
in the cumulus and cytoplasm, as described by Jacquet et al. (1995).  
 
For the immunocytochemistry a total of 160 COCs were used immediately after follicular 
aspiration and 48 COCs after in vitro maturation. Among them, a total of 80 immature 
COCs and 24 in vitro matured oocytes were denuded mechanically by repeated 
aspiration with a fine-bore pipette, as described above. Oocytes were treated with 0.5% 
pronase (Protease type XIV, from Streptomyces griseous®) in PBS for a few min to 
remove the ZP. All the oocytes (denuded or with CCs) before and after in vitro maturation 
were fixed in PBS containing 4% wt/vol buffered neutral paraformaldehyde solution (pH 
7.2–7.4) for 30 min and stored in PBS at 4 ºC until processed.  
 
3.5.2. Collection and selection of early embryos 
 
A total of 23 females were used for the immunocytochemistry of early embryos. First, the 
exact day of ovulation and copulation was determined so each female was checked twice 
a day (at 6:00 am and 18:00 pm) to detect the opening of the vaginal membrane. If half 
of the vaginal membrane was perforated, the female was separated and placed with a 
sexually tested male in the cage; subsequently, the vaginal smears continued once every 
12 h for every female. Vaginal smears to evaluate estrus were performed with sterile 
swab, which was previously moistened with saline solution and gently inserted into the 
vagina at an angle of approximately 45 ºC. After 1 cm of the swab was inserted, the 
angle of insertion varied to 90 ºC and continued inserting it until completing 2 cm lenght. 
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When the swab was fully inserted, the end was rotated a 2 to 3 revolutions, allowing the 
cotton tip to pick up an adequate load of cells. Then the swab was removed gently. The 
smears were prepared immediately after with drawal of the swab by rolling the cotton tip 
along the length of a glass slide. For fixation, slides were dipped 10 min in a container of 
methanol (Panreac, Barcelona, Spain). Then, the slides were then allowed to dry 
completely. After fixation slides were stained with Giemsa 10% (G48900) for 15 min and 
rinsed in distilled water. Examination was done under an optical microscope (Olympus, 
CX31R, Tokyo, Japan). Ovulation (Day 0) was confirmed by leukocyte influx in the 
vaginal smear on the day following the observation of a cornified cell-rich vaginal smear 
(Young, 1937; Suzuki et al., 2003; Grégoire et al., 2012) (Figure 14). 
 
 
 
 
Figure 14. Cytological assessment of vaginal smear of guinea pig. A) Proestrus, round nucleated 
epithelial cells predominated), B) Estrus (the predominant cells are cornified squamous epithelial 
cells), C) Metaestrus (cornified squamous epithelial cells and small stained leukocytes), D) 
Diestrus (nucleated epithelial cells, cornified squamous epithelial cells and leukocytes are 
present). In all the pictures, the representative cell is indicated by the arrow. Photographs by the 
author. 
 
Finally, the presence of a mucous plug in the vagina and vaginal smear analized 
confirmed the copulation. Once the plug was checked, the females were separated from 
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the male. At day 2, 3 and 4 post-ovulation the females were sacrificed and the 
reproductive tract was collected and flushed with PBS supplemented with 0.1% BSA at 
37 °C from the oviduct to the uterus. We recovered embryos in different developmental 
stages that were classificated as: 2 to 4-cells embryos (n=22, recovered at 2 days after 
having detected the mucous plug), 8 to 16-cells embryos (n=21, recovered at 3 days 
after having detected the mucous plug) and morulae (n=16, recovered at 4 days after 
having detected the mucous plug). After several washes in PBS-BSA (0.1 %) selected 
embryos of grade 1 and 2 ((according to the International Embryo Technology Society 
(IETS) guidelines)) were fixed in PBS containing 4% wt/vol buffered neutral 
paraformaldehyde solution (pH 7.2–7.4) during 30 min and then stored at 4 ºC in PBS 
until their use. 
 
3.5.3. Immunocytochemistry of EGF-R and IGF-1R in cumulus-oocyte complexes 
and early embryos 
 
Immunocytochemistry for the detection of EGF-R and IGF-1R were carried out in 
immature COCs (n=40), of which were obtained denuded oocytes (n=20) and CCs 
(n=20). Also, in vitro matured COCs (n=24), in vitro matured oocytes (n=24) and early 
embryos (n=59) were used. Process was performed according to a previously described 
protocol by Agirregoitia et al. (2012), with some modifications. After fixing in PBS 
containing 4% wt/vol buffered neutral paraformaldehyde solution for 30 min, samples 
were placed on a coverslip covered with poly-L-lysine and then permeabilized with 1% 
Triton X-100 for 10 min at rt. The next step was an incubation for 45 min in PBS and 10% 
v/v goat serum at rt. For indirect immunofluorescence staining, the coverslips were 
incubated with EGF-R or IGF-1R rabbit polyclonal IgG (1:100, sc-03 and sc-7952, 
respectively, Santa Cruz Biotechnology, Santa Cruz, CA, USA) overnight at 4 °C. In the 
negative controls the primary antibody incubation was replaced with goat serum after the 
slides were washed three times with PBS. All the samples were incubated with Alexa 
Fluor 488 goat anti rabbit secondary antibody (1:1000 A-11034, Life Technologies, USA) 
for 1 h at rt in the dark; later, they were washed three times with PBS (during the second 
washed the nuclei was stained with Hoechst 33342) and finally they were washed with 
distilled water. For assembly of the oocytes, a drop of Prolong (Gold antifade reagent, 
Invitrogen, Oregon, USA) was placed on a slide. A drop of paraffin was placed in each 
corner of the coverslip to preserve the shape of oocytes and COCs intact. The samples 
were examined by confocal scanning microscopy (Leica, SP2, Wetzlar, Germany) in the 
Interdepartmental Investigation Service (SIdI) of the Universidad Autónoma de Madrid 
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(Madrid, Spain), using using 488 nanometers (nm) excitation laser.  The format, laser 
gain and offset were kept constant for every sample.  
 
3.5.4. Immunocytochemistry of IGFBPs 1-6 in oocytes and cumulus-oocyte 
complexes 
 
Immunocytochemistry for the detection of IGFBPs 1-6 were carried out in a total of 60 
COCs and 60 denuded oocytes. For the IGFBPs localization, the protocol and primary 
antibodies used was performed as described above in section (3.4.3) with some 
modifications. Blocking serum employed was donkey serum diluted to 10% v/v (sc-2044, 
Santa Cruz Biotechnology, CA, USA) and Alexa Fluor 488 of donkey anti goat was used 
as secondary antibody (Ref: 705-545-147, Jackson ImmunoResearch, PA, USA). For 
assembly of the oocytes procedure was the same that described before in section 
(3.5.3.) as well as the visualization.  
 
3.5.5. Quantification of the immunofluorescence intensity 
 
For quantification of the immunofluorescence intensity a total of 40 oocytes and their 
corresponding CCs were used before (n=32) and after (n=8) in vitro maturation to asses 
EGF-R and IGF-1R and IGFBP 1-6. In the 2-4 cell embryos (n=6), 8-16 cell embryos 
(n=6) and morula (n=6) the EGF-R and IGF-1R were localized as well. All the images 
were acquired under the same intensity parameters and the Image J program was used 
for quantification. A First, an analysis area was selected for each receptor and the ROI 
tool (region of interest) was used to provide an average fluorescence intensity. An 
identical ROI (4 equidistant intensity values measured in pixels) were taken for each 
sample. Measure the display area in pixels was analyzed statistically (Papadopulos et 
al., 2007; Jensen, 2013; Dunning et al., 2014).  
 
3.6. Role of EGF and IGF-1 on nuclear and cytoplasmic in vitro oocyte maturation  
 
An IVM dose response study using EGF or IGF-1 and their combination were carried 
out. Assessment of nuclear maturation (M-II rate), cytoplasmic oocyte maturation, in 
terms of cortical granule migration and mitochondria relocation, apoptosis rate in CCs 
and steroidogenic production by the COCs in the spent maturation medium were 
performed. 
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3.6.1. Recovery, selection of cumulus-oocyte complexes and in vitro oocyte 
maturation systems 
 
Ovaries (n=220) were transported from the abattoir to the laboratory at 37 °C in PBS 
supplemented with antibiotic (100 IU, 100 IU/mL) (A5955, antibiotic antimicotic, 
lyophilized ϒ- sterilized by irradiation, cell culture tested).  
 
 
 
Figure 15. Cumulus- oocyte complexes (COCs) suitable for IVM. (CCs) cumulus cells. 
 
Ovaries were transported and COCs (Figure 15) were obtained as described before (see 
section 3.2). The maturation medium consisted of TCM-199 (M4530) enriched with 2 
mM/mL glutamine (G3126, L Glutamine, cell culture tested, irradiated®ϒ), 0.1 mg/mL 
sodium pyruvate (P2256) and 0.003% wt/vol BSA. Stock solutions of EGF from mouse 
submandibulary glands (E4127) and IGF-1 from human recombinant growth factors 
(I3769) were diluted and added to TCM-199 as described above. Groups of 30-32 COCs 
with intact and unexpanded CCs were cultured at 37 °C in 5% CO2 in air and maximum 
humidity for 17 h in an incubator (Forma™ Series II 3110 Water-Jacketed CO2 Incubator, 
USA). 
 
A total of 1746 COCs were used in three experiments and each experiment was repeated 
four times (Figure 16, 17 and 18). In Experiment 1, 622 COCs were IVM with different 
concentration of EGF and 10% FCS. 
 
 
Figure 16. Experimental design of EGF for IVM. 
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In Experiment 2, 624 COCs were IVM with different of concentration IGF-1 and 10% 
FCS. 
 
 
 
Figure 17. Experimental design of IGF-1 for IVM. 
 
In Experiment 3, 500 COCs were supplemented with the concentrations of EGF and 
IGF-1 that showed the best maturation results in experiments 1 and 2 (50 ng/mL EGF 
and 100 ng/mL IGF-1), with or without FCS as follows: group 0 (non- supplemented); 
group EI (EGF + IGF-1); group EI-FCS (EGF + IGF-1 + 10% (v/v) FCS) and group FCS 
(10% (v/v) FCS) 
 
 
Figure 18. Experimental design of EGF and IGF-1 combination for IVM 
 
3.6.2. Assessment of nuclear and cytoplasmic maturation by confocal microscopy 
 
3.6.2.1. Nuclear oocyte maturation  
 
After IVM, oocytes (n=1588) were mechanically denuded by repeated aspiration with a 
fine-bore pipette and fixed in 4% wt/vol buffered neutral paraformaldehyde solution. 
Chromosomes were stained with Hoechst 33342 (10 µg/mL) and nuclear maturation was 
measured as M-II under fluorescent microscope (F550; Leica, Germany). Among these 
oocytes a total of 594 oocytes were also stained to visualize cortical granules (n=382) 
and mitochondria (n=212). 
 
3.6.2.2. Cortical granule and mitochondrial distribution  
 
Visualization of cortical granules was performed according to Arias-Álvarez et al. (2009) 
with minor modifications; oocytes were treated with 0.5% wt/vol pronase after CCs 
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removal, fixed in 4% v/v paraformaldehyde, and stored in PBS at 4 ºC. Then, oocytes 
were treated with 0.02% v/v Tritón X-100 and 7.5% wt/vol BSA in PBS. Cortical granules 
were stained with FITC of Lens culinaris (100 mg/mL). For mitochondrial visualization, 
oocytes were treated with 0.5% wt/vol pronase and stained with 180 nMMitoTracker Red 
CMX Ros (Molecular Probes Inc., USA) following manufacturer’s instructions. The 
fluorescent dye only was accumulated in active mitochondria. Oocytes were examined 
under a confocal laser-scanning microscope (Leica, TCS SP2, Germany) at 488 and 546 
nm to visualize cortical granules and mitochondria, respectively. The format, laser, gain 
and offset were kept constant for every sample. Sections of each 5 µm were made for 
each oocyte and a maximum projection was accomplished for each one. 
 
Furthermore, a total of 40 immature guinea pig oocytes were also used for visualize 
cortical granules (n=20) and mitochondrial migration patterns (n=20) before maturation. 
These migration patterns were described based in the adaptation from previous studies 
in other species for cortical granules (Damiani et al., 1995; Arias-Alvarez et al., 2009) 
and for mitochondria (Li and Fan, 1997; Leoni et al., 2015). 
 
3.6.3. Cumulus cell apoptosis  
 
Apoptosis were analyzed as previously described by Arias-Alvarez et al. (2010) using 
the In Situ Cell Death Detection Kit, POD (Roche Diagnostics S.L., Spain) following the 
manufacturer’s instructions. COCs were washed three times in PBS supplemented with 
0.1% polyvinylpyrrolidone (PVP) (P0930, powder, BioXtra) and then fixed in 4% 
paraformaldehyde solution for 1 h at rt. The COCs were pretreated with Triton X-100 
0.5% diluted in PBS for 1 h 20 min in a humid chamber. Incubation with the TUNEL 
(Terminal deoxynucleotidyl transferase dUTP nick end labeling) reaction was made 
under the same conditions (In Situ Cell Death Detection Kit, POD, Roche Diagnostics 
SL, Applied Science, Barcelona, Spain). Positive control sections were treated with 
deoxyribonuclease (DNase I) (Roche Diagnostics SL, Applied Science) for 10 min at rt 
in a humidified chamber prior to incubation with the TUNEL reagent. For negative 
controls, the samples were incubated only with the label solution TUNEL reaction mixture 
without the enzyme solution. In order to avoid RNA interferences, all COCs were treated 
with RNAses before staining. COCs were counterstained with Hoechst 33342 for 15 min, 
mounted between a coverslip and a glass slide in a mounting solution (ProLong® Gold 
antifade reagent, Invitrogen, USA) and observed under a fluorescent microscope (F550; 
Leica, Germany) (Figure 19). Samples were analyzed using IMAGE J/FIJI 1.46 software 
(Ferreira and Rasband, 2012). The apoptosis index was calculated as the relation 
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between green area and blue area ×100, and was log10-transformed before statistical 
analysis to achieve normal distribution. 
 
 
 
Figure 19. Cumulus cell apoptosis measured by TUNEL assay in guinea pig COCs after in vitro 
maturation. A) Showing all nucleus of CCs stained with Hoechst, B) showing TUNEL staining 
labelled cells considered as apoptotic. Scale bar 30 μm. 
 
3.6.4. Steroidogenic production of cumulus-oocyte complexes 
 
Steroid concentration in the spent maturation medium of each well were collected before 
and after oocyte maturation and stored at -20 ºC until processing. Then, E2 and P4 were 
measured in duplicate by Enzyme-Linked ImmunoSorbent Assay (ELISA) assay, based 
on the principle of competitive binding using a specific kit for E2 and P4 (DEMEDITEC 
Diagnostics GmbH, Kile, Germany) (Arias-Alvarez et al., 2010). The absorbance of the 
samples was analyzed with a spectrophotometer (Benchmark Plus Microplate 
Spectrophotometer, BIO-RAD, Hercules, California USA). Inter and intra-assay 
coefficients of variation were 6.71% and 5.60% for P4, and 5.43% and 5.47% for E2, 
respectively. The range of the assay was between 0-40 ng/mL (P4) and 0-200 pg/mL 
(E2). Results are expressed as the average E2 and P4 levels produced by each COCs 
after IVM. 
 
3.7. Statistical analysis 
 
Data were analyzed using the SPSS version 19 (IBM SPSS Statistics). 
 
The mRNA transcript expression between all genes of interest studied in antral follicle, 
preovulatory follicle and corpus luteum were analyzed by a one-way ANOVA test using 
Tukey post- hoc test or Kruskall-Wallis test for non-parametrical samples. To compare 
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gene expression between oocytes and their corresponding CCs a t-student test was 
used. The Shapiro’ Wilks test was previously used to assess normality and homogeneity 
of variance.  
 
The quantification of the immunofluorescence intensity for EGF-R, IGF-1R in the early 
embryos stages and of IGFBPs in immature CCs and oocytes was analyzed by a one-
way ANOVA test using the Tukey post-hoc test or the Kruskall- Wallis for non-parametric 
samples. A t-student test was used to compare the immunofluorescence intensity 
between mature and immature CCs and oocytes and for comparing diferential 
immunofluorescence between oocytes and CCs for each IGFBP. The Shapiro 'Wilks test 
was previously used to assess the normality and homogeneity of the variance. 
 
Mean values were subjected to Chi-square test to compare nuclear maturation, cortical 
granules and mitochondria migration rates of IVM oocytes among experimental groups.  
 
Apoptotic index and steroidogenesis production by the COCs after IVM were analyzed 
by a one-way ANOVA test using Tukey post- hoc test as well. The Shapiro’ Wilks test 
was previously used to assess normality and homogeneity of variance.  
 
Data were expressed as the mean ± s.e.m. (standard error of the mean) and the 
differences were considered significant when P<0.05. 
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4.1. EXPERIMENT 1. Expression of mRNA encoding EGF, IGF-1 and their receptors 
(EGF-R and IGF-1R), and the IGFBPs 1-6 in the preantral and antral follicles, 
corpus luteum and cumulus-oocyte complexes in the guinea pig model. 
 
We assessed the gene expression of EGF, EGF-R, IGF-1, IGF-1R and the IGFBPs 1-6 
in the guinea pig ovary. Gene expression of all genes mentioned were localized in the 
ovarian structures involved in the final oocyte growth and maturation, such as antral 
follicles and preovulatory follicles, and in the early embryo development, such as corpus 
luteum. Oocytes and their corresponding CCs, also diferentially express all candidate 
genes. Therefore, this Thesis demonstrates that the guinea pig ovary expresses the EGF 
and IGF-1 system, included all IGFBPs. For each sample the mean expression of total 
RNA was determined: whole ovary: 814.3 ng/µL (nanograms/microlitter), preovulatory 
follicles: 549 ng/µL, antral follicles: 485.3 ng/µL, oocyte: 352.6 ng/µL, CCs: 248.6 ng/µL 
and corpus luteum: 575.3 ng/µL. 
 
4.1.1. Expression of mRNA encoding EGF and EGF-R in guinea pig ovaries, antral 
follicles, preovulatory follicles, corpus luteum, denuded oocytes and their 
cumulus cells 
 
Expression of mRNA showed that both EGF and EGF-R were expressed in the guinea 
pig ovary and in all structures studied in the current work (antral follicles, preovulatory 
follicles, denuded oocytes and CCs). The amplified cDNA fragments were identified with 
89 bp for EGF, 130 bp for EGF-R and 158bp for β-actin (Figure 20). 
 
Figure 20. Representative electrophoresis in a 2% agarose gel showing the expression. A) EGF, 
B) EGF-R, C) β-actin in guinea pig. OV (Whole ovary), PF (Preovulatory Follicle), AF (Antral 
Follicles), Oo (Oocytes), CCs (Cumulus Cells), CL (Corpus luteum), NC (Negative Control) and 
Mm (100 bp DNA marker).  
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As it is shown in Figure 21, expression level of EGF and EGF-R was significantly higher 
in antral follicles compared to the preovulatory follicles (P<0.05). Corpus luteum 
showed lower mRNA transcripts of EGF than those observed in antral follicles and 
preovulatory follicles (P<0.05) but showed similar values of EGF-R than those found 
in the antral follicles. In oocytes mRNA transcripts of both EGF and EGF-R were 
significantly higher than in CCs (Figure 22). 
 
 
 
Figure 21. EGF and EGF-R mRNA expression in ovarian antral and preovulatory follicles, and 
corpus luteum. Densitometry readings of A) EGF, B) EGF-R (are presented as ratio of readings 
of corresponding β-actin samples in guinea pig ovarian structures studied. AF (Antral Follicles), 
PF (Preovulatory Follicle), and CL (Corpus luteum). Bar diagram represent the mean of the 
normalized integral density for each mRNA band (mean ± s.e.m). Different letters indicate 
significant differences (P 0.05). 
 
 
 
 
Figure 22. EGF and EGF-R mRNA expression in oocytes and their corresponding cumulus cells. 
Densitometry readings of A) EGF, B) EGF-R (are presented as ratio of readings of corresponding 
β-actin samples in guinea pig. Oo (Oocyte) and CCs (Cumulus Cells). Bar diagram represent the 
mean of the normalized integral density for each mRNA band (mean ± s.e.m). Different letters 
indicate significant differences (P 0.05). 
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4.1.2. Expression of mRNA encoding IGF-1 and IGF-1R in guinea pig antral 
follicles, preovulatory follicles, corpus luteum, denuded oocytes and their 
cumulus cells 
 
Expression of IGF-1 and IGF-1R mRNA could be detected in the whole ovary and 
specifically in antral and preovulatory follicles, corpus luteum, denuded oocytes and their 
CCs. The amplified cDNA fragments were 104 and 122 bp, for IGF-1 and IGF-1R, 
respectively (Figure 23). 
 
 
 
 
Figure 23. Representative electrophoresis in a 2% agarose gel showing the expression of A) IGF-
1, B) IGF-1R, C) β-actin in guinea pig ovary. OV (Whole ovary), PF (Preovulatory Follicle), AF 
(Antral Follicles), Oo (Oocytes), CCs (Cumulus Cells), CL (Corpus luteum), NC (Negative Control) 
and Mm (100 bp DNA marker).  
 
As depicted in Figure 24 expression level of IGF-1 and IGF-1R was significantly higher 
in antral follicles compared to the preovulatory follicles (P<0.05). Corpus luteum showed 
the highest mRNA transcripts of IGF-1R (P<0.05) but showed intermediate values of 
IGF-1 compared with those found in antral and preovulatory follicles. Oocytes showed 
significantly higher IGF-1 mRNA transcripts (P<0.05) but lower IGF-1R (P<0.05) than 
their corresponding cumulus cells.  
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Figure 24. IGF-1 and IGF-1R mRNA expression in ovarian antral and preovulatory follicles, and 
corpus luteum. Densitometry readings of A) IGF-1, B) IGF-1R (are presented as ratio of readings 
of corresponding β-actin samples in guinea pig ovarian structures studied. AF (Antral Follicles), 
PF (Preovulatory Follicle), and CL (Corpus luteum). Bar diagram represent the mean of the 
normalized integral density for each mRNA band (mean ± s.e.m). Different letters indicate 
significant differences (P 0.05). 
 
 
 
 
 
Figure 25. IGF-1 and IGF-1R mRNA expression in oocytes and their corresponding cumulus 
cells. Densitometry readings of A) IGF-1, B) IGF-1R (are presented as ratio of readings of 
corresponding β-actin samples in guinea pig. Oo (Oocyte) and CCs (Cumulus Cells). Bar diagram 
represent the mean of the normalized integral density for each mRNA band (mean ± s.e.m). 
Different letters indicate significant differences (P 0.05). 
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4.1.3. Expression of mRNA encoding IGFBPs 1-6 in guinea pig ovaries, antral 
follicles, preovulatory follicles, corpus luteum, denuded oocytes and their 
cumulus cells 
 
The mRNA expression of the IGFBPs was found in all structures studied by RT-PCR and 
is shown in Figure 26. The amplified cDNA fragments were 117, 139, 60, 141, 71 and 
112 bp, for IGFBP-1, 2, 3, 4, 5 and 6, respectively.  
 
 
Figure 26. Representative electrophoresis in a 2% agarose gel showing the expression of A) 
IGFBP-1, B) IGFBP-2, C) IGFBP-3, D) IGFBP-4, E) IGFBP-5, F) IGFBP-6, G) β-actin in guinea 
pig. OV (Whole ovary), PF (Preovulatory Follicle), AF (Antral Follicles), Oo (Oocytes), CCs 
(Cumulus Cells), CL (Corpus luteum), NC (Negative Control) and Mm (100 bp DNA marker).  
 
In the ovary, the relative mRNA expression of the IGFBPs in different stages of follicles 
and corpus luteum is shown in Figure 27. IGFBP 1, 2 and 4 showed similar expression 
pattern in follicles. mRNA transcripts were significantly down-regulated in antral follicles 
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compared to preovulatory follicles (P<0.05). Corpus luteum showed the highest values 
(P<0.05) for IGFBP-1 and 2 compared to follicles whereas IGFBP-4 showed intermediate 
results. IGFBP 3 and 5 showed similar pattern of gene expression in the structures 
studied. IGFBP-3 and 5 were significantly up-regulated in antral follicles compared to the 
gene expression displayed in preovulatory follicles. Corpus luteum exhibited the lowest 
expression pattern of IGFBP- 3 and 5. mRNA transcript of IGFBP-6 was similar in both 
follicular stages studied whereas Corpus luteum showed the lowest levels of gene 
expression of IGFBP-6. 
 
 
Figure 27. IGFBPs 1-6 mRNA expression. Densitometric readings of IGFBPs 1-6 are presented 
as ratio of readings of corresponding β-actin samples in guinea pig ovarian. AF (Antral Follicles), 
PF (Preovulatory Follicle), and CL (Corpus luteum). Bar diagram represent the mean of the 
normalized integral density for each mRNA band (mean ± s.e.m). Different letters indicate 
significant differences (P 0.05). 
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The relative mRNA expression of the IGFBPs was different in oocytes and their 
corresponding CCs as it is showed in Figure 28. IGFBP-1, 2, 3 and 4 mRNA expression 
was found higher in oocytes than in their corresponding CCs (P<0.05) and contrarily to 
IGFBP 5. The expression of IGFBP-6 was found similar in oocytes and CCs. 
 
 
 
Figure 28. IGFBPs 1-6 mRNA expression in COCs. Densitometric readings of IGFBPs 1-6 are 
presented as ratio of readings of corresponding β-actin samples in guinea pig ovarian. Oo 
(Oocyte) and CCs (Cumulus Cells). Bar diagram represent the mean of the normalized integral 
density for each mRNA band (mean ± s.e.m). Different letters indicate significant differences (P 
0.05). 
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4.2. EXPERIMENT 2. Immunolocalization of EGF-R and IGF-1R and their ligands 
(IGFBPs 1-6) in ovaries, follicles, corpus luteum, cumulus-oocyte complexes and 
early embryos in the guinea pig model 
 
4.2.1. Experiment 2.a. Immunolocalization of EGF-R and IGF-1R and their ligands 
(IGFBPs 1-6) by immunohistochemistry in ovaries of guinea pig. 
 
4.2.1.1. Immunolocalization of EGF-R in guinea pig ovaries 
 
The immunolocalization of EGF-R was found in Corpus luteum and follicles of guinea pig 
in all stages of development as is illustrated in Figure 29. In follicles, EGF-R was localized 
in the granulosa and theca cells and in oocytes (Figure 30). Non-specific immunoreaction 
was observed when staining was performed in the negative control. In the secondary 
and AF, EGF-R immunostaining was distributed in the oocyte, granulosa and theca cells. 
Luteal cells in the CL showed EGF-R immunostaining as well. 
 
 
 
Figure 29. Immunolocalization of EGF-R in guinea pig ovary. Red staining denotes the 
localization of the receptor. A) Primordial and primary follicles (GC, Oo: ++), B) Secondary follicles 
(GC, Oo and T: ++), C) Antral follicles (GC, Oo and T: +++), D) Corpus luteum (CL: +++). Gc 
(Granulose Cells), Oo (Oocyte), T (Theca cells), CL (Corpus luteum), p (Primordial follicle), P 
(Primary follicle). Representative photomicrographs are shown. Non-specific immunoreaction 
was observed in the negative control. Scale is 200 μm. 
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Figure 30. General view of Immunolocalization of EGF-R in guinea pig ovary 
 
As is shown in Table 4, the most of primordial and primary follicles showed moderate 
staining (++) in the granulosa cells and oocyte. In the secondary follicles a stronger EGF-
R immunoreaction (+++) was showed in the granulosa cells and oocyte. Most of the 
theca cells showed moderate immunoreaction (++). In antral follicle, a stronger EGF-R 
immunostaining was localized in both the oocyte, granulosa and theca cells (+++) in the 
majority of follicles. Furthermore, a stronger EGF-R immunoreactivity (+++) was 
observed in the corpus luteum (Figure 30). 
 
4.2.1.2. Immunolocalization of IGF-1R in guinea pig ovaries 
 
IGF-1R immunoreaction was detected in oocytes, granulosa cells and theca cells in 
ovarian follicles of guinea pig in all stages of development as well as in corpus luteum 
(Figure 31). IGF-1R immunostaining was showed in the granulosa and theca cells as 
well as in the luteal cells. Non- specific immunoreaction was observed when staining was 
performed in the negative control. 
 
Differences in the intensity of staining in the stromal cells, granulosa and theca cells, 
oocytes and corpus luteum were shown in Table 5. The primordial and primary follicles 
showed strong staining (+++) in oocytes and granulosa cells. In the secondary follicles, 
strong immunoreaction (+++) was observed in granulosa cells and oocytes whereas the 
most of the theca cells showed weak immunoreaction (+). In antral follicle, a stronger 
(+++) IGF-1R immunostaining was also detected in the oocyte, granulosa and theca 
cells. Furthermore, corpus luteum presented a stronger IGF-1R staining (+++) too. 
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Table 4. Immunolocalization of EGF-R in the guinea pig ovary 
(-) No staining (+) weak staining; (++) moderate staining and (+++) strong staining.  
Follicles 
Granulosa cells Theca cells Oocytes Luteal cells 
+ ++ +++ + ++ +++ + ++ +++ + ++ +++ 
Primordial n 
(%) 
39 
(27.0) 
61 
(42.7) 
44 
(30.5) 
- - - 
12 
(27.9) 
21 
(48.8) 
10 
(23.3) 
- - - 
Primary n 
(%) 
9 
(11.5) 
48 
(61.5) 
21 
(26.9) 
- - - 
10 
(33.3) 
17 
(56.7) 
3 
(10.0) 
- - - 
Secondary n 
(%) 
3 
(12.5) 
8 
(33.3) 
13 
(54.2) 
4 
(16.8) 
11 
(45.8) 
9 
(37.5) 
2 
(12.5) 
2 
(12.5) 
12 
(75.0) 
- - - 
Antral n 
(%) 
2 
(3.8) 
7 
(13.2) 
44 
(83.0) 
3 
(5.7) 
13 
(24.5) 
37 
(69.8) 
3 
(11.1) 
3 
(11.1) 
21 
(77.8) 
- - - 
Corpus luteum n 
(%) 
- - - - - - - - - 
2 
(20.0) 
2 
(20.0) 
6 
(60.0) 
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Figure 31. Immunolocalization of IGF-1R in guinea pig ovary. Red staining denotes the 
localization of the receptor. A) Primordial and primary follicles (GC, Oo: ++), B) Secondary follicles 
(GC, Oo: +++; T: +), C) Antral follicles (GC, Oo and T: +++), D) Corpus luteum (CL: +++). GC 
(Granulosa Cells); Oo (Oocyte); T (Theca cells); CL (Corpus luteum); p (primordial follicle); P 
(primary follicle). Representative photomicrographs are shown. Non-specific immunoreaction was 
observed in the negative control. Scale is 200 μm. 
 
4.2.1.3. Immunolocalization of IGFBPs 1-6 in guinea pig ovaries 
 
The IGFBPs 1, 2, 3, 4, 5 and 6 proteins were inmunolocalized in ovaries of guinea pig. 
Follicles at all stages of development exhibited immunoreaction to each IGFBP and the 
signal was distributed in all follicular compartments (granulosa and theca cells and 
oocyte) and in corpus luteum although with different intensity (Table 6). Non- specific 
immunostaining was observed in the negative controls. 
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Table 5. Immunolocalization of IGF-1R in the guinea pig ovary 
(-) No staining (+) weak staining; (++) moderate staining and (+++) strong staining.  
 
Follicles 
Granulosa cells Theca cells Oocytes Luteal cells 
+ ++ +++ + ++ +++ + ++ +++ + ++ +++ 
Primordial n 
(%) 
55  
(14.7) 
113 
(30.2) 
206 
(55.1) 
- - - 
27 
(36.9) 
36 
(49.31) 
10 
(13.7) 
- - - 
Primary n 
(%) 
39 
(16.0) 
92 
(37.7) 
113 
(46.3 ) 
- - - 
12 
(10.6) 
21 
 (18.6) 
80 
(70.8) 
- - - 
Secondary n 
(%) 
5 
(13.5) 
12 
(32.4) 
20 
(54.1) 
21 
(56.8) 
7 
(18.9) 
9 
(24.3) 
2 
(7.1) 
5 
 (17.9) 
21 
(75.0) 
- - - 
Antral n 
(%) 
2 
(4.4) 
9  
(19.6) 
35 
(76.0) 
6  
(13.0) 
16 
(34.8) 
24 
(52.2) 
2 
 (10.0) 
2  
(10.0) 
16 
(80.0) 
- - - 
Corpus luteum n (%) - - - - - - - - - 
2 
(20.0) 
2 
 (20.0) 
6 
(60.0) 
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i. IGFBP-1 
 
As depicted Figure 32 and Table 6, primordial and primary follicles showed strong 
staining (+++) in granulosa cells for IGFBP-1. In the secondary follicles a stronger 
immunoreaction (+++) was observed in the theca cells whereas oocyte and granulosa 
cells showed moderate staining (++). In antral follicle, oocyte exhibited a moderate 
staining (++) and granulosa and theca cells showed a weak staining (+). Also a moderate 
IGFBP-1 immunoreactivity (++) was observed in the corpus luteum. 
 
 
 
 
Figure 32. Immunolocalization of IGFBP-1 in guinea pig ovary. Red staining denotes the 
localization of the receptor. A) Primordial follicles (GC: +++), B) Secondary (T: +++; GC:++), C) 
Antral follicle (GC and T: +; Oo:++), D) Corpus luteum (CL: ++/+++). GC (Granulosa Cells); Oo 
(Oocyte); T (Theca cells); CL (Corpus luteum); p (primordial follicle); P (primary follicle). 
Representative photomicrographs are shown. Non-specific immunoreaction was observed in the 
negative control. Scale is 200 μm. 
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Table 6. Immunolocalization of IGFBPs 1-6 in the guinea pig ovary 
 IGFBP-1 IGFBP-2 IGFBP-3 IGFBP-4 IGFBP-5 IGFBP-6 
Primordial Follicle 
Oocyte 
(n) 
+ 
(774) 
+ 
(698) 
+ 
(693) 
+ 
(503) 
+ 
(689) 
+ 
(673) 
Granulosa cells  
(n) 
+++ 
(774) 
+++ 
(698) 
+ 
(693) 
+ 
(503) 
+ 
(689) 
+ 
(673) 
Primary Follicle 
Oocyte 
(n) 
+ 
(679) 
+ 
(624) 
+ 
(597) 
+ 
(657) 
+ 
(672) 
+ 
(646) 
Granulosa cells  
(n) 
+++ 
(679) 
+++ 
(624) 
+ 
(597) 
+ 
(657) 
+ 
(672) 
+ 
(646) 
Secondary follicle 
Oocyte 
(n) 
++ 
(103) 
+ 
(128) 
+ 
(114) 
+ 
(119) 
+ 
(123) 
+ 
(118) 
Granulosa cells 
 (n) 
++ 
(103) 
+++ 
(128) 
+ 
(114) 
+ 
(119) 
+ 
(123) 
+ 
(118) 
Theca cells 
(n) 
+++ 
(103) 
+ 
(128) 
+ 
(114) 
+ 
(119) 
+ 
(123) 
+ 
(118) 
Antral  
Oocyte  
(n) 
++ 
(94) 
+ 
(91) 
+ 
(93) 
+ 
(95) 
+ 
(90) 
+ 
(93) 
Granulosa cells  
(n) 
+ 
(94) 
+++ 
(91) 
+ 
(93) 
+ 
(95) 
++ 
(90) 
+ 
(93) 
Theca cells 
(n) 
+ 
(94) 
++ 
(91) 
+ 
(93) 
+ 
(95) 
+ 
(90) 
+ 
(93) 
Corpus luteum  
Luteal cells 
(n) 
++ 
(13) 
+++ 
(13) 
+++ 
(13) 
+ 
(13) 
+ 
(13) 
+ 
(13) 
n: represent number of structures analyzed; (+) weak staining; (++) moderate staining and (+++) 
strong staining.  
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ii. IGFBP-2 
 
Immunoreaction of IGFBP-2 in the granulosa cell of primordial, primary secondary and 
antral follicle was intense (+++) (Figure 33 and Table 6). Oocyte was considerate weak 
stained (+) to IGFBP-2 in all stages of follicular development. Inmunostaining was 
increased in the theca cells from weak staining (+) in secondary to moderate staining 
(++) in antral follicle. In the corpus luteum a strong staining (+++) was observed (Table 
6). There was no staining in the negative controls. 
 
 
 
Figure 33. Immunolocalization of IGFBP-2 in guinea pig ovary. Red staining denotes the 
localization of the receptor. A) Primordial follicles (Oo: +; GC: +++), B) Secondary (Oo: +; GC: 
+++; T:+), C) Antral follicle (Oo: +; GC: +++; T: ++), D) Corpus luteum (CL: +++). GC (Granulosa 
Cells); Oo (Oocyte); T (Theca cells); CL (Corpus luteum); p (primordial follicle). Representative 
photomicrographs are shown. Non-specific immunoreaction was observed in the negative control. 
Scale is 200 μm. 
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iii. IGFBP-3 
 
As it is shown in Figure 34 and Table 6, oocyte, granulosa and theca cells of all follicles 
from primordial to antral showed weak staining (+), whereas Corpus luteum presented 
the strongest signal (+++). There was no staining in the negative controls. 
 
 
 
 
Figure 34. Immunolocalization of IGFBP-3 in guinea pig ovary. Red staining denotes the 
localization of the receptor. A) Primary and primordial follicles (Oo: +; GC: +), B) Secondary (Oo, 
GC and T:+), C) Antral follicle follicle (Oo, GC, and T: +), D) Corpus luteum (CL: +++). GC 
(Granulosa Cells); Oo (Oocyte); T (Theca cells); CL (Corpus luteum); p (primordial follicle), P 
(Primary). Representative photomicrographs are shown. Non-specific immunoreaction was 
observed in the negative control. Scale is 200 μm. 
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iv. IGFBP-4 
 
The localization of IGFBP-4 (Figure 35) was similar for all the compartments in the ovary, 
which exhibited weak staining (+) in oocytes, granulosa cells and theca cells in every 
stage of follicular development (Table 6). Corpus luteum show weak staining for IGFBP-
4 as well. Negative controls didn´t show any immunoreaction signal. 
 
 
 
 
Figure 35. Immunolocalization of IGFBP-4 in guinea pig ovary. Red staining denotes the 
localization of the receptor. A) Primordial follicles (Oo and CG:+), B) Secondary follicle (Oo, GC 
and T: +), C) Antral follicle (Oo, GC and T: +), D) Corpus luteum (CL: +). GC (Granulosa Cells); 
Oo (Oocyte); T (Theca cells); CL (Corpus luteum); p (primordial follicle), P (Primary). 
Representative photomicrographs are shown. Non-specific immunoreaction was observed in the 
negative control. Scale is 200 μm. 
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v. IGFBP-5 
 
As it is shown in Figure 36 and Table 6 the intensity of IGFBP-5 signal was weak (+) in 
oocytes, granulosa cells and theca cells in primordial, primary, secondary and antral 
follicle of guinea pig. Oocytes in antral follicle showed weak/moderate staining (+/++) In 
the corpus luteum a weak staining (+) was also evidenced. There was no staining in the 
negative controls. 
 
 
 
Figure 36. Immunolocalization of IGFBP-5 in guinea pig ovary. Red staining denotes the 
localization of the receptor. A) Primordial and primary follicle (GC and Oo:+), B) Secondary follicle 
(GC, Oo and T: +), C) Antral follicle (Oo: ++ GC and T: +), D) Corpus luteum (CL: +). GC 
(Granulosa Cells); Oo (Oocyte); T (Theca cells); CL (Corpus luteum); p (primordial follicle), P 
(Primary). Representative photomicrographs are shown. Non-specific immunoreaction was 
observed in the negative control. Scale is 200 μm. 
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vi. IGFBP-6 
 
It was found a weak (+) presence of IGFBP-6 in granulosa cells regardless of follicle type 
as well as in the corpus luteum (Figure 37 and Table 6). Signal in oocyte was weak (+) 
for all follicular stages. IGFBP-6 intensity in theca cells showed a weak (+) staining in 
secondary follicles and antral follicle. No specific signal was observed in the negative 
controls 
. 
 
 
 
Figure 37. Immunolocalization of IGFBP-6 in guinea pig ovary. Red staining denotes the 
localization of the receptor. A) Primordial and primary follicles (Oo and GC: +), B) Secondary 
follicle (Oo, GC and T: +), C) Antral follicle (Oo; GC and T: +), D) Corpus luteum (CL: +). GC 
(Granulosa Cells); Oo (Oocyte); T (Theca cells); CL (Corpus luteum); p (primordial follicle), P 
(Primary). Representative photomicrographs are shown. Non-specific immunoreaction was 
observed in the negative control. Scale is 200 μm. 
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4.2.2. Experiment 2.b. Immunolocalization of EGF-R and IGF-1R and their ligands 
(IGFBPs 1-6) by immunocytochemistry in cumulus-oocyte complexes and in the 
early embryos of guinea pig. 
 
4.2.2.1. Immunolocalization of EGF-R in cumulus-oocyte complexes and early 
embryos 
 
Indirect immunofluorescence assays showed that EGF-R was present in immature- and 
in vitro matured oocytes and their corresponding CCs (Figure 38). EGF-R was detected 
in the cellular membrane of the cells for both oocytes and CCs regardless if they were 
matured or immature. Significant differences were found in the immunofluorescence 
staining pattern between immature and matured COCs (P<0.05), being intensity higher 
in both oocyte and CCs after in vitro maturation (P<0.05). There was no staining in the 
negative controls. 
 
Figure 38. Localization by immunocytochemistry of EGF-R in immature and matured Oo and CCs 
of guinea pig. A) Immature Oo, B) Immature CCs, C) Oo matured, D) CCs after in vitro maturation. 
The distribution of EGF-R is shown in green fluorescence. Oo (Oocyte) and CCs (Cumulus Cells). 
Scale 30 μm. Representative photomicrographs are shown. 
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In the embryos, EGF-R immunoreactivity was observed also in the cell membrane of the 
blastomeres (Figure 39). EGF-R was expressed at increasing levels on preimplantation 
embryos to morula stage. Four cell embryos exhibited significantly lower inmunostaining 
compared to morulas (P<0.05) whereas in 8-16 cell embryo displayed intermediate 
levels.  
 
 
Figure 39. Localization of EGF-R in guinea pig preimplantation embryos by immunofluorescence. 
A1), A2) two-cell embryo, B1), B2) 8-16 cells embryo, C1), C2) Morula. The right panel represents 
the merge from the blue staining that denotes the nucleus and the green the positive staining). 
Representative photomicrographs are shown. Scale 30 μm. 
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4.2.2.2. Immunocytochemical localization of IGF-1R in cumulus-oocyte complexes 
and early embryos 
 
IGF-1R staining was detected in CCs and in oocytes. Distribution was shown in the cell 
membrane of the cells for both oocytes and CCs (Figure 40). We observed a diferential 
change in the localization of the receptor between matured and immature oocytes; the 
intensity of the signal was significantly higher in oocytes and CCs after in vitro 
maturation. There was no staining in the negative controls. 
 
 
 
Figure 40. Localization by immunocytochemistry of IGF-1R in immature and matured Oo and 
CCs of guinea pig. A) Immature oocyte, B) Immature COCs, C) Oocyte maturated, D) CCs after 
in vitro maturation. Oo (Oocyte) and CCs (Cumulus Cells).  Green fluorescence denotes the 
distribution of IGF-1R. Representative photomicrographs are shown. Scale 30 μm. 
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In embryos, the IGF-1R was uniformly immunolocalized in the cell membrane of the 
blastomeres in all developmental stages studied. Developing embryos increased the 
intensity of the signal during the early development. Four cell stage embryos exhibited 
the lowest immunostaining compared to morula stage that show the highest signal 
(P<0.05). Eight to 16 cell stage show intermediate fluorescence value (Figure 41). 
 
 
 
Figure 41. Localization of IGF-1R in guinea pig preimplantation embryos by immunofluorescence. 
A1), A2) Four-cell embryo, B1), B2) 8-16 cells embryo, C1), C2) Morula. The right panel 
represents the merge from the blue staining that denotes the nucleus and the green the positive 
staining). Representative photomicrographs are shown. Scale 30 μm. 
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4.2.2.3. Immunolocalization of IGFBPs 1-6 in cumulus-oocyte complexes 
 
Indirect immunofluorescence assay was used to detect the localization of IGFBPs 1 to 6 
in oocytes and CCs of guinea pig (Figure 42, 43 and 44). In both, all the IGFBPs (Figure 
40 and 41) was localized in the cellular membrane of oocyte and CCs.  
 
 
 
Figure 42. Localization of IGFBP-1, 2 and 3 in the CCs and the oocytes guinea pig by 
immunofluorescence. A1), A2) IGFBP- 1, B1), B2) IGFBP- 2, C1, C2) IGFBP- 3. The left panel 
represents the CCs and right the panel represents the oocytes. Green immunofluorescence 
indicates the localization of protein. CCs (Cumulus Cells). Representative photomicrographs are 
shown.  Scale 30 μm. 
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Figure 43. Localization of IGFBP-4, 5 and 6 in the CCs and the oocytes guinea pig by 
immunofluorescence. A1), A2) IGFBP- 4, B1), B2) IGFBP- 5, C1, C2) IGFBP- 5. The left panel 
represents the CCs and right the panel represents the oocytes. Green immunofluorescence 
indicates the localization of protein. CCs (Cumulus Cells). Representative photomicrographs are 
shown.  Scale 30 μm. 
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Figure 44. IGFBPs 1-6 quantification of the immunofluorescence intensity is presented as values 
measured in pixels. A) Represents the comparison between Oo and CCs for each IGFBPs, B) 
Represents the fluorescence intensity of each IGFBPs for the CCs, C) Represents the 
fluorescence intensity of each IGFBPs for the Oo. Oo (Oocytes), CCs (Cumulus cells). Different 
letters indicate significant differences (P<0.05). 
 Results 
101 
 
 
The intensity of the signal for IGFBP-1, 4 and 5 was significantly higher in oocytes than 
in CCs (P<0.05) (Figure 42, 43 and 44). In contrast, fluorescence for IGFBP-3 and 6 was 
significantly lower (P<0.05), (Figure 42, 43 and 44) in oocytes compared to the 
surrounding cumulus cells. IGFBP-2 did not show significant differential staining between 
CCs and oocyte (Figure 42). Among IGFBPs in CCs, IGFBP3 and 6 showed the lowest 
intensity of staining whereas IGFBP-1 and 4 exhibited the higher signal (P<0.05, Figure 
43). In oocytes IGFBP-5 and 6 showed the lower signal compared to IGFBP-1 which 
presented the higher intensity (P<0.05). The rest of IGFBPs showed intermediate results. 
 
 
4.3. EXPERIMENT 3. Study the effect of EGF and IGF-1 on nuclear and cytoplasmic 
in vitro oocyte maturation, apoptosis and steroidogenic production by the 
cumulus-oocyte complexes in the guinea pig model. 
 
4.3.1. Experiment 3a: Characterization of cortical granules and mitochondrial 
distribution patterns during in vitro oocyte maturation in the guinea pig  
 
4.3.1.1. Cortical granules patterns 
 
Cortical granules patterns observed (Figure 45) before and after oocyte maturation were 
defined as: non-migrated A1), cortical granules distributed throughout the cytoplasm 
(considered non- cytoplasmically matured); partially migrated B1), most of the cortical 
granules spread throughout the cortical area and migrated C1), cortical granules 
adjacent to the plasma membrane and peripheral distribution (considered 
cytoplasmically matured). Cortical granules migrated to the periphery were the main 
patterns observed in the oocytes after IVM culture (71.9 - 76.9%, see above) whereas in 
immature oocytes homogeneous distribution of cortical granules was prevalent (70%). 
 
4.3.1.2. Mitochondrial patterns 
 
The mitochondrial patterns (Figure 46) were classified as: non-migrated (A1) when the 
mitochondrias were homogeneously distributed throughout the cytoplasm (considered 
non-cytoplasmically matured); partially migrated (B1), when the mitochondria were 
heterogeneously distributed with granular aggregations and migrated (C1), when the 
mitochondria were relocated to the nuclear pole (considered cytoplasmically matured). 
Peripheral distribution of mitochondria is the most abundant pattern in mature oocytes 
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(66.7- 80.0%). However, mitochondria distributed throughout the cytoplasm were found 
mainly in immature oocytes (60%). 
 
 
 
 
Figure 45. Cortical granule (CG) distribution in guinea pig oocytes after IVM period visualized 
under confocal laser microscopy. Left panel shown CG migration patterns: A1) Homogeneous 
CG distribution; B1) Cortical CG distribution; C1) Peripheral CG distribution.  Middle panel shown 
nuclear chromatin of oocytes stained with Hoechst 33342: A2) Germinal vesicle; B2 and C2) 
Metaphase II. Right panel shown merges the both nucleus and CG.  
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Figure 46. Mitochondrial distribution in guinea pig oocytes after IVM period visualized under 
confocal laser microscopy. Left panel shown CG migration patterns: A1) Non-migrated; B1) 
partially migrated; C1) migrated.  Middle panel shown nuclear chromatin of oocytes stained with 
Hoechst 33342: A2) Germinal vesicle; B2 and C2) Metaphase II. Right panel show merges the 
both nucleus and mitochondria. 
 
 
4.3.2. Experiment 3.b. Role of EGF on in vitro oocyte maturation system of guinea 
pig by the study of nuclear and cytoplasmic oocyte maturation, apoptotic rate in 
cumulus cells and steroidogenic response of cumulus-oocyte complexes. 
 
A higher M-II rate was found when the oocytes were IVM with 50 ng/mL EGF compared 
to the rest of the experimental groups (P<0.05) (see Table 7). Also, this group showed 
higher percentage of oocytes with peripheral migration pattern of cortical granules and 
migrated mitochondrial distribution compared to group without EGF (negative control  
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group) (P<0.05). There were no significant differences among groups in the other cortical 
granules and mitochondrial migration patterns studied. 
 
 
Apoptosis rate was significantly lower for groups with 50 ng/mL EGF or 10% FCS 
compared with those cultured without EGF (P<0.05) 
 
 
Before IVM, E2 and P4 were detected in the control spent maturation medium at a 
concentration of 0.16±0.007 ng/mL and 0.02±0.005 pg/mL, respectively. After IVM a 
significant increase of E2 and P4 production by COCs was found when maturation media 
was supplemented with 50 ng/mL EGF (Figure 45). 
 
 
 
 
Figure 47. Steroidogenic production of COCs after IVM using different concentrations of EGF. 
Bars represent mean concentrations of A) E2, B) P4 produced per each COCs under different 
experimental conditions. Means in bars with different letters in each chart indicate significant 
differences (P<0.05). 
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Table 7. Nuclear and cytoplasmic maturation in guinea pig oocytes and apoptosis in cumulus cells with different concentrations of EGF 
in IVM medium. 
 
 
0 ng/mL 
EGF 
10 ng/mL 
EGF 
50 ng/mL 
EGF 
100 ng/mL 
EGF 
10% 
FCS 
Nuclear maturation 
M-II rate n (%) 115 (43.5)a 114 (51.8)a 116 (75.9)b 108 (53.7)a 111 (50.5)a 
 
Cytoplasmic maturation 
 
Cortical granules distribution patterns 
Migrated n (%) 10 (32.4)a* 14 (45.2)ab 23 (71.9)b 12 (50.0)ab 16 (64.0)ab* 
Partially migrated n (%) 15 (48.4) 11 (35.5) 7 (21.9) 10 (41.7) 7 (28.0) 
Non- migrated n (%) 6 (19.4) 6 (19.4) 2 (6.3) 2 (8.3) 2 (8.0) 
 
Mitochondrial distribution patterns 
Migrated n (%) 5 (27.8)a 8 (57.1)ab 12 (80.0)b 5 (31.3)a 10 (66.7)ab 
Partially migrated n (%) 4 (22.2) 3 (21.4) 1 (6.7) 6 (37.5) 1 (6.7) 
Non-migrated n (%) 9 (50.0) 3 (21.4) 2 (13.3) 5 (31.3) 4 (26.7) 
 
Apoptosis of cumulus cells n(%) 
 
13 (28.7±1.4)a 
 
11 (21.1±1.2)ab 
 
11 (17.2 ± 0.9)b 
 
13 (19.7±1.2)ab 
 
10 (16.0±1.2)b 
Means in rows with different letters differ: a,b P<0.05; *P<0.1  
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4.3.3. Experiment 3.c. Role of IGF-1 on in vitro oocyte maturation of guinea pig by the 
study of nuclear and cytoplasmic oocyte maturation, apoptotic rate in cumulus cells 
and steroidogenic response of cumulu-oocyte complexes. 
 
As shown in Table 8, supplementation with 100 ng/mL IGF-1 significantly stimulated nuclear 
oocyte maturation in guinea pig oocytes (P<0.05). This group showed higher percentage of 
cortical granules peripheral pattern compared with the group without IGF-1 or with 50 ng/mL 
IGF-1 (P< 0.05). The lowest rates of non-migrated oocytes were found for groups 
supplemented with 100 and 200 ng/mL IGF-1 compared to non-supplemented group 
(P<0.05). The percentage of partially migrated and non-migrated was similar for all groups. 
No significant differences were found in mitochondrial patterns among experimental groups. 
 
Apoptotic index of the CCs was significantly lower in groups with 50 or 100 ng/mL IGF-1 
than in group without IGF-1 (P<0.05) (Table 8). The COCs supplemented with 10% FCS 
group showed intermediate values of apoptosis in CCs. 
 
P4 and E2 production by CCs were found significantly higher in the group supplemented with 
100 ng/mL of IGF-1 compared to the other studied groups (P<0.05) (Table 8 and Figure 46). 
 
 
 
Figure 48. Steroidogenic production of COCs after IVM using different concentrations of 
IGF-1. Bars represent mean concentrations of A) E2 , B) P4  produced per each COCs under 
different experimental conditions. Means in bars with different letters in each chart indicate 
significant differences (P<0.05). 
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Table 8. Nuclear and cytoplasmic maturation in guinea pig oocytes and apoptosis in cumulus cells with different concentrations of IGF-
1 in IVM medium. 
 
0 ng/mL 
IGF-1 
50 ng/mL 
IGF-1 
100 ng/mL 
IGF-1 
200 ng/mL 
IGF-1 
10% 
FCS 
Nuclear maturation 
M-II rate n (%) 113 (38.9)a 114 (48.2)a 112 (72.3)b 112 (54.5)a 117 (50.4)a 
 
Cytoplasmic maturation 
 
Cortical granules distribution patterns 
Migrated n (%) 9 (31.0)a 13 (43.3)a 23 (76.7)b 16 (55.2)ab 15 (53.6)ab 
Partially migrated n (%) 10 (34.5) 15 (50.0)* 6 (20.0)* 12 (41.4) 10 (35.7) 
Non- migrated n (%) 10 (34.5)a 2 (6.7)b 1 (3.4)b 1 (3.4)b 3 (10.7)a 
 
Mitochondrial distribution patterns 
Migrated n (%) 6 (40.0) 8 (53.3) 11 (73.3) 7 (46.7) 9 (60.0) 
Partially migrated n (%) 5 (33.3) 3 (20.0) 4 (26.7) 4 (26.7) 3 (20.0) 
Non-migrated n (%) 4 (26.7) 4 (26.7) 0 (0.0) 4 (26.7) 3 (20.0) 
 
Apoptosis of cumulus cells n (%) 
 
11 (34.6±1.5)a 
 
12 (14.5±1.1)bc 
 
11 (12.8± 0.9)b 
 
11 (21.7±1.2)ac 
 
11 (17.5±1.2)abc 
Means in rows with different letters differ: a,b P<0.05; *P<0.1  
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4.3.4. Experiment 3.d. Study of the effect of EGF and IGF-1 on in vitro oocyte 
maturation of guinea pig by the study of nuclear and cytoplasmic oocyte 
maturation, apoptotic rate in cumulus cells and steroidogenic response of 
cumulus-oocyte complexes 
 
M-II rate significantly increased in oocytes IVM with the combination of both growth 
factors alone or with 10% FCS compared to the group without growth factors (negative 
control) and the FCS group (positive control) (P<0.05) (Table 9). The highest percentage 
of oocytes with migrated cortical granules distribution was shown in the EI-FCS group 
(P<0.05) whereas group 0 showed the highest rate of oocytes with non-migrated pattern 
of cortical granules (P<0.05). There were not found significant differences in the 
mitochondrial distributions studied among groups.  
 
The percentage of apoptosis in CCs of EI-FCS group was significantly lower compared 
to the rest of experimental groups (P<0.05).  
 
The combination of EGF+IGF-1 and FCS showed higher P4 and E2 production by COCs 
(P<0.05) (Figure 49). 
 
 
 
Figure 49. Steroidogenic production of COCs after IVM using combinations of EGF and 
IGF-1. Bars represent mean concentrations of A) E2, B) P4 produced per each COCs 
under different experimental conditions. Means in bars with different letters in each chart 
indicate significant differences (P<0.05). 
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Table 9. Nuclear and cytoplasmic maturation in guinea pig oocytes with EGF and IGF -1 combined in IVM medium. Means in rows with different 
letters differ: a, b,c P<0.05; * P<0.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Group 0: not supplemented with EGF and IGF-1; EI group: supplemented with 50 ng/mL EGF+100 ng/mL IGF-1; EI-FCS group, supplemented 
with 50 ng/mL EGF + 100 ng/mL IGF-1 + 10% FCS; and FCS group: supplemented with 10% (v:v) FCS 
 0 EI EI-FCS FCS 
Nuclear maturation 
M-II rate n (%) 
 
112 (38.4)a 
 
115 (78.3)b 
 
116 (83.7)b 
 
113 (55.8)c 
Cytoplasmic maturation 
Cortical granules distribution patterns 
Migrated n (%) 5 (23.8)a* 13 (59.1)ab* 20 (76.9)b 12 (50.0)ab 
Partially migrated n (%) 6 (28.6) 7 (31.8) 5 (19.2) 11 (45.8) 
Non- migrated n (%) 10 (47.6)a 2 (9.1)b 1 (3.8)b 1 (4.2)b 
 
Mitochondrial distribution patterns 
Migrated n (%) 5 (35.7) 8 (53.3) 10 (66.7) 8 (53.3) 
Partially migrated n (%) 4 (28.6) 2 (13.3) 2 (13.3) 4 (26.7) 
Non-migrated n (%) 5 (35.7) 5 (33.3) 3 (20.0) 3 (20.0) 
 
Apoptosis of cumulus cells n (%) 
11 (25.8±1.4)a 11 (22.7±1.3)a 11 (6.6±0.7)b 
 
11 (22.8±1.3)a 
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The follicular development is regulated by several factors which stimulate the 
differentiation and proliferation of somatic cells and the development and growth of the 
oocytes enclosed. The intraovarian system of EGF and IGF-1 plays a key role in those 
events, since they are involved in steroidogenesis, granulosa cell proliferation, 
apoptosis, oocyte maturation outcome and corpus luteum formation and function. The 
biologic effects of both factors are mediated throughout their corresponding cell 
membrane receptors (EGF-R and IGF-1R) and in IGF system also for the IGFBPs 1-6, 
which can potentiate or inhibit the IGF action at the target cells. Therefore, the 
investigation of the expression patterns and localization of these developmentally 
important genes in animal models is necessary for the study of the ovarian physiology in 
animals and human. 
 
In this context, oocyte IVM has emerged as a promising procedure for infertility treatment 
in woman since it has the potential to substitute standard IVF and superovulation 
protocols. IVM may be the method of choice, not only for infertile couples but also for 
obtaining meiotically competent oocytes for preservation of fertility in cancer patients 
(Lim et al., 2013). Although advances in IVM protocols have led to satisfactory pregnancy 
rates, the technique yielded limited success and further improvements are needed. 
Furthermore, comparison of multiple media appears very difficult in a human IVM 
context, in which material donated for research is extremely rare. Therefore, the use of 
animal models is needed as well. The guinea pig is a valuable laboratory animal model 
for reproductive studies since it shares similar characteristics related to the ovarian 
physiology, but the IVM systems are rarely developed in this specie. 
 
For these reasons, in this Thesis it has been characterized the EGF and its receptor; the 
IGF-1 and its receptor, and the IGFBPs 1-6, described in woman´s ovary, to use the 
guinea pig as a possible animal model for the study of ovarian physiology in human. 
Finally, we studied the effect of both growth factors (EGF and IGF-1) on in vitro oocyte 
maturation as a possible way to set up an in vitro defined maturation system in this 
specie; it would be valuable as source of M-II oocytes needed for ARTs (used in human 
experiments and guinea pig conservation of genetic pool).  
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5.1. Gene expression and immunolocalization of EGF and EGF-R 
 
5.1.1. Characterization of EGF and EGF-R system in the guinea pig ovary 
 
The mRNA expression of EGF and EGF-R showed a similar pattern in the antral and 
preovulatory follicles in the guinea pig in which significantly higher expression was shown 
for both genes in antral follicles than in preovulatory ones. Both protein and mRNA for 
EGF-R have been found in antral follicles in other species, but also in pre- antral and 
earlier follicles (pig: Singh et al., 1995; cat: Goritz et al., 1996; human: Maruo et al., 1993; 
Bennett et al., 1996; Qu et al., 2000; hamster: Roy and Greenwald, 1990; Singh et al., 
1995; Garnett et al., 2002). The simultaneous expression of EGF and EGF-R in guinea 
pig suggests that an autocrine and paracrine mode of EGF action may exist to regulate 
final follicular growth, including the selection and regression process and oocyte 
maturation in the ovary. However, the presence of EGF in human ovarian tissue is still 
in debate. EGF gene expression was not observed in thecal or granulosa cells of rats, 
bovines, and humans (Skinner and Coffey, 1988; Yeh et al., 1993; Tamura et al., 1995). 
The presence of EGF in antral follicles in porcine and human has been reported 
contradictorily by several laboratories (Reeka et al., 1998; Hsu et al., 1987, Westergaard 
and Andersen, 1989; Volpe et al., 1991).  
 
Concomitantly, we also have observed EGF-R immunolocalization in all developing 
follicles of the ovary in both granulosa and theca cells, oocytes and luteal cells. EGF-R 
signal dynamically changes in oocytes and granulosa cells throughout the follicular 
stages; from moderate immunoreactivity in primordial follicles to strong signal in antral 
follicles, as also was appreciated in theca cells. EGF-R inmunolocalized with strong 
intensity in antral follicles and corpus luteum confirms the findings of the gene expression 
study for this receptor. Previous studies have localized EGF-R in granulosa, theca and 
luteal cells in human (Maruo et al., 1993; Reeka et al., 1998; Tamura et al., 1995; Qu et 
al., 2000) and in other mammalian species such as, primate (de Prada et al., 2009), 
bovine (Vlodavsky et al., 1978), goat (Gall et al., 2004; Silva et al., 2006; Pereira et al., 
2012); sheep (Santos et al., 2014), cat (Goritz et al., 1996), porcine (Fujinaja et al., 1992), 
equine (Lorenzo et al., 2002) and hamster (Garnett et al., 2002).  
 
All these observations suggest that EGF may regulate the growth of follicles through 
binding to EGF-R in ovarian tissues. In human the results are controversial, since some 
authors was not found inmunostaining for EGF or EGF-R in primordial follicles (Maruo et 
al., 1993) but other have reported positive reaction in all stages of the follicular 
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development in granulosa cells, oocytes and theca (Qu et al., 2000). EGF throughout it 
receptor promotes granulosa cell proliferation, increases the follicular daily growth rate 
in rat follicles (Dekel and Sherizly, 1985; Das et al., 1994), stimulate the growth of primary 
and secondary follicles of goat (Silva et al., 2004; Celestino et al., 2011) and, in bovine 
antral follicles, improves antrum formation in vitro (Santos et al., 2014). 
 
Similarly, with our results, the EGF-R expression related to follicle size increased in 
oocytes and in granulosa cells in human (Maruo et al., 1993). In this sense, several 
authors also have shown strong inmunostaining in granulosa cells of antral follicles of 
several species (rat: St-Arnaud et al., 1983, Ergin et al., 2008; pig: Fuginaga et al., 1992; 
hamster: Roy and Greenwald, 1990; human: Maruo et al., 1993, Qu et al., 2000; rabbit: 
Lorenzo et al., 2000; goat: Silva et al., 2006 and bovine: Caixeta et al., 2009). The 
increasing staining in theca cells when the follicle growth showed in the present study 
may be related with the involvement of EGF on the growth of granulosa cells as has been 
pointed out. Thecal cells are important site of synthesis of growth factors involved in cell-
to-cell interactions since they secreted androgens, which indeed stimulate the growth of 
granulosa cells (Skinner et al., 1987).  
 
It is known that the growth of follicles depends on gonadotropins after preantral stage 
(Scaramuzzi et al., 2011). Prior to the LH surge, FSH significantly stimulated LH and 
EGF-R expression in the granulosa cell (Erickson et al., 1989; El-Hayek et al., 2016). 
Indeed, the EGF inhibited FSH-induced aromatization of androgen to estrogen and the 
formation of LH receptors in human granulosa cells (Peters et al., 1994). In this sense, 
Volpe et al. (1991) found that EGF levels in FF were significantly higher in patients with 
polycystic ovary disease than those of normally ovulating infertile women in an IVF-ET 
program. Oocytes acquire meiotic competence at an early antral stage, and meiosis 
resumes in PF as a result of the LH surge. EGF-R is a decisive mediator of LH signaling 
(Jaffe and Egbert, 2016). LH binds to its receptors on mural granulosa cells and 
stimulates the expression of EGF-like peptides in vivo (Park et al., 2004). These peptides 
then act directly on CCs, bind to the EGF-R and consequently stimulate the resumption 
of meiosis and expansion of the CCs in a variety of species (cattle: Lonergan et al., 1996; 
sheep: Guler et al., 2000; dog: Hatoya et al., 2009). The increased expression of mRNA 
EGF and EGF-R in the antral follicles accompanied with the EGF-R strong 
inmunoreactivity found in present study support EGF participation in the developmental 
competence of the oocyte in the guinea pig. 
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In current work, abundance of EGF and EGF-R mRNA was found in corpus luteum being 
EGF-R gene expression increased. The inmunolocalization of EGF-R found in antral 
follicles persisted in corpus luteum, with high intensity as well. EGF-R expression was 
described in corpus luteum in human (Maruo, 1993) and other species too (rat: Tekpetey 
et al., 1995; pig: Kennedy et al., 1993, Singh et al., 1995). These findings, support EGF 
affects the function of corpus luteum during the early luteal phase in the guinea pig by 
autocrine and paracrine ways. Corpus luteum secretion of P4 is essential for the 
establishment and maintenance of pregnancy. Inadequate P4 production is a major 
cause of infertility and embryonic loss in several species (Equine: Bergfelt et al., 1992; 
Bovine: Wiltbank et al., 2014; goat: Thammasiri et al., 2016). EGF augments P4 
biosynthesis in luteinized human granulosa cells in culture and in rat luteal cells 
(Tekpetey et al., 1995) in a dose-dependent manner (Jones et al.,1982). Furthermore, 
growth of the corpus luteum depends on the development of new blood vessels. Apart 
from their steroidogenic properties, EGF play an important role in dynamic luteogenesis 
(Assarsson et al., 1995) by stimulating angiogenesis as well (Chouhan et al., 2014). 
Besides, EGF endowed with well-established anti-apoptotic properties during luteal 
development (Ptak et al., 2004; Yang and Rajamahendran, 2000; Parborell et al., 2002; 
Okuda et al., 2009) possibly through stimulating expression of survival factors and 
suppressing that of pro-apoptotic factors as has been evidenced in granulosa cells 
(Babitha et al., 2014). 
 
 
5.1.2. Characterization of EGF and EGF-R system in the guinea pig cumulus-
oocyte complexes 
 
In this context, we also observed that EGF and EGF-R gene expression was localized in 
both oocytes and CCs. These findings confirm that both oocytes and CCs, can directly 
respond to EGF by an autocrine and paracrine way. The presence of EGF and its 
receptor indicates that this system may exert a key role in the resumption of meiosis, 
cAMP production and CCs expansion in guinea pig as has been demonstrated in human 
(Yerushalmi et al., 2014) and other species (mouse: Su et al., 2010; goat: Gall et al., 
2004; pig: Sugimura et al., 2015). Also, we have showed the EGF-R inmunolocalization 
in the cell membrane of both immature and matured oocytes and their corresponding 
CCs. Localization pattern of EGF-R revealed higher signal in in vitro matured COCs 
compared with the immature ones. This is according with the results of Bhardwaj et al. 
(2016) in which brilliant cresyl blue (BCB) positive oocytes showed significantly higher 
expression of EGF-R transcripts than BCB negative oocytes. In mouse CCs, their 
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expression increased dramatically after 4 h of culture in FSH-enriched media (Shimada 
et al., 2006). This increase is also reported in bovine (Assidi et al., 2008). Over expression 
of EGF-R in CCs can enhance the proliferation of CCs and oocyte meiosis resumption 
and maturation through the activation of MAPK3/1 in mice (Yang et al., 2016). Therfore 
EGF-R could be used as molecular marker of oocyte competence. Recently has been 
described proteolytic enzyme of EGF-like factors (TACE/ADAM17) which activity 
increased in CCs that expressed in FSH/LH-stimulated GC and CCs together with 
activation of the EGFR-MAPK3/1 pathway. When Tumor necrosis factor-alpha-
converting enzyme (TACE/ADAM) activity is suppressed granulosa cell luteinization, 
cumulus expansion and oocyte maturation were inhibited in an in vitro culture (Yamashita 
and Shimada, 2012). 
 
In other species it has been evidenced that EGF-R are only located in CCs, but not in 
the oocyte (murine: Downs et al., 1989; bovine: Yoshida et al., 1998; mouse: Park et al., 
2004, Panigone et al., 2008; Su et al., 2010). The hypothesis is that EGF major site of 
action when regulating oocyte maturation is the CCs in human (Qu et al., 2000; Tamura 
et al., 1995) and rat (Dekel and Sherizly, 1985). As has been mentioned previously, the 
mechanisms of action involve EGF-like peptides which act directly on CCs, bind to the 
EGF-R and consequently stimulate the resumption of meiosis and expansion of the CCs. 
However, previous studies have reported that in the oocytes EGF-R associated tyrosine 
kinase activation triggers meiosis even if they are denuded (Park et al., 2004; Li et al., 
2008). In fact, EGF-R has been localized in human (Maruo et al., 1993; Bennett et al., 
1996; Qu et al., 2000), hamster (Garnett et al., 2002), pig (Singh et al., 1995; Uhm et al., 
1999; Sugimura et al., 2015), macaque (de Prada et al., 2009), mouse (Das et al., 1991; 
Hill et al., 1999) and goat (Gall et al., 2004) oocytes. Although, some works have 
demonstrated that EGF acts on denuded oocytes or COCs (mouse: Das et al., 1991; 
cattle: Lonergan et al., 1996), the presence of a functional receptor for EGF in oocyte is 
still controversial in mammalian species (Gall et al., 2004). Our findings imply that EGF 
may act on CCs and directly on the oocyte throughout its receptor. This suggests that 
the effect of EGF could be in part independent of the CCs and that the oocyte could be 
a direct target for EGF via its receptor (Gall et al., 2004; Pereira et al., 2012) through an 
autocrine/paracrine pathway (Jamnongjit et al., 2005; Park et al., 2004). Furthermore, 
Jamnongjit et al. (2005) demonstrated that EGF signaling through the EGF-R is essential 
for steroidogenesis in mouse COCs. The EGF-R-mediated steroidogenesis is regulated 
by StAR pathway and increased the signaling by posttranslational modifications or 
phosphorylation (Jammongit et al., 2005). The EGFR-induced steroidogenesis (P4 and 
E2) indirectly promoted the maturation where oocytes are held in meiotic arrest. 
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5.1.3. Characterization of EGF and EGF-R system in the guinea pig early embryos 
 
Finally, in the guinea pig embryos EGF-R was temporally inmunolocalized in the cell 
membrane throughout the preimplantation developmental stages studied. Increased 
EGF-R signal in the periphery of blastomeres as development progressed from 2 cell 
embryo to morula stage has been found. Our findings indicate that the EGF could be 
involved in the early embryo development in the guinea pig by two ways: 1) by stimulating 
the survival and P4 production in the corpus luteum, but also; 2) acting directly by its cell 
surface receptor in the early embryos. However, further studies are needed to 
corroborate this hypothesis. These findings are according toThongkittidilok et al. (2015), 
which found that cat early embryos expressed EGF-R. Besides, EGF-R is expressed in 
the 2-cell to blastocyst stage in the mouse and from the 8-cell stage to the blastocyst 
stage in humans (Paria et al., 1993; Kane et al., 1997) thus transcription after maternal 
transition has been suggested. EGF-R was detected in porcine morula and blastocyst 
as well (Kim et al., 1999; Wei et al., 2001). EGF binds with its receptor and stimulates 
MAP/ERK and PI3K/Akt pathways that, in turn, enhance cell proliferation (Fujihara et al., 
2014). By this mechanism, EGF can directly promotes cleavage and enhances 
blastocyst formation in the mouse, cow, buffalo, sheep and cat (Paria et al., 1990; Lee 
et al., 1995; Lim et al., 1996; O´Neil, 1997; Hardy and Spanos, 2002; Sirisathien et al., 
2003; Neira et al., 2010; Shabankareh et al., 2010; Song et al., 2011; Chandra et al., 
2012). It is responsible of increased protein synthesis in embryos (Wood and Kaye, 
1989) and it is involved in the implantation of the embryo (Wiley et al., 1992; Das et al. 
1994) and regulates the development of the peri-implantation uterus by the ERK1/2 
MAPK pathway (Jeong et al., 2016). In fact, embryos from knockout EGF-R mothers fail 
to implant (Threadgill et al., 1995). 
 
5.2. Expression and localization of IGF-1 and IGF-1R  
 
5.2.1. Characterization of IGF-1 and IGF-1R system in the guinea pig ovary 
 
The IGF-1 system consisting of peptide hormone (IGF-1), cell surface receptor (IGF-1R) 
and six circulating binding proteins (IGFBPs 1–6) (Paveli´c et al., 2007). The intrinsic 
tyrosine kinase pathway gets activated and facilitates the essential biological role of IGF-
1. All the components act together and regulate a number of crucial biological outcomes 
such as cellular growth, proliferation, differentiation, survival against apoptosis, and 
migration (Khandwala et al., 2000; Pollak et al., 2008). Besides according to the results 
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of earlier studies, the IGF system differ between womans with PCOS and normal ovaries 
(Homburg, 1998; Suikkari et al., 1989; Vendola et al., 1999; Stubbs et al., 2013) 
 
In the present study, relative mRNA expression of IGF-1 and IGF-1R was higher in antral 
follicles than in preantral ones. Both mRNA transcripts and protein have been identified 
in human antral follicles (El-Roeiy et al., 1993; Voutilainen et al., 1996), and preantral 
follicles (Samoto et al., 1993; Qu et al., 2000). IGF-1 gene expression have been also 
identified in rat (Murphy et al., 1987; Oliver et al., 1989), porcine (Hammond et al., 1988), 
bovine (Armstrong et al., 2000) and mice (Demeestere et al., 2004) ovary. Besides, IGF-
1R transcripts were described in rat (Ergin et al., 2008), buffalo (Zhou and Bondy et al., 
1993; Zhao et al., 2001; Uniyal et al., 2015), and rat (Oliver et al., 1989) ovary as well. 
These results support the notion that the selection of a future dominant follicle could be 
affected when the intrafollicular IGF system is altered (Fortune et al., 2004.) Althouugth 
the pathogenesis of PCOS is still unclear, it is demonstrated that in PCOS women, 
concentrations of IGF-1 in the follicular fluid are higher than in healthy women (Abd et 
al., 2005). The increased secretion of IGF-1 and androgen by theca cells is attributable 
to this alteration. 
 
According to these findings, the immunohistochemical analysis revealed that most of the 
follicles in all stages of development studied in guinea pig exhibited moderate expression 
for IGF-1R in oocytes and granulosa cells in preantral follicles but the staining was 
stronger in the most of antral follicles. Theca cells presented differential expression since 
IGF-1R staining changed from mainly weak in secondary follicles to strong signal in the 
most of antral follicles. These findings are according to the literature in other species, 
where IGF-1R was immunolocalized in the follicles (human: Qu et al., 2000b; rat: Zhao 
et al., 2002), GC (buffalo: Singh et al., 2015; bovine: Gong et al., 1994) and oocytes 
(human: El-Roeiy et al.,1993, 1994; bovine: Wang et al., 2009a; primate: Zhou and 
Bondy, 1993; Vendola et al., 1999; buffalo: Singh et al., 2015). Conversely, 
immunoreactive IGF-1 has been localized in several studies in the theca-interstitial 
compartment (bovine: Schams et al., 2002) but not in others (human: Poljicanín et al., 
2015). IGF-1 acts throughout its receptor in the follicle cells and oocyte (Murphy et al., 
1987; Yu and Ge, 2007; Zhou et al., 2016) and is mainly produced in granulosa cells in 
the ovary. Then, observations here described was expected as its key function is 
granulosa cell proliferation and differentiation and steroidogenesis stimulation of different 
follicular stages via PI3K-Akt activation (Louhio et al., 2000; Fortune, 2003; Monget et 
al., 2002; Cara and Rosenfield, 1988). 
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The moderate inmunostaining in granulosa cells and oocytes of IGF-1R in all preantral 
follicles suggests physiological functions before recruitment but, the increase in 
inmunostaining of IGF-1R and the mRNA gene expression of IGF-1 and IGF-1R in antral 
follicles stages advise a key role in the later stages of the follicular development in an 
autocrine and paracrine manner as well. According to our results, in several species, 
IGF-1 mRNA was localized in follicles of all sizes (human: Qu et al., 2000b; Samoto et 
al., 1993; pig: Zhou et al., 1996; cow: Schams et al., 2002). IGF-1 increased progression 
from the primordial to the primary stage in in vitro cultured human ovarian cortex but in 
absence of IGF-1 the follicles also growth (Louhio et al., 2000; Stubbs et al., 2013). As 
occur with EGF, the intraovarian IGF-1 system plays a key role in regulating proliferation 
and differentiation of granulosa and theca cells, steroidogenesis and apoptosis either 
alone or in synergy with gonadotropins (Baker et al., 1996). Increase in IGF-1R 
expression is concomitant with increase in FSH and LH receptors as follicle enlarges 
size in cattle (Wandji et al., 1992). IGF-1 contributes to improve the final maturation of 
follicle events (Monget and Bondy, 2000) and the amplification of FSH action by 
increasing the aromatase activity (Baker et al., 1996; Zhou et al., 1997), production of 
estrogens and LH receptors (Magofﬁn and Weitsman, 1994; Tsuchiya et al., 1999; 
Huang et al., 2001), and antrum formation (Monget and Bondy, 2000). Therefore, it is 
suggested that IGF-1 has a permissive rather than a decisive role on follicular cell 
proliferation and survival and was not essential for the recruitment of primordial follicles 
and growing of preantral ones (Baker et al., 1996), where an endocrine mechanism for 
the IGF-1 regulation of antral follicles has been suggested (Armstrong, 2000).  Besides, 
IGF-1 seems to play a key role in increasing the sensitivity of non- gonadotropin 
dependent follicles (small antral follicles) to gonadotropin action and to their transition to 
the dependence of gonadotropin (Monget et al., 2002). In fact, previous studies have 
shown that in woman IGF are possible regulators of beginning of follicular growth, and 
accelerated preantral follicular growth on PCOS may be due to increased activity of 
endogenous IGF (Stubbs et al., 2013). 
 
On the other hand, IGF-1 and IGF-1R genes were also expressed in the corpus luteum. 
IGF-1R mRNA transcripts were higher than IGF-1 ones. Data was confirmed by the high 
expression for IGF-1R in the luteal cells by immunohistochemistry. mRNA expression of 
IGF-1, and IGF-1R was also observed during the early luteal phase (Days 1–4) in bovine 
corpus luteum (Vandehaar et al., 1995; Kirby et al., 1996; Perks et al., 1999; Woad et 
al., 2000). mRNA expression of IGF-1R and localization in large luteal cells was also 
observed in pig corpus luteum (Ge et al., 2000) but not was detected in rats (Oliver et 
al., 1989). IGF-1 acts by stimulating the uptake of cholesterol, modifying its cytoskeleton, 
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and actively stimulating the secretion of P4 (Schams et al., 1980; McArdle and Holtorf, 
1989; Einspanier et al., 1990) in rats (Chouhan et al., 2014), sheep (Khan-Dawood et 
al., 1994), pigs (Pescador et al., 1999; Miller et al., 2003; Ptak et al., 2004), and cattle 
(McArdle and Holtorf, 1989; Sauerwein et al., 1992). As well as EGF, IGF-1 maintains 
luteal size (Parmer et al., 1991) promotes proliferation, decreases of DNA fragmentation, 
and prevents the spontaneous onset of apoptosis by stimulating P4 production or by 
regulating the expression of survival gene and pro-apoptotic gene (Ptak et al., 2004; 
Yang et al., 2000; Parborell, et al., 2002; Sugino, et al., 2000).  However, a less potent 
role than EGF in angiogenesis has been elucidated (Chouhan et al., 2014). Therefore, 
the IGF-1 seems to play an important role in the process of early corpus luteum function 
and therefore in the endometrium development, embryo survival and early embryonic 
losses (Webb et al., 2002). However, these functions are modulated by the IGFBPs. 
 
5.2.2. Characterization of IGF-1 and IGF-1R system in the guinea pig cumulus-
oocyte complexes 
 
IGF-1 system expression has been scarcely studied in the COCs. It is known that the 
oocyte produces paracrine signals which act together with surrounding CCs to regulate 
gonadotropin and IGF-1 stimulated steroidogenesis (Li et al., 2000). In guinea pig, we 
evidenced IGF-1 and IGF-1R gene expression suggesting an autocrine and paracrine 
role of IGF-1 in the bidirectional communication of oocytes and their corresponding CCs. 
Higher mRNA transcripts of IGF-1R were found in CCs than in oocytes which can be 
related with higher response of CCs to IGF-1 action than oocytes. According to our 
results, IGF-1R was detected in human CCs but the mRNA levels were different if the 
follicles were obtained from woman with PCOS or not (Kwon et al., 2010). IGF-1R was 
also localized in bovine (Nuttinck et al., 2004; Wang et al., 2009) and ovine (Pissani et 
al., 2008) CCs and oocytes. But controversially, it is not completely clear if IGF-1 is 
expressed in the oocytes of all mammals. According with our results, some authors 
detected IGF-1 in immature bovine (Yoshida et al., 1998; Satrapa et al., 2013) and sheep 
(Pissani et al; 2008) oocytes but others have reported no expression in the oocytes being 
mRNA restricted exclusively to CCs (Nuttinck et al., 2004; Wang et al., 2009). The 
intensity of the inmunofluorescence for IGF-1R increased in both oocytes and CCs 
during in vitro maturation in the guinea pig. It disagrees to previous studies where no 
modifications in the localization of IGF-1R within the oocyte were detected after oocyte 
maturation (Yoshida et al., 1998; Nuttinck et al., 2004). In contrast other reports have 
shown that IGF-1R increase after oocyte maturation depends on the type of IVM medium 
used (Warzych et al., 2007). Higher gene expression of IGF-1R after oocyte maturation 
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is related to higher blastocyst rate and lowere apoptosis in embryos deloped form those 
oocytes (Warzych et al., 2007). Other studies also have detected mRNA for IGF- in 
immature and matured oocytes (bovine: Wang et al., 2009, Farin et al., 2010) and buffalo 
(Vikash et al., 2011) suggesting that supplementation of IGF-1 may be useful for in vitro 
oocyte maturation.  
 
5.2.3. Characterization of IGF-1 and IGF-1R system in the guinea pig early embryos 
 
IGF-1 is an important growth factor during preimplantation embryo development in 
mammals (bovine: Schultz et al., 1992; Matsui et al., 1995, Palma et al., 1997, Yoshida 
et al., 1998; Lonergan et al., 2000, Yaseen et al., 2001, Moore et al., 2007; Warzych et 
al., 2007; buffalo: Pawshe et al., 1998; murine: Schultz et al., 1992) since can enhance 
embryo cell proliferation and mitogenesis (Adashi et al., 1985; Kamada et al., 1992) via 
Akt phosphorylation (Green and Day, 2014). IGF-1R is regulated during embryogenesis 
and IGF-1 has effects on glucose, metabolism and cell differentiation (Bassas et al., 
1985; Heyner et al., 1989, 1993; Rappolee et al., 1992; Adamson, 1993; Schultz et al., 
1993). In current work, we demonstrated the distribution of the IGF-1R in guinea pig 
embryos in the cell membrane of the totality of embryo blastomers from 4 cell embryos 
to morula stage showing the temporal localization of IGF-1R protein. Bedzhov et al. 
(2012) also localized IGF-1R throughout the embryo membrane, but they discovered that 
co-expression with E-cadherin in cell contact sites in the embryo was essential for 
appropriate activation of the receptor and to avoid apoptotic signaling. Some authors 
have also found IGF-1R in all the preimplantation stages (cattle: Watson et al., 1992; 
Rappolee et al., 1992; Yoshida et al., 1998; Qu et al., 2017) while others only detected 
it after maternal transition: 8-cell stage in mouse (Smith et al., 1993; Schultz et al; 1993) 
and pig (Xia et al., 1994) embryos and morulae and blastocysts in rabbit (Santos et al., 
2008). High gene expressions of IGF-2, IGF-1 receptor, IGF-2 receptor, and insulin 
receptor are associated with high growth potential in day 3– day 6 human embryos 
(shortly before implantation) (Liu et al., 1997). These results suggest that human 
embryonic development at the preimplantation stage is regulated by IGF from both 
embryos. Probably, IGF-1 and insulin are provided both by the mother and the embryo 
(Kane et al., 1997). The insulin is needed to increase the protein synthesis and 
development of blastocyst (Harvey and Kaye, 1988, 1990, 1992; Rappolee et al., 1992). 
The IGF-1 and IGF-1R are highly expressed in TE (precursor to placenta) to regulate 
embryonic growth (Rappolee et al., 1992) highlighting the differential role of IGF-1 in the 
embryos. 
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In addition, as we mentioned previously an increasing immunoreaction pattern as 
development progressed in the guinea pig embryo is shown. It could be related to the 
regulation of the metabolic processes that may modulate cell proliferation rates when the 
embryo genome is activated in which IGF system is involved (Senior et al., 1990). Our 
results match with the increased expression from the 3- to 4-cell stage up to the 
blastocyst stage found in human embryos (Lee et al., 1993). In cattle, greatest increase 
occurred after hatching (Yaseen et al., 2001) although IGF-1R is expressed in all the 
preimplantation stages (Yoshida et al., 1998; Schams et al., 2002; Wang et al., 2009; 
Vikash et al., 2011) suggesting that supplementation of IGF-1 may be useful for in vitro 
embryo development. In fact, many studies point out the importance of IGF-1 and IGF-
1R in the paracrine dialog between preimplantation embryos and uterine tissues (Murphy 
and Barron, 1993; Chandra et al., 2012) since higher gene expression of IGF-1R has 
been related to higher blastocyst rate and survival as well (Warzych et al., 2007). 
 
All the described findings in guinea pig confirm the important role of IGF-1 and IGF-1R 
in regulation mainly of final maturation stages of folliculogenesis, oocyte maturation, 
corpus luteum formation and function and, embryo development. However, there are 
differences in the spatial and temporal location of the IGF-1 system among mammals 
suggesting different mechanisms of action (Yuan et al., 1998; Gutierrez et al., 1997; 
Schams et al., 1999; Armstrong et al., 2000; Mao et al., 2002; Sharma et al., 2010; 
Magalhaes-Padilhaa et al., 2012). Besides, the bioactivity of IGF during follicular 
development and corpus luteum formation is mediated by the cell membrane receptors 
and the family of specific IGFBPs 1-6. Hence, changes in any component of this system 
could potentially disturb follicular development and related events. 
 
5.3. Expression and localization of IGFBPs 1 to 6  
 
5.3.1. Expression and localization of IGFBPs 1 to 6 in guinea pig ovary 
 
Insulin-like growth factor binding proteins present within the ovary bind with IGF, 
modulating the concentrations of bioactive IGF. The proteins, IGFBPs 1 to 6, share a 
common domain organization consisting of cysteine-rich N and C terminal domains 
connected by a flexible linker region. IGF binding sites are located on both the N and C 
domains and both are required for wild-type affinity (Hwa et al., 1999; Carrick et al., 
2001). 
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IGFBPs are present within the ovary where they are mainly produced, secreted and 
degraded (Besnard et al., 1996; Stewart et al., 1996; Zhou et al., 1996). As described in 
the results, we clearly demonstrate that the IGFBPs 1–6 are located within ovary in all 
follicular stages, corpus luteum and oocyte and CCs of guinea pig, but different 
expression pattern is showed for each IGFBPs indicating a regulatory role in the IGF-1 
bioavailability during the developmental stages of follicular development. In general, the 
IGFBPs, by sequestering IGF away from the IGF receptor, show inhibitory effects on IGF 
action (Firth and Baxter, 2002). In the ovary IGFBPs inhibits follicular growth and 
differentiation induced by gonadotrophins; because their shift lead to changes in IGF-1 
bioavailability (Spicer and Echternkamp, 1995), making it non-available to its receptors 
(Armstrong, 1997). In contrast, in vitro studies showed stimulatory activity (Schams et 
al., 1999; Dubey et al., 2015) and it is also described IGF-1-independent actions (Wright 
et al., 2002), such as regulation of glucose homeostasis by IGFBP-1 and IGFBP-3 
(Murphy, 2003). The proteolytic degradation of IGFBPs in healthy follicles has an 
important role reversing inhibition action of the IGFBPs and increasing availability of IGF 
or generating IGFBPs fragments with novel bioactivity (Firth and Baxter, 2002). Then, 
IGF-1 action can be inhibited or potentiated by IGFBPs 1-6 (Jones and Clemmons, 1995; 
Rajaram et al., 1997) and these actions depends on cell surface association, ECM 
association and phosphorylation or proteolysis, which alter the affinity of IGFBPs for the 
ligands (Schams et al., 2002; Singh et al., 2015).  
 
The existence of IGFBPs 1-6 mRNA transcripts in the guinea pig ovary is according to 
findings in other species (cattle: Schams et al., 2002; sheep: Hasti et al., 2004, buffalo: 
Singh et al., 2015, macaque: Brogan et al., 2010, rat and mouse: Goubau et al., 1996; 
human: El-Roeiy et al., 1994; Voutilainen et al., 1996).  
 
Gene expression of IGFBP-1 was detected in antral and preovulatory follicles, corpus 
luteum, and in COCs in the guinea pig. This agrees with the fact that IGFBP-1 mRNA 
has been detected in granulosa cells of dominant follicles in human (El-Roeiy et al., 
1994), luteinizing follicles (Thierry et al., 1996) and follicles containing mature oocytes 
(Kawano et al., 1997). In our work, relative mRNA expression of IGFBP-1 was higher in 
preovulatory follicles than in antral follicles whereas the IGF-1 mRNA transcrips followed 
the inverse relationship. Higher inmunofluorescent signal for IGFBP 1 and 3, in oocytes 
and CCs obtained from preovulatory follicles as also found in guinea pig, as described 
below. High IGFBP-1 and low IGF-1 in the ovary may play an important role in follicular 
growth and maturation (Wang et al., 2006). IGFBP-1, -2 and -3 inhibit IGF-1 action on 
the ovary. Therefore, IGFBP-1 and -3 are observed in dominant follicles. IGFBP-1 
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modulates the mitogenic activity of IGF-1 in granulosa and CCs in the later stages of 
follicular development contributing to the proliferation of cells, probably enhancing 
gonadotropin action (Singh et al., 2015), and to the processes related to the stablishment 
of follicular dominance and oocyte developmental competence. IGFBP-1 is believed to 
inhibit IGF-1-induced androgen production by theca cells and in turn inhibit/prevent 
follicular atresia. In fact, IGFBP-1 is observed in granulosa cells of dominant follicles but 
not in those atetric (El-Roeiy et al., 1994). An increase in IGF-1 expression and a 
decrease in IGFBP-1 and IGF-2 in theca and stroma cells isolated from PCOS suggests 
a negative effect of IGF-1 on folliculogenesis and ovulation. In these woman and excess 
of androgen and insulin levels in follicles, affects granulosa cells by increasing IGFBP-2 
and -4 levels and reducing IGFBP-1 levels (Greisen et al., 2002; Druckmann and Rohr 
et al., 2002; Balen, 2004). However, in the immunohystochemical study the expression 
for IGFBP-1 has been described higher signal in preantal follicular stages but the 
intensity decreased in granulosa cells and theca of antral follicles in the guinea pig. 
These results may be indicating that the relatively amount of mRNA for the IGFBPs does 
not necessarily indicate that there is a constant inhibition of the action of the IGF 
(Besnard et al., 1996, 1997) and other IGFBPs could be modulating the bioavaiability of 
IGF-1 during follicular development. 
 
In corpus luteum, IGFBP-1 gene expression was higher than in follicles of both sizes 
although moderate immunoreaction was observed in luteal cells. In agreement with our 
results, IGFBP-1 expression was also localized in luteinized granulosa cells and corpus 
luteum for several species (Buyalo et al., 1994; Baxter 2000; Bondy, 1993; Sayre et al., 
2000; Neuvians et al., 2003) and human (Hartshorne and Lee, 1990) whereas, in others, 
IGFBP-1 mRNA could not be detected (rat: Nakatani et al., 1991, sheep: Hastie and 
Haresign, 2006). Therefore, controversial results about the luteal function of IGFBP-1 
are reported. Some studies attributed a stimulatory role of IGFBP-1 on luteal function 
since they found a significantly high expression of IGFBP-1, -3, -5, and -6 either in the 
early or in the mid-luteal phase (Uniyal et al., 2015). However, other authors have 
reported an increase of IGFBP-1 mRNA transcripts during luteolysis (Sayre et al., 2000) 
which may inhibit the steroidogenic effects of IGF-1.  
 
Our results imply a key role for IGFBP-1 in the development of the dominant follicle and 
in corpus luteum regulation in the guinea pig. However, its implication in the stablisment 
of the follicular dominance and function of corpus luteum need further investigations. 
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For IGFBP-2 significantly higher mRNA transcripts have been showed in preovulatory 
follicles than in antral follicles. mRNA IGFBP-2 was detected in mouse granulosa cells 
in which is highly expressed (Seppälä et al., 1984, Nakatani et al., 1991, Adashi et al., 
1997, Wandji et al., 1998). However, in the rat ovary IGFBP-2 mRNA is specifically 
localized in thecal cells (Nakatani et al., 1991). In situ hybridization studies have shown 
that, in human dominant follicles, IGFBP-2 and IGFBP-3 mRNA are localized in both 
granulosa cells and theca cells (Zhou and Bondy, 1993; El-Roeiy et al., 1993). It is 
proposed that lower levels of mRNA for IGFBP-2 in antral follicle can be associated with 
increased sensitivity to FSH (Armstrong et al., 1996; 1998). FSH may increase 
production of proteases and decreases IGFBP-2 (Schams et al., 1999) resulting in a 
greater expression of the IGF-1 in the granulosa cells and theca cells (Singh et al., 2015). 
Atretic follicles present predominantly as IGFBPs, IGFBP-2 and IGFBP-4 which are 
selectively eliminated in healthy follicles (Wright et al., 2002). However, Giudice (1992) 
indicated that IGFBP-2 may be also important during early stages of follicular 
development. In fact, mRNA IGFBP-2 was detected in granulosa cells of primordial, 
primary, and small antral follicle in the rhesus monkey (Arraztoa et al., 2002). In our 
immunohistological study, we also showed that IGFBP-2 showed higher sinal in 
granulosa cells in all follicular stages, including the primordial follicles, whereas theca 
cells and oocyte presented fewer inmunostaining. These findings suggest a possible 
regulatory role of IGFBP-2 in the follicular development according to Sharms et al., 
(2002) and Ge et al., (2003).  
 
In corpus luteum, IGFBP-2 was highly expressed as well as has been demonstrated in 
the early luteal stage in buffalo (Uniyal et al., 2015) but, in mid-, late, and regressing 
luteal phases in equine (Watson et al., 2005). In sheep gene expression of IGFBP-2 was 
relatively constant during the luteal phase of the cycle, and decreased 20-40 h after 
PGF2α induced luteolysis, indicating that they may not play an active role in luteolysis 
(Hastie and Haresign, 2006). Although in present study the expression of IGFBP-2 was 
found high, it has been suggested that the inhibitory effects might have been masked by 
higher expression of other stimulatory factors (Uniyal et al., 2015). Also a role for IGFBP-
2 in the developing corpus luteum has been elucidated in bovine (Gregson et al., 2016).  
 
In later stages of follicular development, differential gene expression of IGFBP-3 was 
described since relative mRNA expression was significantly higher in the antral follicles 
than in preovulatory follicle. Higher expression of IGFBP-3 in antral follicle correlates with 
higher gene expression of IGF-1 and IGF-1R in those follicles compared to the 
preovulatory follicle. IGFBP-3 is present in granulosa cells of different type of follicles as 
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has been reported in buffalo (Dubey et al., 2015; Singh et al., 2015), cattle (Yuan et al., 
1998; Armstrong, 2002), and pig (Samaras et al., 1993). Besides, IGFBP-3 was 
expressed in oocytes of bovine preantral follicle (Armstrong et al., 2002) and in oocytes 
and stroma in rhesus monkey ovaries (Arraztoa et al., 2002). It is also expressed in 
luteinized granulosa of porcine (Wandji et al., 2000) and human follicles (Adashi et al., 
1990). In current work, the immunohistochemical study showed slight expression of 
IGFBP-3 in all follicular stages in oocytes, granulosa and theca cells. Previous authors 
also have detected IGFBP-3 mRNA are in both human granulosa and theca cells (Zhou 
and Bondy, 1993; el-Roeiy et al., 1994) and no differences were demostrated in mRNA 
levels of IGFBP-3 betwenn granulosa cells from inmature- and mature follicles (Kwon et 
al., 2010). It is in contrast with previous findings in which demonstrated that IGFBP-3 
presence increases with the enlargement in follicular size in bovine (Rebouças et al., 
2014). Besides higher concentrations of IGFBP-3 in estrogen dominant follicles have 
found compared with androgen dominant ones (Thierry Van Dessel et al., 1996; Ge et 
al., 2003), but this results are contradictory (San Roman and Magoffin et al., 1993). 
Although, in humans, IGFBP-3 is the most important and abundant binding protein that 
intervenes in the maintenance of the circulating IGF-1 level (Batista et al., 2012), the 
IGFBP-3 exerts dual functions in modulating IGF action in vivo. Soluble IGFBP-3 inhibits 
IGF-1 action by sequestering and preventing IGF-1 receptor binding, whereas surface-
associated IGFBP-3 enhances the growth-promoting effects of IGF-1 in bovine 
fibroblasts (Conover et al.,1990). 
 
Increasing levels of IGFBP-3 has been observed in the early (Schams et al., 2002; 
Brogan et al., 2010) and mid-luteal phase (Uniyal et al., 2015), which correlates with the 
highest expression for IGF-1, IGF-2 and IGF-1R and it is attributed to the stimulatory 
effect of IGF-1 on the production of IGFBP-3 as studied in cultured porcine GCs (Grimes 
and Hammond, 1992) and bovine fibroblast cells (Bale et al., 1992). In contrast, gene 
expression of IGFBP-3 was highest throughout the luteal phase but lower in regressing 
corpus luteum in sheep (Hastie and Haresign, 2006). In primate corpus luteum IGFBP-
3 plays a regulatory role in angiogenesis and luteal function as well (Fraser et al., 1998). 
In current work, corpus luteum showed lower mRNA transcripts than in the those found 
in follicles and moderate inmunostaining. In some cases the glycosylation in the 
biological actions of IGFBP-3 may affect the detection of protein and the interaction with 
IGF-1 (Giudice, 1992; Schams et al., 1999; Masnikosa et al., 2010; Rodriguez et al., 
2011). 
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IGFBP-4 mRNA was expressed in antral and preovulatory follicles and corpus luteum, in 
guinea pig with a similar pattern than IGFBP-1 and 2 although corpus luteum showed 
intermediate values. IGF binding to IGFBP-4 may be mediated through the 
activation/production of specific IGFBP-4 proteases present in the granulosa cells 
(Besnard et al., 1996) and in porcine, equine and bovine preovulatory follicles 
(Mazerbourg et al., 2000). IGFBP-4 specific protease is stimulated in human granulosa 
cells by FSH (Iwashita et al., 1998) being in the dominant follicle increased. The higher 
mRNA levels of IGFBP-4 in preovulatory follicles in guinea pig are according with 
previous findings in which found high protease PAPP-A (Pregnancy-associated plasma 
protein-A) and low IGFBP-4 during the selection of dominant follicles (Conover et al., 
1999,1990; San Roman and Magoffin, 1993; Hourvitz et al., 2000). This situation shift to 
low PAPP-A and high IGFBP-4 in the late and more mature follicles shortly before oocyte 
maturation and ovulation (Wang et al., 2006). Therefore, decreased levels of IGFBP-4 
and increased levels of its protease PAPP-A (Conover et al., 1999) have been 
associated with the selection of dominant follicles (San Roman and Magoffin, 1993; 
Hourvitz et al., 2000; Mazerbourg et al., 2001). In contrast, an excess of androgen and 
insulin levels in follicles of woman with PCOS, increases IGFBP-2 and -4 levels and 
reducing IGFBP-1 levels (Greisen et al., 2002; Druckmann and Rohr et al., 2002; Balen 
2004).  
 
Schams et al. (2002) confirm the IGFBP-4 expression and regulation in pre-ovulatory 
follicles in bovine species. It is described that it is essentially expressed in thecal cells 
from healthy and atretic follicles (human: Zhou and Bondy et al., 1993; sheep: Besnard 
et al., 1996; Armstrong et al., 1996), but it has also been localized in granulosa cells in 
pig (Grimes et al., 1994) and buffalo (Singh et al., 2015) and in atretic follicles in the rat 
(Nakatani et al., 1991; Erickson et al., 1992). IGFBP-4, a potent inhibitor of FSH-induced 
estradiol secretion by granulosa cells, is expressed in atresic follicles in the rat (Nakatani 
et al., 1991; Erickson et al., 1992).  In current work, we didn´t observe any difference in 
the immunolocalization between cellular compartments according to human (El-Roeiy et 
al., 1994), where IGFBP-4 is expressed in both granulosa and thecal cells. It has been 
demonstrated that IGFBP-4 inhibits steroid production in granulosa and theca cells in 
woman (Mason et al., 1998). In our study, the signal was weak for this protein according 
to Mason et al. (1998).  
 
In corpus luteum gene expression of IGFBP-4 showed intermediate values compared to 
follicles, being signal found by immunohistochemistry weak. Uniyal et al. (2015) and 
Hastie and Haresign, (2006) found maximum IGFBP-4 expression in the early luteal 
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phase, and afterwards decreased. In current work, IGFBP-2 showed higher gene 
expression and inmunostaining than IGFBP-4. In buffalo, it has been reported that 
IGFBP-2 is more important inhibitory binding protein than IGFBP-4 (Uniyal et al., 2015). 
Hossner et al., (1997) also showed that IGFBP-4 exhibits only inhibitory effects in pig 
 
IGFBP-5 is considered to have a key role in the IGF axis (Beatti et al., 2006) and shows 
a relative constant expression in all cycle (Schams et al., 2002). It was detected in all 
studied tissues and immunolocalized with a weak reaction in all the cells from primordial 
to antral follicles, and in corpus luteum in guinea pig. mRNA expression pattern was 
similar to IGFBP-3, in which antral follicle showed the maximum relative expression.  
 
In humans, IGFBP-3 is the most important and abundant binding protein that intervenes 
in the maintenance of the circulating IGF-1 level (Batista et al., 2012) and second one is 
IGFBP-5 (Firth and Baxter, 2002). In human, higher expression of IGFBP-5 in granulosa 
cells was observed in woman with PCOS suggesting that this increase is related with 
inhibition of oocyte maturation by decreasing IGF-1 availability (Kwon et al., 2010). The 
IGFBP-5 mRNA was mainly present in theca cells from healthy follicles and in granulosa 
cells from atretic follicles (Zhou and Bondy et al., 1993). However, expression in 
granulosa cells appears to be species-dependent. In the rodent, it is concentrated in a 
subpopulation of small follicles probably destined for selection (mouse: Wandji et al., 
1998) or atresia (rat: Erickson et al., 1992). However, in the porcine, IGFBP-5 is not 
detected in the granulosa of any follicles, small or large (Wandji et al., 2000). In the 
sheep, cow, and goat as well as in the rat, IGFBP-5 mRNA is detected in the granulosa 
of atretic follicles (Besnard et al., 1996, Erickson et al., 1992) since follicular atresia, is 
characterized by a decrease in intrafollicular IGFBP-4 and -5 proteolytic activity (Besnard 
et al., 1996). Also the IGFBP-5 was isolated in the porcine FF (Shimasaki et al., 1990; 
Shimasaki and Ling,1991). 
 
In current work gene expression and inmunolocalization of IGFBP-5 in corpus luteum 
were low. IGFBP-5 has been localized in corpus luteum in previous studies (Erickson et 
al., 1992). In sheep IGFBP-5 mRNA gene expression increased in early regressing 
corpus luteum 20 h after prostaglandin-induced luteolysis (Hastie and Haresign, 2006), 
which was also evident in a previous study in cattle (Neuvians et al., 2003). E2 has been 
suggested to participate in the regulation of luteal steroidogenesis and luteal cell 
morphology. In this sense, a recent study has suggested an inhibitory role for E2 in the 
regulation of luteal steroidogenesis, morphology and proliferation. IGFBP-5 was one the 
Discussion 
132 
 
E2 responsive genes with important role in the mediation of this hormone actions such 
as E2-induced phosphorylation of PI3K/Akt kinase pathway in rats (Tripathy et al., 2016).  
 
We evidenced the expression of IGFBP–6 in the guinea pig ovary. mRNA abundance 
was comparable between antral and preovulatory follicles being both of them significantly 
higher than in corpus luteum, as occurred for IGFBP-3 and 5 too. Also, protein 
distribution was weak in all the compartments of the ovary except for the oocyte, which 
signal increased from secondary to antral follicle. During ﬁnal growth of bovine follicles, 
IGFBP–6 has been detected in the theca-interstitial cell and granulosa cell compartment 
(Schams et al., 1999). Moreover, studies have demonstrated that this binding protein 
has lower binding affinity by IGF-1 (Bach, 2015). Recent evidences suggested that 
IGFBP-6 induced apoptosis appeared to be IGF-dependent (Hale et al., 2000) or 
independent (Iosef et al., 2010; Sueoka et al., 2000) in different cell lines and may be 
inhibit oocyte maturation (Kwon et al., 2010). In this line, IGFBP-6 mRNA levels were 
lower in mature follicles than in those inmatue (Kwon et al., 2010). 
 
The gene expression and immunolocalization of IGFBP-6 in corpus luteum was low as 
occur with IGFBP-5. In bovine IGFBP-6 is poor expressed during estrus cycle, but a 
significant up-regulation for IGFBP-6 mRNA at 64 h after induced luteolysis occur 
(Neuvians et al., 2003). In contrast, a reduction of IGFBP-6 gene expression was 
observed in sheep corpus luteum after PGF2α-induced luteolysis, indicating that all of 
them may not play an active role in luteolysis in sheep (Hastie and Haresign, 2006).  
 
5.3.2. Expression and localization of IGFBPs 1 to 6 in guinea pig cumulus-oocyte 
complexes 
 
Current work it is demonstrated that oocytes and CCs expressed all IGFBPs genes. The 
inmunolocalization of IGFBPs family was confirmed by the expression of mRNA 
transcripts in both. In other especies IGFBP-1 (Kamangar et al., 2006), 2 (Nuttinck et al., 
2004), 3 (Ingman et al., 2000), 4 (Giudice, 2001) 5 (Ingman et al., 2000) and 6 (Kamangar 
et al., 2006) are also located in oocytes. IGFBP-1 (Kwon et al., 2010; Kim et al., 2013), 
2 (Nuttinck et al., 2004; Kwon et al., 2010; Kim et al., 2013), 3 (Kwon et al., 2010; Ingman 
et al., 2000), 4 (Nuttinck et al., 2004; Kwon et al., 2010) 5 (Ingman et al., 2000, Kwon et 
al., 2010) and 6 (Kwon et al., 2010) are also located in CCs.  
 
Our findings indicate that IGFBPs seems to be implicated in the oocyte maturation by 
the modulation of the action of IGF-1 between the oocyte and CCs since all IGBBPs 
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proteins were localized in both of them. Wang et al. (2006) have shonw that he 
combination of high IGF-2, high IGFBP-3, high IGFBP-4, and low PAPP-A levels in FF 
at the time of oocyte retrieval correlates with better oocyte maturation and early embryo 
development. In addition, high IGFBP-1, high IGFBP-4, and low IGF-1 levels may be 
favorable factors in later embryo development after oocyte retrieval. According with these 
results, the highest signal was found for IGFBP-1 in both oocytes and CCs and for 
IGFBP-4 in CCs of guinea pig. Preovulatory follicles also showed higher gene expression 
levels for IGFBP-1 and 4 and lower levels for IGF-1 and IGF-1R compared to antral 
follicles. However, the lowest fluorescence intensity was found for IGFBP- 6 in oocytes 
and CCs and for IGFBP-3 in CCs, whereas the rest of IGFBPs (2 and 5) showed 
intermediate results in CCs. Previous results have showed a decrease of IGFBP-6 in 
mature-follicles in both normal woman and woman with PCOS suggesting that IGFBP-6 
may inhibit oocyte maturation (Kwon et al., 2010). Other authors have reported that 
granulosa cell production of IGFBP-2 and -5 plays an inhibitory role in intrafollicular IGF 
action, and IGFBP-2 is prominent in atretic follicles in primates (Liu et al., 1993; Spicer 
et al., 1997; Spicer and Chamberlain, 1999; Davidson et al., 2002).   
 
Comparing the results between the oocytes and their corresponding CCs, the present 
study showed that mRNA transcripts for the majority of IGFBPs are up-regulated in 
oocytes compared to their gene expression in CCs, except for IGFBP-5. Together with 
the results found for IGF-1 and IGF-1R in ooctes and CCs, in the experiment 1b we can 
hipothesize that IGF-1 can be acting mainly on CCs in the guinea pig throgouth its 
receptor. Elevation of IGF-1 in luteinized CCs of matured follicles implies that IGF-1 plays 
an important role in steroid synthesis at the time preceding ovulation (Kwon et al., 
2010b). According with the results in gene expression IGFBP-1 and 4 fluorescence was 
also higher in oocytes. However, CCs showed higher intensity for IGFBP- 3 and 6 
compared to oocytes. While the mRNA expression of IGFBP-1 to 6 is diverse and 
consistent with complex regulation, there is a generalized increase in mRNA levels of 
IGFBP-3, 5, and 6 during the first 12 h following hCG, with a concomittent increase in 
protein for IGFBP-3 and 5 in the FF (Brogan et al., 2010). Increase in IGFBP-3 and 5 
can induce a reduction in IGF-1 bioavailability helping to final maturation events as the 
earliest steps in granulosa cell luteinization (Brogran et al., 2010).  
 
We have shown for the first time the patterns of mRNA expression and protein 
inmunolocation for all IGFBPs in the guinea pig COCs. More investigations are needed 
to study the differences found between the gene expression and immunofluorescence 
study for IGFBP-2, 3, 5 and 6 in the COCs of guinea pig and their implication in the 
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oocyte maturation in these species. A deedply research about the changes of those 
IGFBPs throgouth oocyte maturation are required to understand the role of the IGFBPs 
in the maturation of the guinea pig oocyte. 
 
5.4. Role of EGF and IGF-1 in guinea pig in vitro oocyte maturation  
 
5.4.1. Cortical granules migration and mitochondrial distribution patterns in the 
guinea pig 
 
In this Thesis we established by the first time the cortical granules and mitochondrial 
distribution patterns in guinea pig. Cortical migration is related to density decrease of 
cortical granules in the central area of oocyte compared to the periphery as maturation 
proceeds (Adona et al., 2008). It has been used as a reliable indicator for the cytoplasmic 
maturation of oocytes in cattle (Damiani et al., 1995), porcine (Wang et al., 1997), horse 
(Carneiro et al., 2001), mouse (Li and Albertini, 2013) and rabbit (Arias-Alvarez et al., 
2009). However, different patterns are shown among species. From our best knowledge, 
no references described cortical granules migration pattern in guinea pig oocytes. Our 
findings showed that cortical granules migrated to the periphery in most of the oocytes 
after IVM whereas in immature oocytes homogeneous distribution of cortical granules 
was prevalent. These findings are similar to that found in calf (Damiani et al., 1995), 
rabbit (Arias–Alvarez et al., 2009), bovine (Hosoe and Shioya, 1997), and equine (Willis 
et al., 1994) oocytes.  In human mature oocytes also form one to three discontinuous 
layers of cortical granules beneath the oolemma (Sathananthan et al., 1985; Ghetler et 
al., 2006; Shahedi et al., 2013). Conversely, mice oocytes showed asymmetric 
distribution of cortical granules (Ducibella et al., 1988). This difference in the distribution 
of cortical granules in mouse and the similarity of the distribution to other species, 
including humans, emphasizes the importance of using the guinea pig as a potential 
biomodel for IVM studies. 
 
On the other hand, reorganization of mitochondria is also an essential process for oocyte 
maturation. The capacity of mitochondria to produce ATP by oxidative phosphorylation 
and their distribution could vary among species, perhaps due to site specific 
requirements within the ooplasm in the maturing oocyte (Van Blerkom, 2004). Schon et 
al. (2000) and Barnett et al, (1996) suggest that changes in the location of mitochondria 
can be correlated with the ability of hamster and cattle embryos to develop in vitro. 
Regarding mitochondrial patterns, we found that there wasa relationship between oocyte 
maturation and mitochondrial distribution. We determined that great number of the 
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oocytes after IVM showed peripheral distribution to the nuclear pole. This is according to 
mitochondrial migration pattern described in horse (Torner et al., 2007), mouse (Nishi et 
al., 2003; Calarco, 1995) and human oocytes (Eichenlaub–Ritter et al., 2004) in which a 
clustering of polarized mitochondrial in the hemisphere containing the second 
metaphase plate was described (Van Blerkom, 2011; Eichenlaub–Ritter et al., 2004). 
However, mitochondria homogeneously distributed throughout the cytoplasm was found 
mainly in immature oocytes of guinea pig according to previously described in other 
species such as swine (Cran, 1985; Sun et al., 2001), cattle (Krisher and Bavister, 1998), 
mouse (Li and Fan, 1997; Wang et al., 2009b), hamster (Barnett et al., 1996), cat 
(González et al., 2012), dog (De Los Reyes et al., 2011) and human (Wilding et al., 
2001). 
 
5.4.2. Effect of EGF supplementation on the maturation medium 
 
As we have extensively reported in this work, EGF intervene on several events related 
to the oocyte growth, maturation process and the resumption of meiosis (Gall et al., 
2005) as well as on embryonic development (Cai et al., 2003). EGF is associated to 
cumulus expansion (Downs, 1989; Tsafriri et al., 2005) and EGF-like ligands induce the 
activity of MAPK and stimulate the occurrence of GVBD in the immature follicles (Pang 
and Ge, 2002). Studies have reported that EGF promotes Ca2+ efﬂux in the CCs 
(O’Donnell et al., 2004) and stimulate the estrogen production by aromatase activation 
in the GC (Misajon et al., 1999; Behl and Pandey, 2001). In addition, EGF can inhibit LH 
receptor or inhibin secretion (Luciano et al., 1994; Hattori et al., 1995).  When EGF is 
supplemented in the maturation medium in vitro, it was described the stimulation of 
ovarian granulosa cell proliferation (May et al., 1987;1992; Morbeck et al., 1993), 
steroidogenesis (Hsueh et al., 1981; Misajon et al., 1999), and the improvementof 
nuclear maturation by inducing the resumption of meiosis in several species (bovine: 
Lorenzo et al., 1994; Lonergan et al., 1996; rats: Dekel and Sherizly 1985; Hsu et al., 
1987; mice: Downs 1989; Das et al., 1991; dog: Hatoya et al., 2009; rabbit: Lorenzo et 
al., 1996; pigs: Singh et al., 1997, Prochazka et al., 2000; goat: Cognié et al., 2002; Silva 
et al., 2004; sheep: Guler et al., 2000 and human: Westergaard and Andersen, 1989; 
Das et al., 1991). Also, cytoplasmic maturation of mouse (Das et al., 1991), bovine 
(Kobayashi et al., 1994), porcine (Ding and Foxcroft, 1994) and human (Goud et al., 
1998) oocytes is enhanced with EGF addition in the IVM medium.  
 
Our results of IVM showed that supplementation with 50 ng/mL of EGF enhances M-II 
rate and cytoplasmic maturation, both in terms of cortical granules migration and 
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mitochondrial redistribution in guinea pig oocytes; besides the quality of CCs seemed to 
be enhanced, since lower apoptotic rate and higher E2 and P4 secretion by COCs were 
found. Lower (10 ng/mL) and higher (100 ng/mL) concentrations showed intermediate 
values in cortical granules and mitochondria migration rates, in CCs apoptosis and 
steroidogenesis production but nuclear maturation was not improved in neither of them. 
These results agree with those of previous authors reporting that EGF at 50 ng/mL 
concentration promotes nuclear and cytoplasmic maturation (Farin et al., 2007), 
improves oocyte developmental competence and mitochondrial activity (Richani et al., 
2014), stimulates granulosa cell proliferation (May et al., 1987) and steroidogenesis 
(Hsueh et al., 1981), acting as a mitogen and apoptotic survival factor during early 
embryo development (Byrne et al., 1999). 
 
5.4.3. Effect of IGF-1 supplementation on the maturation medium 
 
In the ovary, IGF-1 is involved in the ovarian function (Adashi et al., 1985; Adashi and 
Rohan, 1992) because it stimulates the granulosa cells proliferation and E2 secretion 
(Gutierrez et al., 2000; Zhao et al., 2001; McCaffery et al., 2000) and also it has been 
reported as anti-apoptotic factor during oocyte maturation in human (Van Blerkom and 
Davis, 1998), porcine (Guthrie et al., 1998) and bovine oocytes (Wasielak and Bogacki, 
2007).These studies confirm that IGF-1 is an important factor in the maturation medium. 
Indeed, when IGF-1 is added into the maturation medium, studies have demonstrated 
substantial improvements in nuclear (Lorenzo et al., 1994, 1996) and cytoplasmic 
maturation, in terms of cortical granules migration rates (Wang, 1997; Liu and Min, 2011). 
Ergin et al. 2008 showed that IGF-1 regulates rat luteal steroidogenesis by an increase 
in P4 and E2 production. However, other authors failed to detect any stimulatory effect of 
IGF-1 on murine (Downs, 1989; Demeestere et al., 2004) and sheep oocytes (Guler et 
al., 2000). In guinea pig, the addition of 100 ng/mL IGF-1 to the maturation medium 
significantly increases rates of M-II and cortical granules migration in oocytes, produces 
higher amounts of E2 and P4 released by COCs and lower index of apoptosis in CCs. 
These findings match with that described in other species, as it is reported to enhance 
the proportion of oocytes that reach M-II of oocytes in bovine (Lorenzo et al., 1994; 
Herrler et al., 1992), horse (Carneiro et al., 2001), cat (Yıldırım et al., 2014), human 
(Gómez et al., 1993), pig (Xia et al., 1994) and rabbit (Lorenzo et al., 1996); and the 
cytoplasmic maturation of oocytes (Liu et al., 2003) also in terms of cortical granules 
migration in horse (Carneiro et al., 2001), calf (Damiani et al., 1995) and pig (Wang et 
al., 1997).However, in the present study no differences were found in mitochondria 
patterns with the different concentrations of IGF-1 tested in IVM, but the percentages are 
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high. No previous works in the literature were found about the effect of IGF-1 on 
mitochondrial distribution in any specie. Further studies are needed to deduce 
intracellular mechanisms that link the effect of IGF-1 and mitochondrial function in this 
specie. Maybe, it was necessary the addition of gonadotrophins to the IVM medium to 
accomplish the complete cytoplasmic maturation since IGF-1R expression is associated 
with increase in FSH and LH receptors presence, which amplificate FSH effect (Baker et 
al., 1996). For the rest of IGF concentrations, we did not find nuclear maturation 
enhancement whereas migrated cortical granules increased when medium is 
supplemented with 200 ng/mL but apoptotic index is also increased with this 
concentration, reaching better results with 50 ng/mL. In any case, steroidogenic 
secretion is lower than when we use 100 ng/mL. 
 
5.4.4. Effect of EGF and IGF-1 supplementation on the maturation medium 
 
As we expected, the addition of both growth factors together with FCS improved nuclear 
maturation, cortical granules migration rate and steroid-level secretion of COCs and 
reduced apoptotic index compared to COCs in vitro- matured without growth factors. The 
stimulatory effects of EGF and IGF-1 on aromatase activity of CCs had also been 
described in other species (Lorenzo et al., 1997). The interaction between growth factors 
and CCs can modify steroid production, which indirectly affects oocyte maturation and 
proliferation of CCs (Gutierrez et al., 1997). Also, it has been demonstrated that IGF and 
EGF interaction can promote the oocyte maturation and activation of MAPK pathway 
(Yoshimura et al., 1996; Pozios et al., 2001; Adams et al., 2004; Laviola et al., 2007; 
Paul et al., 2009; Su et al., 2010; Nelson and Van Der Kraak, 2010; Yao et al., 2014). 
The concentrations at which both growth factors improve nuclear oocyte maturation in 
guinea pig oocytes are similar to that found in other species (rabbit: Lorenzo et al., 1996; 
cattle: Lorenzo et al., 1994; Sakaguchi et al., 2000; buffalo: Kumar and Purohit, 2004; 
Jainudeen et al., 1993; Totey et al., 1992; pig: Isobe and Terada, 2001).Surprisingly, 
both growth factors together without FCS did not exert a synergic effect on oocyte 
maturation compared when they were added alone as has been demonstrated in rabbit 
(Lorenzo et al., 1997). Moreover, no significant improvements were found in 
mitochondria patterns as well as occurred with only IGF-1 supplementation, but the 
percentages achieved were quite similar. The cellular and molecular mechanisms by 
which IGF-1 alone or together with EGF influences on mitochondrial migration are 
unknown for any specie but combination of EGF and IGF-1 under in vitro conditions 
probably stimulate a cascade of events, including protein synthesis which eventually 
generate positive signals for resumption of meiosis in oocytes (Purohit et al., 2005; Gehm 
Discussion 
138 
 
et al., 2000; Sakaguchi et al., 2000), as has demonstrated in the present work. The 
apoptotic rate of COCs in the group IVM with both growth factors together with FCS was 
lower compared to the rate obtained in COCs cultured with 50 ng/mL EGF or 100 ng/mL 
IGF-1 but no significant differences were found. IGF-1 E2 released by COCs in the 
maturation medium supplemented with 100 ng/mL IGF-1 were similar to the combined 
medium with FCS whereas P4 showed intermediate values. IGF-1 increased E2 
production by bovine granulosa cells cultured under serum-free conditions irrespective 
of the size of follicle (Gong et al., 1994). IGF-1 and EGF stimulate cell number and E2 
production, even in the absence of FSH, demonstrating the gonadotropic action of these 
growth factors (Adashi and Rohan, 1992). Other studies also demonstrated that P4 
secretion by CCs may be modulated by E2 because the cells are able to secrete P4 when 
maturation is performed in the presence of low concentrations of E2 (Jamnongjit et al., 
2005). 
 
The majority of IVM protocols are based on serum-enriched culture media (Otoi et al., 
1999; Luvoni et al., 2005) since FCS is considered crucial for animal oocyte maturation. 
However, the exact beneficial effects of serum are unknown and in most cases 
unpredictable (Bolamba et al., 2002; Lee et al., 2007) due to the adverse long term 
effects of FCS during ARTs protocols on the health and behavior of the progeny 
(Fernández- Gonzalez et al., 2004). Therefore, establishment of serum free and 
chemically defined media are preferred for future IVM protocols used in ARTs in both 
animals and humans. In our experimental conditions and based in our results, a defined 
IVM medium supplemented only with 50 ng/mL EGF or 100ng/mL IGF-1 successfully 
support nuclear and cytoplasmic maturation, and improves COCs quality because it 
stimulates steroidogenic capacity and reduces the apoptotic rate. The addition of both 
growth factors in the combined medium with or without FCS did not substantially improve 
the oocyte maturation parameters measured, except for the apoptotic percentage found 
that was lower when FCS was added. FCS can be contained gonadotropins that may be 
acting as a survival factors in the CCs as has been previously mentioned. However, to 
check this possibility is preferred to include FSH and/or LH in the IVM medium instead 
of FCS. In any case, the medium proposed in this Thesis reached good results of nuclear 
and cytoplasmic maturation, avoiding FCS addition to elude possible negative long- term 
effects in the fetal development and health of progeny. However, further studies are 
needed to assess the long term consequences of these media.  
 
In summary, in this Thesis it has been characterized the EGF and IGF-1 system included 
IGFBPs in the ovary of the guinea pig, oocytes and their corresponding CCs and in early 
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embryos for the first time. The data indicate that both systems are play a key regulatory 
role in follicular development, oocyte maturation, luteogenesis and corpus luteum 
function, and early embryogenesis by autocrine and paracrine pathway. mRNA 
transcripts and protein inmunolocalization of EGF and IGF-1, EGF-R, IGF-1R and 
IGFBPs 1-6 are differentially expressed and widely distributed in the ovary, oocytes and 
embryos. Although this does not necessarily involve that transcripts are translated in 
protein or that the receptors are functionally involved in signal transduction, the presence 
of transcripts and the proteins implies a physiological role in ovarian function in guinea 
pig, especially in antral follicles, early corpus luteum, cumulus-oocyte complexes and 
early embryo development. Therefore, EGF and IGF-1R could be exerting a pivotal role 
on the acquisition of oocyte developmental competence and function of early corpus 
luteum, and indeed, in oocyte maturation and early embryo development. Part of this 
hypothesis is confirmed with the in vitro maturation experiment. This Thesis present the 
first study that describe in detail the cortical granules and mitochondrial patterns as a 
indicators of cytoplasmic maturation in guinea pig as well as the effect of EGF and IGF-
1 on the oocyte in vitro maturation. Our results suggest that both EGF and IGF-1 
improves nuclear and cytoplasmic maturation, increases steroidogenic response and 
reduces apoptotic rate in CCs, improving the guinea pig COCs quality in vitro. In our 
experimental conditions, a defined IVM medium with 50 ng/mL of EGF or 100 ng/mL of 
IGF-1 and without FCS is a suitable IVM medium for guinea pig. These findings may 
serve as a base to future investigations of the mechanisms and agents involved in the 
generation of physiological signals regulating oocyte maturation for the improvement of 
IVM systems in the guinea pig animal model useful for ARTs.  
 
 
 
  
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6. CONCLUSIONS 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusions 
  
145 
 
 
 
1. The mRNA transcripts of EGF and IGF-1, their receptors and the IGFBPs genes in 
antral and preovulatory follicles, in corpus luteum and in cumulus-oocyte complexes 
implies that both systems are directly involved in the acquisition of oocyte developmental 
competence during oocyte maturation and in the luteal function; and therefore indirectly 
involved in the early embryo development in the guinea pig. 
 
2. The differential immunolocalization of EGF and IGF-1 receptors and the IGFBPs in all 
stages of follicular development and early embryos demonstrates the responsiveness of 
such structures to both growth factors throughout their receptor and the influence of 
these systems on follicular development, oogenesis and early embryo development in 
the guinea pig model. Both growth factors acting in a paracrine and autocrine manner 
having IGFBPs 1-6 an important regulatory role on IGF-1 function.  
 
3. Cortical granules and mitochondrial distribution patterns are defined by the first time 
in guinea pig. Oocytes are considered cytoplasmically matured when they show cortical 
granules adjacent to the plasma membrane and when the mitochondria are relocated to 
the nuclear pole. In contrast, those oocytes that show cortical granules and mitochondria 
homogeneously distributed throughout the cytoplasm are considered non- 
cytoplasmically matured. The cytoplasmic patterns characterized contribute to improve 
the knowledge of oocyte maturation in the guinea pig model.  
 
4. In our experimental conditions, a defined IVM medium supplemented with 50 ng/mL 
EGF appears to be the best option to use in the IVM medium in the guinea pig since 
successfully supports nuclear and cytoplasmic maturation, and improves COCs quality 
because it stimulates steroidogenic capacity and reduces the apoptotic rate. However, 
we cannot discard the supplementation with 100 ng/ mL IGF-1 as a suitable option, since 
the percentage of oocytes with mitochondrias migrated is quite well. The addition of both 
growth factors with FCS does not substantially improve the oocyte maturation 
parameters. 
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1. La presencia de transcritos y la inmunolocalización de las proteínas del EGF, IGF-1, 
sus receptores y las IGFBPs, en los folículos antrales y preovulatorios, en el cuerpo 
lúteo y en los complejos cúmulo oocito implica que ambos sistemas pueden estar 
directamente involucrados en la adquisición de la competencia del oocito durante la 
maduración, y en la función luteal, y por lo tanto, indirectamente relacionados con el 
desarrollo embrionario temprano en la cobaya. 
 
2. La inmunolocalización de los receptores del EGF, del IGF-1 y de las IGFBPs en todas 
las etapas del desarrollo folicular y en los embriones tempranos de cobaya demuestra 
el posible papel regulador de estos factores de crecimiento sobre todos los estadios del 
desarrollo folicular, la oogenesis y sobre el desarrollo temprano del embrión de manera 
directa y a través de sus receptores. Ambos factores de crecimiento actuarían mediante 
un mecanismo paracrino y autocrino teniendo las IGFBPs 1-6 un papel regulador 
importante en la función del IGF-1. 
 
3. Los patrones de distribución de los gránulos corticales y las mitocondrias se definen 
por primera vez en la cobaya. Los oocitos se consideran citoplásmicamente maduros 
cuando muestran gránulos corticales adyacentes a la membrana plasmática y cuando 
las mitocondrias son redistribuidas al polo nuclear. Por el contrario, los oocitos que 
muestran gránulos corticales y mitocondrias homogéneamente distribuidos en el 
citoplasma se consideran inmaduros citoplasmáticamente. Por lo tanto, los patrones 
citoplasmáticos caracterizados contribuyen a mejorar el conocimiento sobre los 
procesos que acontecen durante la maduración de oocitos en la cobaya. 
 
4. En nuestras condiciones experimentales, el medio de maduración in vitro 
suplementado con 50 ng/mL de EGF parece ser la mejor opción para estimular la 
maduración de los oocitos de cobaya in vitro, ya que proporciona los mejores resultados 
de maduración nuclear y citoplasmática y mejora la calidad de los COCs ya que estimula 
la capacidad esteroidogénica y reduce la tasa de apoptosis en las células del cúmulo. 
Sin embargo, no podemos descartar la suplementación con 100 ng/mL de IGF-1 como 
una opción también adecuada, ya que el porcentaje de oocitos con mitocondrias 
migradas es satisfactorio. La adición de ambos factores de crecimiento con suero fetal 
no mejora sustancialmente los parámetros de maduración de los oocitos. Por lo tanto, 
el medio propuesto podría ser válido como una herramienta para mejorar las técnicas 
de reproducción asistida in the cobaya. 
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